Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 106
Encontrada(s) 2 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Assessing the relative role of climate on litterfall in Mediterranean cork oak forests

  • Andivia Muñoz, Enrique
  • Bou, Jordi
  • Fernández, Manuel
  • Caritat, Antonia
  • Alejano, Reyes
  • Vilar, Lluís
  • Vázquez Piqué, Javier
Litterfall plays a key role in the dynamic of forest ecosystems, ultimately determining forest productivity and carbon and nutrient cycling. Increasing our understanding on the role of structural and environmental factors controlling litterfall amount and seasonality is of paramount importance for modelling and estimating soil carbon sequestration and nutrient cycling under climate change scenarios. However, the effect of climatic conditions on litterfall has been scarcely studied, especially in Mediterranean ecosystems. Here, we used nine years of seasonally collected litterfall data in two contrasting Mediterranean cork oak forests to evaluate the effect of climatic variables on leaf fall and litterfall. First, we isolated the litterfall seasonal trend and the between-sites differences in production by using linear mixed models. Then, we evaluated the effect of climatic variables and whether this effect was site-specific. We found a consistent litterfall seasonal pattern, mainly determined by leaf shedding (70% of litterfall). Leaf fall mainly occurs in spring with a second but much smaller peak in autumn some years. Mean temperature, precipitation and mean wind speed strongly influenced litterfall, but this effect was site-specific. In the forest site located at higher latitude and altitude, leaf fall increased linearly with temperature and showed a positive quadratic response to precipitation. In the water-limited site, leaf fall was reduced as temperature increased and did not respond to precipitation. These results have implications for modelling and predicting soil carbon sequestration, nutrient cycling, and the forest ecosystem productivity. Specifically, carbon and nutrient cycling models can be improved by incorporating idiosyncratic forest sites responses to climatic variability.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Bosch, Rosa|||0000-0002-7596-183X
  • Soler Artigas, María|||0000-0002-3213-1107
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Llonga, Natalia|||0000-0003-4325-6201
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Carabí-Gassol, Pau
  • Arribas, Lorena|||0000-0002-9683-9999
  • Macias-Chimborazo, Valeria
  • Español-Martín, Gemma|||0000-0002-2362-8189
  • del Castillo, Clara
  • Martínez, Laura
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Pagespetit, Èlia
  • Prat, Raquel|||0000-0001-8097-6617
  • Puigbó, Julia
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Reproductive Toxicity of Nanomaterials Using Silver Nanoparticles and Drosophila as Models

  • Alaraby, Mohamed|||0000-0001-7488-3318
  • Abass, Doaa|||0009-0003-2520-5790
  • Gutiérrez-García, Javier|||0009-0007-7376-8933
  • Velázquez Henar, Antonia|||0000-0003-3254-4312
  • Hernández, Alba|||0000-0001-6938-1233
  • Marcos, Ricard|||0000-0001-7891-357X
Reproductive toxicity is of special concern among the harmful effects induced by environmental pollutants; consequently, further studies on such a topic are required. To avoid the use of mammalians, lower eukaryotes like Drosophila are viable alternatives. This study addresses the gap in understanding the link between reproductive adverse outcomes and the presence of pollutants in reproductive organs by using Drosophila. Silver nanoparticles (AgNPs) were selected for their ease of internalization, detection, and widespread environmental presence. Both male and female flies were exposed to AgNPs (28 ± 4 nm, 100 and 400 µg/mL) for one week. Internalization and bioaccumulation of AgNPs in organs were assessed using transmission electron microscopy, confocal microscopy, and inductively coupled plasma mass spectrometry. Substantial accumulation of AgNPs in the gastrointestinal tract, Malpighian tubules, hemolymph, reproductive organs (ovaries and testes), and gametes were observed. The highest AgNP content was observed in testes. Exposure to AgNPs reduced ovary size and fecundity, though fertility and gender ratios of the offspring were unaffected. Significant deregulation of reproductive-related genes was observed, particularly in males. These findings underscore the utility of Drosophila as a model for evaluating reproductive hazards posed by AgNP exposure. The ease of AgNP internalization in Drosophila reproductive targets could be extrapolated to mammalians, raising concerns about the potential impacts of nanoparticle exposure on reproduction toxicity in humans.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Quantification of rare somatic single nucleotide variants by droplet digital PCR using SuperSelective primers

  • Pablo-Fontecha, Verónica|||0000-0001-9084-4597
  • Hernández-Illán, Eva
  • Reparaz, Andrea
  • Asensio, Elena
  • Morata, Jordi|||0000-0002-6146-4322
  • Tonda, Raúl
  • Lahoz, Sara|||0000-0002-4491-9911
  • Parra, Carolina
  • Lozano, Juan José
  • García-Heredia, Anabel
  • Martínez-Roca, Alejandro
  • Beltran i Agulló, Sergi|||0000-0002-2810-3445
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Jover, Rodrigo
  • Castells, Antoni|||0000-0001-8431-2033
  • Trullàs, Ramon
  • Podlesniy, Petar
  • Camps, Jordi|||0000-0003-2929-4228
Somatic single-nucleotide variants (SNVs) occur every time a cell divides, appearing even in healthy tissues at low frequencies. These mutations may accumulate as neutral variants during aging, or eventually, promote the development of neoplasia. Here, we present the SP-ddPCR, a droplet digital PCR (ddPCR) based approach that utilizes customized SuperSelective primers aiming at quantifying the proportion of rare SNVs. For that purpose, we selected five potentially pathogenic variants identified by whole-exome sequencing (WES) occurring at low variant allele frequency (VAF) in at-risk colon healthy mucosa of patients diagnosed with colorectal cancer or advanced adenoma. Additionally, two APC SNVs detected in two cancer lesions were added to the study for WES-VAF validation. SuperSelective primers were designed to quantify SNVs at low VAFs both in silico and in clinical samples. In addition to the two APC SNVs in colonic lesions, SP-ddPCR confirmed the presence of three out of five selected SNVs in the normal colonic mucosa with allelic frequencies ≤ 5%. Moreover, SP-ddPCR showed the presence of two potentially pathogenic variants in the distal normal mucosa of patients with colorectal carcinoma. In summary, SP-ddPCR offers a rapid and feasible methodology to validate next-generation sequencing data and accurately quantify rare SNVs, thus providing a potential tool for diagnosis and stratification of at-risk patients based on their mutational profiling.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Occurrence, analysis, and toxicity of polyethylene terephthalate microplastics, a review

  • Alaraby, Mohamed|||0000-0001-7488-3318
  • Abass, Doaa|||0009-0003-2520-5790
  • Velázquez Henar, Antonia|||0000-0003-3254-4312
  • Hernández, Alba|||0000-0001-6938-1233
  • Marcos, Ricard|||0000-0001-7891-357X
Global microplastic contamination of almost all biological and environmental media is an emerging threat to human health that recently fostered intense research. Here, we review polyethylene terephthalate with focus on microplastics, characteristics, uses, concentration, degradation, toxicity, and remediation. Plastic remediation can be done by landfills, incineration, pyrolysis, and biodegradation. We present microplastic occurrence in food, beverages, dust, wildlife, and human tissues. We observed inconsistencies in measurement techniques, limitations in detection reliability, and gaps in risk assessment.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex-specific chrono-nutritional patterns and association with body weight in a general population in Spain (GCAT study)

  • Pons-Muzzo, Luciana
  • de Cid, Rafael|||0000-0003-3579-6777
  • Obón-Santacana, Mireia|||0000-0003-4646-3513
  • Straif, Kurt
  • Papantoniou, Kyriaki|||0000-0002-0340-9659
  • Santonja, Isabel|||0000-0002-6736-7988
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Palomar-Cros, Anna|||0000-0001-8151-9290
  • Lassale, Camille|||0000-0002-9340-2708
Background: Altered meal timing patterns can disrupt the circadian system and affect metabolism. Our aim was to describe sex-specific chrono-nutritional patterns, assess their association with body mass index (BMI) and investigate the role of sleep in this relationship. Methods: We used the 2018 questionnaire data from the population-based Genomes for Life (GCAT) (n = 7074) cohort of adults aged 40-65 in Catalonia, Spain, for cross-sectional analysis and its follow-up questionnaire data in 2023 (n = 3128) for longitudinal analysis. We conducted multivariate linear regressions to explore the association between mutually adjusted meal-timing variables (time of first meal, number of eating occasions, nighttime fasting duration) and BMI, accounting for sleep duration and quality, and additional relevant confounders including adherence to a Mediterranean diet. Finally, cluster analysis was performed to identify chrono-nutritional patterns, separately for men and women, and sociodemographic and lifestyle characteristics were compared across clusters and analyzed for associations with BMI. Results: In the cross-sectional analysis, a later time of first meal (β 1 h increase = 0.32, 95% CI 0.18, 0.47) and more eating occasions (only in women, β 1 more eating occasion = 0.25, 95% CI 0.00, 0.51) were associated with a higher BMI, while longer nighttime fasting duration with a lower BMI (β 1 h increase=-0.27, 95% CI -0.41, -0.13). These associations were particularly evident in premenopausal women. Longitudinal analyses corroborated the associations with time of first meal and nighttime fasting duration, particularly in men. Finally, we obtained 3 sex-specific clusters, that mostly differed in number of eating occasions and time of first meal. Clusters defined by a late first meal displayed lower education and higher unemployment in men, as well as higher BMI for both sexes. A clear "breakfast skipping" pattern was identified only in the smallest cluster in men. Conclusions: In a population-based cohort of adults in Catalonia, we found that a later time of first meal was associated with higher BMI, while longer nighttime fasting duration associated with a lower BMI, both in cross-sectional and longitudinal analyses.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Decoding depression by exploring the exposome-genome edge amidst COVID-19 lockdown

  • Farré Ramon, Xavier|||0000-0001-6838-9479
  • Blay, Natalia|||0000-0002-7160-8529
  • Espinosa, Ana|||0000-0001-7399-3267
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Carreras Nolla, Anna|||0000-0002-8789-067X
  • Garcia-Aymerich, Judith|||0000-0002-7097-4586
  • Cardis, Elisabeth|||0000-0003-0999-6839
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Goldberg, Ximena|||0000-0001-9681-5826
  • de Cid, Rafael|||0000-0003-3579-6777
Risk of depression increased in the general population after the COVID-19 pandemic outbreak. By examining the interplay between genetics and individual environmental exposures during the COVID-19 lockdown, we have been able to gain an insight as to why some individuals are more vulnerable to depression, while others are more resilient. This study, conducted on a Spanish cohort of 9218 individuals (COVICAT), includes a comprehensive non-genetic risk analysis, the exposome, complemented by a genomics analysis in a subset of 2442 participants. Depression levels were evaluated using the Hospital Anxiety and Depression Scale. Together with Polygenic Risk Scores (PRS), we introduced a novel score; Poly-Environmental Risk Scores (PERS) for non-genetic risks to estimate the effect of each cumulative score and gene-environment interaction. We found significant positive associations for PERS (Social and Household), PERS (Lifestyle and Behaviour), and PERS (Wider Environment and Health) scores across all levels of depression severity, and for PRS (Broad depression) only for moderate depression (OR 1.2, 95% CI 1.03-1.40). On average OR increased 1.2-fold for PERS and 1.6-fold for PER and PER from mild to severe depression level. The complete adjusted model explained 16.9% of the variance. We further observed an interaction between PERS and PRS showing a potential mitigating effect. In summary, stressors within the social and behavioral domains emerged as the primary drivers of depression risk in this population, unveiling a mitigating interaction effect that should be interpreted with caution.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

New insights into the reproductive hazards posed by polystyrene nanoplastics

  • Alaraby, Mohamed|||0000-0001-7488-3318
  • Abass, Doaa|||0009-0003-2520-5790
  • Velázquez Henar, Antonia|||0000-0003-3254-4312
  • Hernández, Alba|||0000-0001-6938-1233
  • Marcos, Ricard|||0000-0001-7891-357X
Reproductive toxicity from micro/nanoplastics (MNPLs) is an emerging concern requiring further investigation to close existing knowledge gaps. This study explores the reproductive toxicity of polystyrene nanoplastics (PSNPLs) using Drosophila as an in vivo model. Males and females were exposed to PSNPLs (100 and 500 µg/mL) for one/two weeks. Confocal and transmission electron microscopy revealed widespread distribution of PSNPLs across various tissues, including ovaries, testes, and gametes (ova and sperm). Structural damage, such as hole formation in the seminiferous tubules and ovarian atrophy, was observed following exposure. The physical presence of PSNPLs in reproductive organs disrupted reproductive outcomes, particularly in matings between exposed males and females. Key impairments included reduced fecundity, lower fertility, and a skewed sex ratio, especially after one week of exposure, with minimal effects after two weeks. Significant disruptions in the expression of reproductive and developmental genes were observed in both sexes, with males exhibiting greater sensitivity to PSNPLs, regardless of exposure concentration or duration. These findings provide critical insights into the reproductive toxicity of PSNPLs, underscoring both physical disruptions in reproductive tissues and molecular alterations. This highlights the potential for MNPLs to cause hidden reproductive damage and emphasizes the sex-dependent nature of these toxic effects.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Nanoplastic exposure affects the intestinal microbiota of adult Drosophila flies

  • Rocabert, Arnau|||0009-0002-0950-2157
  • Martín-Pérez, Joan|||0009-0006-9137-3604
  • Pareras, Laia|||0000-0002-1381-8894
  • Egea, Raquel|||0000-0002-6201-4112
  • Alaraby, Mohamed|||0000-0001-7488-3318
  • Cabrera Gumbau, Jordi Manuel|||0009-0007-3952-7589
  • Sarmiento Guardia, Iris
  • Martínez-Urtaza, Jaime|||0000-0001-6219-0418
  • Rubio, Laura|||0000-0002-2088-3803
  • Barguilla, Irene|||0000-0003-1081-4457
  • Marcos, Ricard|||0000-0001-7891-357X
  • García-Rodríguez, Alba|||0000-0002-1175-7418
  • Hernández, Alba|||0000-0001-6938-1233
Micro- and nanoplastics (MNPLs) are emerging environmental pollutants that have garnered significant attention over the past few decades due to their detrimental effects on human health through various exposure pathways. This study investigates the impact of MNPLs on gut microbiota, utilizing Drosophila melanogaster as a model organism. Drosophila was selected for its microbiota's similarities to humans and its established role as an accessible and well-characterized model system. To analyze microbiota, full-length 16S rRNA gene sequencing was performed using the Nanopore sequencing platform, enabling comprehensive profiling of the microbial populations present in the samples. As models of MNPLs, two commercial polystyrene nanoplastics (PS-NPLs, 61.20 and 415.22 nm) and one lab-made polylactic acid nanoplastic (PLA-NPLs, 463.90 nm) were selected. As a positive control, zinc oxide nanoparticles (ZnO-NPs) were used. The observed findings revealed that exposure to MNPLs induced notable alterations in gut microbiota, including a reduction in bacterial abundance and shifts in species composition. These results suggest that MNPLs exposure can lead to microbial dysbiosis and potential gut health disruptions through its interaction, either with the gut epithelial barrier or directly with the resident microorganisms.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Evaluating the implementation of PROMs and PREMs in routine clinical care, co-design of tools from the perspective of patients and healthcare professionals

  • Amat-Fernandez, Clara|||0000-0001-9595-0970
  • Pardo Cladellas, Yolanda|||0000-0003-4982-5495
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
  • Bosch, Guillermo
  • Lizano-Barrantes, Catalina|||0000-0003-1690-631X
  • Briseño Diaz, Renata
  • Vernet-Tomas, Maria|||0000-0002-5575-2475
  • Fumadó, Lluís|||0000-0003-3996-167X
  • Beisani, Marc|||0000-0002-3773-5209
  • Redondo-Pachón, Dolores|||0000-0002-0458-0052
  • Bach Pascual, Anna|||0000-0003-0571-6131
  • Garin, Olatz|||0000-0001-6193-0779
Implementation of patient-reported measures (PRMs) is an integral element for patient-centered models; however, there is still hardly any quantitative evidence regarding its impact in routine care settings. The objective of this study was to codesign two concise tools that allow for a standardized and longitudinal assessment of the implementation of PRMs in routine care in terms of acceptability and perceived value from the perspective of both patients and healthcare professionals. A list of constructs and items to be presented, separately, to patients and healthcare professionals was created from evidence gathered through a narrative literature review. Focus groups, composed of either patients or healthcare professionals from different chronic conditions, were conducted for the co-design of independent assessments. Once agreement was reached, the content validity was examined in separate consensus meetings. A total of 10 patients and 10 healthcare professionals participated in the focus groups. After 7 focus groups, the PRMs Implementation Assessment Tool for patients (PRMIAT-P) was developed with 33 items in 9 constructs, and the tool for healthcare professionals (PRMIAT-HP) had 33 items in 16 constructs. Content validity was confirmed for both tools. The perspective of patients and healthcare professionals regarding the implementation of PRMs in routine care can be evaluated quantitively with the PRMIAT tools. These tools are understandable, concise and comprehensive, and can be used in multiple settings and for different chronic conditions. They have been codesigned as a standard set to facilitate both longitudinal assessments and performing benchmarking among different initiatives.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Polytetrafluoroethylene microplastic properties, pollution, toxicity and analysis, a review

  • Alaraby, Mohamed|||0000-0001-7488-3318
  • Abass, Doaa|||0009-0003-2520-5790
  • Velázquez Henar, Antonia|||0000-0003-3254-4312
  • Hernández, Alba|||0000-0001-6938-1233
  • Marcos, Ricard|||0000-0001-7891-357X
Cooking with polytetrafluoroethylene-coated pans releases thousands to millions of microplastic and nanoplastic particles per use, directly contaminating food and the environment. Here we review polytetrafluoroethylene microplastics with emphasis on polytetrafluoroethylene characteristics, environmental occurrence, and detection methods. Polytetrafluoroethylene has high chemical stability and is used in medical devices, clothes and protective suits, aerospace, non-sticking pans, cables and insulation, filtration, irrigation and electronics. We discuss plastic utensils as microplastic sources, and the influence of temperature and aging on microplastic release. The presence of microplastics in humans, wild animals, sediments, water and the atmosphere is described. Limitations of actual analytical methods such as density separation are detailed. Polytetrafluoroethylene accounts for about 60% of the global fluoropolymer market, and is a major contributor to microplastic pollution, accounting for up to 44% of microplastics in sediments, 74% in benthic fish, and 60% in human organs. Our meta-analysis shows that polytetrafluoroethylene microplastic concentrations average 7.3 ± 13.3 particles per L in water, 3,685.7 ± 4,832.0 particles per kg in sediment, 24.9 ± 37.1 particles per individual in fish, and 482.5 ± 554.1 particles per kg in human tissues. Polytetrafluoroethylene microplastics may impair physiological homeostasis by inducing oxidative stress, inflammation, necrosis, and disruption of key cellular signaling pathways.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Polytetrafluoroethylene (PTFE, Teflon) microplastics and nanoplastics induce oxidative stress, mitochondrial damage, and genotoxicity in human intestinal cells

  • Abass, Doaa|||0009-0003-2520-5790
  • Alaraby, Mohamed|||0000-0001-7488-3318
  • Elkady, Elham Farghal
  • Morataya Reyes, Michelle|||0000-0001-9620-2069
  • Banaei, Gooya|||0000-0001-9136-8828
  • Martín-Pérez, Joan|||0009-0006-9137-3604
  • Rubio, Laura|||0000-0002-2088-3803
  • Barguilla, Irene|||0000-0003-1081-4457
  • Marcos, Ricard|||0000-0001-7891-357X
  • Hernández, Alba|||0000-0001-6938-1233
  • García-Rodríguez, Alba|||0000-0002-1175-7418
Polytetrafluoroethylene (PTFE, Teflon™), widely used in non-stick cookware, can degrade into micro- and nanoplastics (MNPLs). This raises concerns about human exposure, which remain largely unexplored. In the present study, we used physiologically relevant in vitro intestinal monoculture and co-culture models (Caco-2/HT29-MTX) to systematically assess the effects of PTFE-MNPLs (∼250 nm and ∼2 µm) at concentrations of 50-200 µg/mL over 24-48 h. PTFE-MNPLs, particularly nanosized particles, readily entered both differentiated and undifferentiated cells. They interacted with nuclear membranes and mitochondria, inducing structural and physiological disturbances without significantly affecting cell viability. These interactions led to mitochondrial damage and triggered inflammation, oxidative stress, and DNA damage. The severity of these effects increased with particle size, dose, and exposure duration. These findings challenge the assumption that PTFE particles are biologically inert, highlighting hazards arising from their physical interactions, especially at the nanoscale. Given the relevance of the co-culture in vitro model of intestinal barrier to human intestinal physiology, the results underscore potential intestinal health risks from PTFE-MNPL exposure. Future studies should focus on chronic, low-dose exposures to elucidate the specific cellular pathways activated by PTFE-MNPL exposure.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Associations between air pollution and surrounding greenness with internalizing and externalizing behaviors among schoolchildren

  • Zubizarreta-Arruti, Uxue
  • Bosch, Rosa|||0000-0002-7596-183X
  • Soler Artigas, María|||0000-0002-3213-1107
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Llonga, Natalia|||0000-0003-4325-6201
  • Carabí-Gassol, Pau
  • Macias-Chimborazo, Valeria
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Prat, Raquel|||0000-0001-8097-6617
  • Rivas, Cristina|||0000-0002-8074-9550
  • Pagespetit, Èlia
  • Puigbó, Júlia
  • Español-Martín, Gemma|||0000-0002-2362-8189
  • Raimbault, B.|||0000-0003-0226-0220
  • Valentín, Antònia|||0000-0002-9275-7101
  • Sunyer Deu, Jordi|||0000-0002-2602-4110
  • Foraster, Maria|||0000-0003-4450-4123
  • Gascon, Mireia|||0000-0003-4537-8472
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
Air pollution and greenness are emerging as modifiable risk and protective factors, respectively, in child psychopathology. However, research shows inconsistencies. Here, we examined associations between air pollution and surrounding greenness with internalizing and externalizing behaviors. In addition, the potential modifying role of the genetic susceptibility for these traits and socioeconomic status (SES) was explored. This population-based study included 4485 schoolchildren aged 5-18 years from Spain. Internalizing and externalizing behaviors were assessed using the Child Behavior Checklist (CBCL). Average air pollution (NO, PM, PM, PM, and PM absorbance) and surrounding greenness (NDVI within 100-m, 300-m, and 500-m buffers) school exposure were estimated for 12 months before outcome assessment. Genetic liability was assessed by computing polygenic risk scores (PRS) and SES was calculated using the Hollingshead Four-Factor Index. Associations were analyzed using negative binomial mixed-effects models. Although no associations survived multiple testing, we found that increases of 5.48 μg/m 3 in PM and 2.93 μg/m 3 in PM were associated with a 6% (Mean Ratio (MR) = 1.06; 95% CI: 1.01-1.12) and a 4% (MR = 1.04; 95% CI: 1.00-1.09) increase in internalizing behavior scores. A 0.1 increase in NDVI within a 100-m buffer was associated with a 6% decrease in externalizing behavior (MR = 0.94; 95% CI: 0.89-0.99). Neither differences by sex or age, or moderation effects by PRS or SES, were observed. We found preliminary evidence of detrimental effects of air pollution on internalizing behavior and protective effects of greenness on externalizing behavior, which were not modified by sex, age, SES, or genetic liability. If confirmed, these results reinforce the need for improving air quality, especially around schools, as part of preventive strategies focused on childhood psychopathology.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder

  • Strom, Nora I.|||0000-0002-5261-8852
  • Gerring, Zachary F.|||0000-0002-2445-1266
  • Galimberti, Marco|||0000-0001-6052-156X
  • Yu, Dongmei|||0000-0001-7901-4365
  • Halvorsen, Matthew W.|||0000-0002-6707-2418
  • Abdellaoui, Abdel|||0000-0003-1088-6784
  • Rodriguez-Fontenla, Cristina|||0000-0002-9829-6393
  • Sealock, Julia M.|||0000-0002-9346-3498
  • Bigdeli, Tim
  • Coleman, Jonathan R. I.|||0000-0002-6759-0944
  • Mahjani, Behrang|||0000-0001-6087-9537
  • Thorp, Jackson G.|||0000-0002-9461-6417
  • Bey, Katharina|||0000-0001-6392-4997
  • Burton, Christie L.|||0000-0002-8955-6528
  • Luykx, Jurjen J.|||0000-0002-6439-2774
  • Zai, Gwyneth|||0000-0002-0894-6867
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Andre, Christine
  • Askland, Kathleen D.|||0000-0003-1467-8923
  • Bäckman, Julia
  • Banaj, Nerisa|||0000-0002-6317-8549
  • Barlassina, Cristina|||0000-0001-7407-2697
  • Nissen, Judith Becker|||0000-0003-4063-6866
  • Bienvenu, O. Joseph|||0000-0002-8466-102X
  • Black, Donald|||0000-0001-8038-1971
  • Bloch, Michael H.|||0000-0003-0352-4080
  • Børte, Sigrid|||0000-0001-9540-3256
  • Bosch, Rosa|||0000-0002-7596-183X
  • Breen, Michael
  • Brennan, Brian P.|||0000-0001-5468-6552
  • Brentani, Helena|||0000-0001-5192-4682
  • Buxbaum, Joseph D.|||0000-0001-8898-8313
  • Bybjerg-Grauholm, Jonas|||0000-0003-1705-4008
  • Byrne, Enda M.|||0000-0002-9491-7797
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Camarena, Beatriz
  • Camarena, Adrian|||0000-0001-8512-0607
  • Cappi, Carolina|||0000-0001-6661-3756
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Cavallini, Maria Cristina|||0000-0001-5913-1468
  • Ciullo, Valentina|||0000-0002-4095-7806
  • Cook, Edwin H.|||0000-0002-5848-5114
  • Crosby, Jesse
  • Cullen, Bernadette A.|||0000-0003-1762-092X
  • De Schipper, Elles J.|||0000-0001-9494-451X
  • Delorme, Richard|||0000-0002-5614-3663
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Elias, Jason A.
  • Estivill, Xavier|||0000-0002-0723-2256
  • Falkenstein, Martha J.|||0000-0001-5074-3409
  • Fundin, Bengt T.|||0000-0002-6037-7331
  • Garner, Lauryn
  • Gironda, Christina
  • Goes, Fernando S.|||0000-0001-6262-8264
  • Grados, Marco A.|||0000-0002-0178-1764
  • Grove, Jakob|||0000-0003-2284-5744
  • Guo, Wei|||0000-0002-4322-3699
  • Haavik, Jan|||0000-0001-7865-2808
  • Hagen, Kristen|||0000-0002-4286-1277
  • Harrington, Kelly|||0000-0001-9668-183X
  • Havdahl, Alexandra|||0000-0002-9268-0423
  • Höffler, Kira D.|||0000-0002-0837-1469
  • Hounie, Ana G.|||0000-0002-5026-2880
  • Hucks, Donald|||0000-0002-2700-5798
  • Hultman, Christina|||0000-0002-0327-2410
  • Janecka, Magdalena|||0000-0001-7406-0776
  • Jenike, Eric
  • Karlsson, Elinor K.|||0000-0002-4343-3776
  • Kelley, Kara
  • Klawohn, Julia|||0000-0002-9436-6948
  • Krasnow, Janice E.|||0000-0003-0316-6279
  • Krebs, Kristi|||0000-0003-0494-2751
  • Lange, Christoph|||0000-0002-9691-4741
  • Lanzagorta, Nuria|||0000-0001-6769-6813
  • Levey, Daniel|||0000-0001-8431-9569
  • Lindblad-Toh, Kerstin|||0000-0001-8338-0253
  • Macciardi, Fabio|||0000-0003-0537-4266
  • Maher, Brion|||0000-0001-9809-0064
  • Mathes, Brittany
  • McArthur, Evonne|||0000-0003-4566-4321
  • McGregor, Nathaniel|||0000-0001-7195-4993
  • McLaughlin, Nicole C.|||0000-0002-4016-2747
  • Meier, Sandra|||0000-0002-3287-5894
  • Miguel, Euripedes C.|||0000-0002-9393-3103
  • Mulhern, Maureen|||0000-0001-8642-4741
  • Nestadt, Paul S.
  • Nurmi, Erika L.|||0000-0003-4893-8957
  • O'Connell, Kevin S.|||0000-0002-6865-8795
  • Osiecki, Lisa|||0000-0002-9408-8722
  • Ousdal, Olga Therese|||0000-0002-0728-3141
  • Palviainen, Teemu|||0000-0002-7847-8384
  • Pedersen, Nancy L.|||0000-0001-8057-3543
  • Piras, Fabrizio|||0000-0003-3566-5494
  • Piras, Federica|||0000-0002-9546-7038
  • Potluri, Sriramya|||0000-0003-3877-0038
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Rauch, Scott|||0000-0001-7699-6754
  • Reichenberg, Abraham|||0000-0003-2729-8575
  • Riddle, Mark A.|||0000-0001-8764-2134
  • Ripke, Stephan|||0000-0003-3622-835X
  • Rosário, Maria C.|||0000-0002-8577-3306
  • Sampaio, Aline S.|||0000-0001-5568-6167
  • Schiele, Miriam A.|||0000-0003-2613-6515
  • Skogholt, Anne Heidi|||0000-0001-7466-0405
  • Sloofman, Laura G Sloofman G.|||0000-0001-7628-4378
  • Smit, Jan
  • Soler Artigas, María|||0000-0002-3213-1107
  • Thomas, Laurent|||0000-0003-0548-2486
  • Tifft, Eric|||0000-0002-7480-0276
  • Vallada, Homero|||0000-0001-5123-8295
  • van Kirk, Nathanial|||0000-0002-1975-4238
  • Veenstra-VanderWeele, Jeremy|||0000-0002-6349-1076
  • Vulink, Nienke N.|||0000-0001-8991-9627
  • Walker, Christopher P.|||0000-0002-6069-0184
  • Wang, Ying
  • Wendland, Jens|||0000-0001-5106-5013
  • Winsvold, Bendik Slagsvold|||0000-0003-4171-8919
  • Yao, Yin|||0000-0001-7487-4294
  • Zhou, Hang|||0000-0002-7694-6391
  • Agrawal, Arpana|||0000-0002-0313-793X
  • Alonso, Pino|||0000-0002-5779-9111
  • Berberich, Götz|||0000-0001-8300-9294
  • Bucholz, Kathleen K.|||0000-0003-3794-0736
  • Bulik, Cynthia M.|||0000-0001-7772-3264
  • Cath, Danielle|||0000-0001-9539-4118
  • Denys, Damiaan|||0000-0002-3191-3844
  • Eapen, Valsamma|||0000-0001-6296-8306
  • Edenberg, Howard J.|||0000-0003-0344-9690
  • Falkai, Peter|||0000-0003-2873-8667
  • Fernandez, Thomas V.|||0000-0003-0830-022X
  • Fyer, Abby J.|||0000-0002-0944-2505
  • Geller, Dan A.|||0000-0001-8692-4156
  • Grabe, Hans J.|||0000-0003-3684-4208
  • Greenberg, Benjamin D.|||0000-0002-5648-0002
  • Hanna, Gregory L.|||0000-0002-0742-6990
  • Hickie, Ian B.|||0000-0001-8832-9895
  • Hougaard, David M.|||0000-0001-5928-3517
  • Kathmann, Norbert|||0000-0002-1348-7060
  • Kennedy, James L.|||0000-0002-8733-3806
  • Lai, Dongbing|||0000-0001-7803-580X
  • Landén, Mikael|||0000-0002-4496-6451
  • Le Hellard, Stéphanie|||0000-0002-8085-051X
  • Leboyer, Marion|||0000-0001-5473-3697
  • Lochner, Christine|||0000-0002-4766-3704
  • McCracken, James T.|||0000-0003-0370-0777
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Mortensen, Preben Bo|||0000-0002-5230-9865
  • Neale, Benjamin M.|||0000-0003-1513-6077
  • Nicolini, Humberto|||0000-0003-2494-0067
  • Nordentoft, Merete|||0000-0003-4895-7023
  • Pato, Michele
  • Pato, Carlos|||0000-0002-5858-266X
  • Pauls, David L.|||0000-0002-8107-345X
  • Piacentini, John|||0000-0003-4195-7194
  • Pittenger, Christopher|||0000-0003-2117-9321
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Rasmussen, Steven A.|||0000-0002-8327-0692
  • Richter, Margaret A.|||0000-0001-5450-2936
  • Rosenberg, David R.|||0000-0002-0005-4151
  • Ruhrmann, Stephan|||0000-0002-6022-2364
  • Samuels, Jack F.|||0000-0002-6715-7905
  • Sandin, Sven|||0000-0001-6994-4884
  • Sandor, Paul|||0000-0003-2397-0758
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • Stein, Dan J.|||0000-0001-7218-7810
  • Stewart, S. Evelyn|||0000-0002-0994-6383
  • Storch, Eric A.|||0000-0002-7631-3703
  • Stranger, Barbara E.|||0000-0001-9021-7331
  • Turiel, Maurizio|||0000-0002-8793-2112
  • Werge, Thomas|||0000-0003-1829-0766
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Walitza, Susanne|||0000-0002-8161-8683
  • Hveem, Kristian|||0000-0001-8157-9744
  • Hansen, Bjarne K.|||0000-0001-5659-1119
  • Rück, Christian P.|||0000-0002-8742-0168
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Milani, Lili|||0000-0002-5323-3102
  • Mors, Ole|||0000-0002-5660-0393
  • Reichborn-Kjennerud, Ted|||0000-0003-4653-0034
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Kvale, Gerd|||0000-0001-5449-2344
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Domschke, Katharina|||0000-0002-2550-9132
  • Grünblatt, Edna|||0000-0001-8505-7265
  • Wagner, Michael
  • Zwart, John-Anker|||0000-0001-5721-0154
  • Breen, Gerome|||0000-0003-2053-1792
  • Nestadt, Gerald|||0000-0001-9461-5249
  • Kaprio, Jaakko|||0000-0002-3716-2455
  • Arnold, Paul D.|||0000-0003-2496-4624
  • Grice, Dorothy E.|||0000-0002-8833-2549
  • Knowles, James A.|||0000-0002-3307-5741
  • Ask, Helga|||0000-0003-0149-5319
  • Verweij, Karin|||0000-0001-9868-7821
  • Davis, Lea K.|||0000-0001-5143-2282
  • Smit, Dirk J.|||0000-0001-8301-8860
  • Crowley, James J.|||0000-0001-9051-1557
  • Scharf, Jeremiah M.|||0000-0002-4742-5896
  • Stein, Murray B.|||0000-0001-9564-2871
  • Gelernter, Joel|||0000-0002-4067-1859
  • Mathews, Carol A.|||0000-0003-2208-7058
  • Derks, Eske M.|||0000-0002-6292-6883
  • Mattheisen, Manuel|||0000-0002-8442-493X
Obsessive-compulsive disorder (OCD) affects ~1% of children and adults and is partly caused by genetic factors. We conducted a genome-wide association study (GWAS) meta-analysis combining 53,660 OCD cases and 2,044,417 controls and identified 30 independent genome-wide significant loci. Gene-based approaches identified 249 potential effector genes for OCD, with 25 of these classified as the most likely causal candidates, including WDR6, DALRD3 and CTNND1 and multiple genes in the major histocompatibility complex (MHC) region. We estimated that ~11,500 genetic variants explained 90% of OCD genetic heritability. OCD genetic risk was associated with excitatory neurons in the hippocampus and the cortex, along with D and D type dopamine receptor-containing medium spiny neurons. OCD genetic risk was shared with 65 of 112 additional phenotypes, including all the psychiatric disorders we examined. In particular, OCD shared genetic risk with anxiety, depression, anorexia nervosa and Tourette syndrome and was negatively associated with inflammatory bowel diseases, educational attainment and body mass index.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Real-life nanoplastics induce endothelial dysfunction in primary human endothelial cells

  • Martín-Pérez, Joan|||0009-0006-9137-3604
  • Morataya Reyes, Michelle|||0000-0001-9620-2069
  • Villacorta, Aliro|||0000-0003-2737-4232
  • Anguita Solé, Claudia|||0009-0004-1644-2206
  • Ferrer-Crespo, Juan Francisco|||0000-0002-7705-3579
  • Barguilla, Irene|||0000-0003-1081-4457
  • Alaraby, Mohamed|||0000-0001-7488-3318
  • Marcos, Ricard|||0000-0001-7891-357X
  • Hernández, Alba|||0000-0001-6938-1233
  • García-Rodríguez, Alba|||0000-0002-1175-7418
Understanding how nanoplastics (NPLs) exposure affects vascular endothelium is essential for determining their potential cardiovascular risk. To this end, four different NPLs of similar nominal sizes (about 200 nm), but different environmental relevance, have been used. They are: (i) spherical and monodisperse pristine polystyrene (PS), (ii) biodegradable polylactic acid (PLA), (iii) moderately irregular and polydisperse polytetrafluoroethylene (PTFE), and (iv) highly irregular and polydisperse polyethylene terephthalate (PET) derived from post-consumer bottles. To determine their hazardous risk, primary human umbilical vein endothelial cells (HUVECs) were used as a physiologically relevant model of the vascular endothelium. Results show that all NPLs were internalized by HUVECs, although uptake efficiency and intracellular distribution varied among polymers. None of the NPLs induced cytotoxicity or DNA damage at 25 µg/mL for 24 h. However, PTFE- and PET-NPLs elicited functional alterations consistent with endothelial dysfunction. PET-NPLs triggered IL-6 secretion and intracellular cholesterol accumulation, while both PTFE- and PET-NPLs significantly impaired cell migration, reducing wound closure. These findings reveal a clear gradient of biological impact, with irregular NPLs inducing stronger endothelial stress responses. By linking morphological realism to vascular inflammation, cholesterol dysregulation, and impaired migration, this study underscores the relevance of environmentally realistic NPLs into human health risk assessment frameworks.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Life-Stage–Dependent Variation in Gastrointestinal Microbial Communities of Drosophila melanogaster

  • Rocabert, Arnau|||0009-0002-0950-2157
  • Pareras, Laia|||0000-0002-1381-8894
  • Egea, Raquel|||0000-0002-6201-4112
  • Alaraby, Mohamed|||0000-0001-7488-3318
  • Rubio, Laura|||0000-0002-2088-3803
  • Marcos, Ricard|||0000-0001-7891-357X
  • García-Rodríguez, Alba|||0000-0002-1175-7418
  • Hernández, Alba|||0000-0001-6938-1233
Drosophila melanogaster has been a useful biological model since its first use, more than 100 years ago. Mainly due to its genetic similarity with humans, as it allowed it to be an accurate representation of how different biological systems work, such as immune function, illness related pathways, gene inheritance, egg development and, in this case, the microbial ecosystem. Age-related changes in the gut microbiota of D. melanogaster offer valuable insights into the dynamic relationship between a host and its microorganisms across lifespan and can be extrapolated to other organisms. This study focusses on the potential changes that microbiota undergoes across the several stages of the fly life cycle, generating robust and high-resolution data using MinION nanopore sequencing as a cutting-edge approach to microbiota analysis Our findings highlight the highly dynamic nature of the gut microbiota across the D. melanogaster lifespan and underscore the necessity of explicitly accounting for developmental stage and chronological age in microbiota-focused studies. Moreover, a clearer understanding of these temporal microbial shifts provides valuable insight into how host-microbiota interactions are shaped during development, maintained during adulthood, and ultimately altered during aging. Currently, the gut microbiota stabilized following post-eclosion establishment, while age-associated dysbiosis and immune decline have not yet emerged. Consequently, using flies around 1-week-old maximizes experimental consistency and sensitivity, making them an optimal model for investigating microbiota-targeted interventions.
Dipòsit Digital de Documents de la UAB
Publication

Insights into the in vivo toxicity of polytetrafluoroethylene micro- and nanoplastics

  • Alaraby, Mohamed|||0000-0001-7488-3318
  • Abass, Doaa|||0009-0003-2520-5790
  • Egea, Raquel|||0000-0002-6201-4112
  • Velázquez Henar, Antonia|||0000-0003-3254-4312
  • Hernández, Alba|||0000-0001-6938-1233
  • Marcos, Ricard|||0000-0001-7891-357X
This study investigated the potential health effects of micro- and nanoplastics MNPLs derived from polytetrafluoroethylene (PTFE), a material commonly used in non-stick cookware and household products. We examined the biological impacts of PTFE-derived micro- and nanoplastics using the fruit fly (Drosophila melanogaster) as a model organism. Herein, flies exposed to both micro-sized (MPLs) and nano-sized (NPLs) PTFE particles and tracked their uptake, distribution, and effects on cellular function. Both particle types accumulated in the gut, particularly near the protective peritrophic membrane and gut microbiota. The particles also showed signs of bioerosion, generating additional nanoscale particles. Exposure to PTFE particles caused oxidative stress, DNA damage, and mitochondrial dysfunction, with NPLs particles producing stronger effects than MPLs. Genome-wide transcriptomic analyses and RT-PCR revealed significant changes in genes involved in stress responses, metabolism, and cellular transport. Overall, the findings demonstrate that PTFE-MNPLs can cross biological barriers and disrupt normal cellular processes, suggesting they may pose previously underestimated health risks. The study highlights the need for further research into the environmental and biological impacts of PTFE-derived plastic particles.
Repisalud
Publication Artículo científico (JournalArticle)

The proteomic signature of circulating extracellular vesicles following intracerebral hemorrhage: Novel insights into mechanisms underlying recovery

  • Casado-Fernández, Laura
  • Laso-García, Fernando
  • Piniella, Dolores
  • Gómez-de Frutos, Mari Carmen
  • Otero-Ortega, Laura
  • Bravo, Susana-Belén
  • Fuentes-Gimeno, Blanca
  • Docando, Felix
  • Alonso-López, Elisa
  • Ruiz-Ares, Gerardo
  • Rodríguez-Pardo, Jorge
  • Rigual, Ricardo
  • de Celis-Ruiz, Elena
  • Hervás, Carlos
  • Díez-Tejedor, Exuperio
  • Gutiérrez-Fernández, María
  • Alonso de Leciñana, Maria
Circulating extracellular vesicles (EVs) can participate in innate repair processes triggered after intracerebral hemorrhage (ICH). We aimed to describe changes in the proteomic profile of circulating EVs between the acute and subacute phases of ICH and to compare the findings depending on outcomes, as an approach to unraveling such repair mechanisms. This was a prospective observational study including patients with non-traumatic supratentorial ICH. Exclusion criteria were previous disability, signs of herniation on baseline computed tomography, or limited life expectancy. EVs were isolated from blood samples at 24 h and 7 days after symptom onset. After 6-months' follow-up, patients were dichotomized into poor and good outcomes, defining good as an improvement of >10 points or > 50 % on the National Institutes of Health Stroke Scale and a modified Rankin Scale of 0-2. The protein cargo was analyzed by quantitative mass spectrometry and compared according to outcomes. Forty-four patients completed follow-up, 16 (35.5 %) having good outcomes. We identified 1321 proteins in EVs, 37 with differential abundance. In patients with good outcomes, proteins related to stress response (DERA, VNN2, TOMM34) and angiogenesis (RHG01) had increased abundance at 7 days. EVs from patients with poor outcomes showed higher levels of acute-phase reactants (CRP, SAA2) at 7 days compared with 24 h. In conclusion, the protein content of circulating EVs in patients with ICH changes over time, the changes varying depending on the clinical outcome, with greater abundance of proteins potentially involved in the repair processes of patients with good outcomes.
Repisalud
Publication Artículo científico (JournalArticle)

Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients

  • Sannino, Giuseppina
  • Marchetto, Aruna
  • Ranft, Andreas
  • Jabar, Susanne
  • Zacherl, Constanze
  • Alba-Rubio, Rebeca
  • Stein, Stefanie
  • Wehweck, Fabienne S
  • Kiran, Merve M
  • Hölting, Tilman L B
  • Musa, Julian
  • Romero-Pérez, Laura
  • Cidre-Aranaz, Florencia
  • Knott, Maximilian M L
  • Li, Jing
  • Jürgens, Heribert
  • Sastre, Ana
  • Alonso, Javier
  • Da Silveira, Willian
  • Hardiman, Gary
  • Gerke, Julia S
  • Orth, Martin F
  • Hartmann, Wolfgang
  • Kirchner, Thomas
  • Ohmura, Shunya
  • Dirksen, Uta
  • Grünewald, Thomas G P
BACKGROUND: Up to 30-40% of Ewing sarcoma (EwS) patients with non-metastatic disease develop local or metastatic relapse within a time span of 2-10 years. This is in part caused by the absence of prognostic biomarkers that can identify high-risk patients and thus assign them to risk-adapted monitoring and treatment regimens. Since cancer stemness has been associated with tumour relapse and poor patient outcomes, we investigated in the current study the prognostic potential SOX2 (sex determining region Y box 2) - a major transcription factor involved in development and stemness - which was previously described to contribute to the undifferentiated phenotype of EwS. METHODS: Two independent patient cohorts, one consisting of 189 retrospectively collected EwS tumours with corresponding mRNA expression data (test-cohort) and the other consisting of 141 prospectively collected formalin-fixed and paraffin-embedded resected tumours (validation and cohort), were employed to analyse SOX2 expression levels through DNA microarrays or immunohistochemistry, respectively, and to compare them with clinical parameters and patient outcomes. Two methods were employed to test the validity of the results at both the mRNA and protein levels. FINDINGS: Both cohorts showed that only a subset of EwS patients (16-20%) expressed high SOX2 mRNA or protein levels, which significantly correlated with poor overall survival. Multivariate analyses of our validation-cohort revealed that high SOX2 expression represents a major risk-factor for poor survival (HR = 3·19; 95%CI 1·74-5·84; p < 0·01) that is independent from metastasis and other known clinical risk-factors at the time of diagnosis. Univariate analyses demonstrated that SOX2-high expression was correlated with tumour relapse (p = 0·002). The median first relapse was at 14·7 months (range: 3·5-180·7). INTERPRETATION: High SOX2 expression constitutes an independent prognostic biomarker for EwS patients with poor outcomes. This may help to identify patients with localised disease who are at high risk for tumour relapse within the first two years after diagnosis. FUNDING: The laboratory of T. G. P. Grünewald is supported by grants from the 'Verein zur Förderung von Wissenschaft und Forschung an der Medizinischen Fakultät der LMU München (WiFoMed)', by LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative, the 'Mehr LEBEN für krebskranke Kinder - Bettina-Bräu-Stiftung', the Walter Schulz Foundation, the Wilhelm Sander-Foundation (2016.167.1), the Friedrich-Baur foundation, the Matthias-Lackas foundation, the Barbara & Hubertus Trettner foundation, the Dr. Leopold & Carmen Ellinger foundation, the Gert & Susanna Mayer foundation, the Deutsche Forschungsgemeinschaft (DFG 391665916), and by the German Cancer Aid (DKH-111886 and DKH-70112257). J. Li was supported by a scholarship of the China Scholarship Council (CSC), J. Musa was supported by a scholarship of the Kind-Philipp foundation, and T. L. B. Hölting by a scholarship of the German Cancer Aid. M. F. Orth and M. M. L. Knott were supported by scholarships of the German National Academic Foundation. G. Sannino was supported by a scholarship from the Fritz-Thyssen Foundation (FTF-40.15.0.030MN). The work of U. Dirksen is supported by grants from the German Cancer Aid (DKH-108128, DKH-70112018, and DKH-70113419), the ERA-Net-TRANSCAN consortium (project number 01KT1310), and Euro Ewing Consortium (EEC, project number EU-FP7 602,856), both funded under the European Commission Seventh Framework Program FP7-HEALTH (http://cordis.europa.eu/), the Barbara & Hubertus Trettner foundation, and the Gert & Susanna Mayer foundation. G. Hardiman was supported by grants from the National Science Foundation (SC EPSCoR) and National Institutes of Health (U01-DA045300). The laboratory of J. Alonso was supported by Instituto de Salud Carlos III (PI12/00816; PI16CIII/00026); Asociación Pablo Ugarte (TPY-M 1149/13; TRPV 205/18), ASION (TVP 141/17), Fundación Sonrisa de Alex & Todos somos Iván (TVP 1324/15).
Repisalud
Publication Artículo científico (JournalArticle)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

  • Vega-Garcia, Nerea
  • Benito, Rocío
  • Esperanza-Cebollada, Elena
  • Llop, Marta
  • Robledo, Cristina
  • Vicente-Garcés, Clara
  • Alonso, Javier
  • Barragan, Eva
  • Fernández, Guerau
  • Hernández-Sánchez, Jesús M
  • Martín-Izquierdo, Marta
  • Maynou, Joan
  • Minguela, Alfredo
  • Montaño, Adrián
  • Ortega, Margarita
  • Torrebadell, Montserrat
  • Cervera, José
  • Sánchez, Joaquín
  • Jiménez-Velasco, Antonio
  • Riesco, Susana
  • Hernández-Rivas, Jesús M
  • Lassaletta, Álvaro
  • Fernández, José María
  • Rives, Susana
  • Dapena, José Luis
  • Ramírez, Manuel
  • Camós, Mireia
  • Spanish Society of Pediatric Hematology and Oncology (SEHOP). Group of Leukemia
The development of Next-Generation Sequencing (NGS) has provided useful diagnostic, prognostic, and therapeutic strategies for individualized management of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) patients. Consequently, NGS is rapidly being established in clinical practice. However, the technology's complexity, bioinformatics analysis, and the different available options difficult a broad consensus between different laboratories in its daily routine introduction. This collaborative study among Spanish centers was aimed to assess the feasibility, pros, and cons of our customized panel and other commercial alternatives of NGS-targeted approaches. The custom panel was tested in three different sequencing centers. We used the same samples to assess other commercial panels (OncomineTM Childhood Cancer Research Assay; Archer®FusionPlex® ALL, and Human Comprehensive Cancer Panel GeneRead Panel v2®). Overall, the panels showed a good performance in different centers and platforms, but each NGS approach presented some issues, as well as pros and cons. Moreover, a previous consensus on the analysis and reporting following international guidelines would be preferable to improve the concordance in results among centers. Our study shows the challenges posed by NGS methodology and the need to consider several aspects of the chosen NGS-targeted approach and reach a consensus before implementing it in daily practice.
Repisalud
Publication Artículo científico (JournalArticle)

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

  • Ferreira, Manuel A
  • Gamazon, Eric R
  • Al-Ejeh, Fares
  • Aittomäki, Kristiina
  • Andrulis, Irene L
  • Anton-Culver, Hoda
  • Arason, Adalgeir
  • Arndt, Volker
  • Aronson, Kristan J
  • Arun, Banu K
  • Asseryanis, Ella
  • Azzollini, Jacopo
  • Balmaña, Judith
  • Barnes, Daniel R
  • Barrowdale, Daniel
  • Beckmann, Matthias W
  • Behrens, Sabine
  • Benitez, Javier
  • Bermisheva, Marina
  • Białkowska, Katarzyna
  • Blomqvist, Carl
  • Bogdanova, Natalia V
  • Bojesen, Stig E
  • Bolla, Manjeet K
  • Borg, Ake
  • Brauch, Hiltrud
  • Brenner, Hermann
  • Broeks, Annegien
  • Burwinkel, Barbara
  • Caldés, Trinidad
  • Caligo, Maria A
  • Campa, Daniele
  • Campbell, Ian
  • Canzian, Federico
  • Carter, Jonathan
  • Carter, Brian D
  • Castelao, Jose E
  • Chang-Claude, Jenny
  • Chanock, Stephen J
  • Christiansen, Hans
  • Chung, Wendy K
  • Claes, Kathleen B M
  • Clarke, Christine L
  • Couch, Fergus J
  • Cox, Angela
  • Cross, Simon S
  • Czene, Kamila
  • Daly, Mary B
  • de la Hoya, Miguel
  • Dennis, Joe
  • Devilee, Peter
  • Diez, Orland
  • Dörk, Thilo
  • Dunning, Alison M
  • Dwek, Miriam
  • Eccles, Diana M
  • Ejlertsen, Bent
  • Ellberg, Carolina
  • Engel, Christoph
  • Eriksson, Mikael
  • Fasching, Peter A
  • Fletcher, Olivia
  • Flyger, Henrik
  • Friedman, Eitan
  • Frost, Debra
  • Gabrielson, Marike
  • Gago-Dominguez, Manuela
  • Ganz, Patricia A
  • Gapstur, Susan M
  • Garber, Judy
  • García-Closas, Montserrat
  • García-Sáenz, José A
  • Gaudet, Mia M
  • Giles, Graham G
  • Glendon, Gord
  • Godwin, Andrew K
  • Goldberg, Mark S
  • Goldgar, David E
  • González-Neira, Anna
  • Greene, Mark H
  • Gronwald, Jacek
  • Guénel, Pascal
  • Haiman, Christopher A
  • Hall, Per
  • Hamann, Ute
  • He, Wei
  • Heyworth, Jane
  • Hogervorst, Frans B L
  • Hollestelle, Antoinette
  • Hoover, Robert N
  • Hopper, John L
  • Hulick, Peter J
  • Humphreys, Keith
  • Imyanitov, Evgeny N
  • Isaacs, Claudine
  • Jakimovska, Milena
  • Jakubowska, Anna
  • James, Paul A
  • Janavicius, Ramunas
  • Jankowitz, Rachel C
  • John, Esther M
  • Johnson, Nichola
  • Joseph, Vijai
  • Karlan, Beth Y
  • Khusnutdinova, Elza
  • Kiiski, Johanna I
  • Ko, Yon-Dschun
  • Jones, Michael E
  • Konstantopoulou, Irene
  • Kristensen, Vessela N
  • Laitman, Yael
  • Lambrechts, Diether
  • Lazaro, Conxi
  • Leslie, Goska
  • Lester, Jenny
  • Lesueur, Fabienne
  • Lindström, Sara
  • Long, Jirong
  • Loud, Jennifer T
  • Lubiński, Jan
  • Makalic, Enes
  • Mannermaa, Arto
  • Manoochehri, Mehdi
  • Margolin, Sara
  • Maurer, Tabea
  • Mavroudis, Dimitrios
  • McGuffog, Lesley
  • Meindl, Alfons
  • Menon, Usha
  • Michailidou, Kyriaki
  • Miller, Austin
  • Montagna, Marco
  • Moreno, Fernando
  • Moserle, Lidia
  • Mulligan, Anna Marie
  • Nathanson, Katherine L
  • Neuhausen, Susan L
  • Nevanlinna, Heli
  • Nevelsteen, Ines
  • Nielsen, Finn C
  • Nikitina-Zake, Liene
  • Nussbaum, Robert L
  • Offit, Kenneth
  • Olah, Edith
  • Olopade, Olufunmilayo I
  • Olsson, Håkan
  • Osorio, Ana
  • Papp, Janos
  • Park-Simon, Tjoung-Won
  • Parsons, Michael T
  • Pedersen, Inge Sokilde
  • Peixoto, Ana
  • Peterlongo, Paolo
  • Pharoah, Paul D P
  • Plaseska-Karanfilska, Dijana
  • Poppe, Bruce
  • Presneau, Nadege
  • Radice, Paolo
  • Rantala, Johanna
  • Rennert, Gad
  • Risch, Harvey A
  • Saloustros, Emmanouil
  • Sanden, Kristin
  • Sawyer, Elinor J
  • Schmidt, Marjanka K
  • Schmutzler, Rita K
  • Sharma, Priyanka
  • Shu, Xiao-Ou
  • Simard, Jacques
  • Singer, Christian F
  • Soucy, Penny
  • Southey, Melissa C
  • Spinelli, John J
  • Spurdle, Amanda B
  • Stone, Jennifer
  • Swerdlow, Anthony J
  • Tapper, William J
  • Taylor, Jack A
  • Teixeira, Manuel R
  • Terry, Mary Beth
  • Teulé, Alex
  • Thomassen, Mads
  • Thöne, Kathrin
  • Thull, Darcy L
  • Tischkowitz, Marc
  • Toland, Amanda E
  • Torres, Diana
  • Truong, Thérèse
  • Tung, Nadine
  • Vachon, Celine M
  • van Asperen, Christi J
  • van den Ouweland, Ans M W
  • van Rensburg, Elizabeth J
  • Vega, Ana
  • Viel, Alessandra
  • Wang, Qin
  • Wappenschmidt, Barbara
  • Weitzel, Jeffrey N
  • Wendt, Camilla
  • Winqvist, Robert
  • Yang, Xiaohong R
  • Yannoukakos, Drakoulis
  • Ziogas, Argyrios
  • Kraft, Peter
  • Antoniou, Antonis C
  • Zheng, Wei
  • Easton, Douglas F
  • Milne, Roger L
  • Beesley, Jonathan
  • Chenevix-Trench, Georgia
Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer.
Repisalud
Publication Artículo científico (JournalArticle)

Sitting less and moving more: the impact of physical activity on mortality in the population of Spain

  • de la Cámara, Miguel Á
  • Ortiz Burgos, Cristina
  • Granero-Melcón, Beatriz
  • Martínez-Portillo, Alejandro
  • Neira-León, Montserrat
  • Galan, Iñaki
Background: Sitting time (ST) constitutes a significant aspect of sedentary behavior, and its worldwide escalation raises concerns regarding public health. International guidelines recommend limiting sedentary time and replacing it with physical activity (PA) to reduce the risk of diseases and mortality. This study examines the impact of replacing ST with PA on all-cause, cardiovascular disease (CVD), and cancer mortality in a representative cohort of the population of Spain. Methods: We included 30 955 participants aged 15-69 years from two National Health Surveys performed in 2011 and 2017. Data were linked to mortality records as of December 2022. Data on ST, light PA (LPA), and moderate-vigorous PA (MVPA) were collected as part of the International Physical Activity Questionnaire at baseline. Isotemporal substitution analysis from Poisson regression models was used to estimate the relative risk ratio (RR) of replacing ST with LPA or MVPA. Results: During a median follow-up of 5.7 years, 957 deaths were reported. The replacement of 1 h per week of ST with 1 h per week of MVPA was significantly associated with a lower risk of all-cause (3.3%), CVD (6.7%), and cancer mortality (3.1%). Similarly, replacing 1 h per week of ST with 1 h per week of LPA was significantly associated with a lower risk of all-cause (1.6%) and cancer mortality (2.1%). Finally, substituting 1 h per week of LPA with 1 h per week of MVPA was significantly associated with a 7.6% lower risk of CVD mortality. Conclusions: Substituting one hour per week of ST with an equivalent amount of PA was associated with a lower risk of all-cause, CVD, and cancer mortality.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Effect of dietary protein level and source on digestive proteolytic enzyme activity of juvenile Senegalese sole, Solea senegalensis Kaup 1850

  • Rodiles, Ana
  • Santigosa, Ester
  • Herrera, Marcelino
  • Hachero Cruzado, Ismael
  • Cordero, María Luisa
  • Martínez-Llorens, Silvia
  • Lall, Santosh P.
  • Alarcón, Francisco Javier
The effect of dietary protein level and protein source on growth and proteolytic activity of juvenile Solea senegalensis was studied. In Experiment 1, fish were fed on four experimental diets containing increased protein levels (36, 46, 56 and 67%). In Experiment 2, Senegalese soles were fed on five diets with partial substitution of fish meal by soybean meal, soybean protein concentrate, soybean protein isolate, wheat gluten meal or pea protein concentrate. Results prove that growth and proteolytic activity in the distal intestine of fish were affected by the quantitative increase in dietary protein. The origin of protein source used in the elaboration of experimental diets affected both the amount and composition of the alkaline proteases secreted into the intestinal lumen; however, it did not decrease animal growth. Juvenile Senegalese sole showed capability to modulate digestive protease secretion when the concentration and/or source of dietary protein were modified. Quantity and quality of dietary protein affected protein hydrolysis in Senegalese sole intestine. This study establishes that 30% fish meal protein can be replaced by soybean derivatives without affecting intestinal proteases. Replacement with wheat gluten meal or pea protein concentrate should be taken cautiously, but further research is needed to establish whether growth performance and digestive enzyme physiology of Senegalese sole are affected by plant protein-supplemented diets in a long-term trial., This work was supported by Projects INIA RTA-2007-00026-C02-01 and 02, and the European Regional Development Fund. Ana Rodiles Guerrero was financially supported by the grant "Technology in the Larval Rearing of New Species of Fish" (IFAPA, Andalusian Regional Government, Spain). The authors thank Jose I. Navas Triano, Sean Tibbetts, Joyce Milley, Toni Barros and Andres Monino for their technical assistance. The authors are grateful to Francisco Trujillo for the revision of the English language text. Part of experimental work was carried out at CEIA3 facilities.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Development and validation of novel senolytic strategies for targeting and eliminating senescent cells

  • Escriche Navarro, Blanca
[ES] Esta tesis doctoral titulada "Desarrollo y validación de nuevas estrategias senolíticas para la selección y eliminación de células senescentes" se centra en el diseño, síntesis y validación de nanodispositivos y profármacos para eliminar células senescentes, con el objetivo de tratar enfermedades relacionadas con el envejecimiento y el cáncer. En el primer capítulo experimental, presentamos un nanodispositivo para eliminar selectivamente células senescentes explotando la actividad enzimática específica del secretoma senescente. Los resultados mostraron que tras la inducción de senescencia en fibroblastos WI-38 proliferantes con radiación ionizante, las células secretan altos niveles de metaloproteinasa de matriz 3 (MMP-3). Basándose en esto, se cargaron MSNs con navitoclax y se recubrieron con un péptido específico de MMP-3 ( "puerta molecular"), obteniendo NPs(Nav)@MMP-3. Los estudios celulares demostraron una liberación preferencial de la carga en células senescentes en comparación con células proliferantes. Además, el tratamiento de células senescentes con NPs(Nav)@MMP-3 indujo una disminución de la viabilidad celular similar a la del navitoclax, mientras que se observó un efecto protector sobre las células proliferantes. Partiendo de estos resultados en el segundo capítulo experimental describimos una nanopartícula para terapia senolítica mediada por células inmunitarias. Para ello, las nanopartículas recubiertas con el péptido específico de MMP-3 se decoraron con la quimioquina CXCL12 (NPs@CXCL12), potenciando el reclutamiento de células inmunitarias al microambiente senescente. Se verificó la liberación progresiva y específica de la proteína CXCL12 en presencia de MMP-3 mediante ensayos de liberación controlada. Posteriormente, se confirmó la capacidad de las nanopartículas para atraer células T Jurkat a un microambiente senescente mediante ensayos de migración. Los resultados revelaron que las NPs@CXCL12 ejercían un efecto quimiotáctico más significativo que la CXCL12 libre. Además, también se evaluó la capacidad de las células asesinas naturales primarias humanas para eliminar WI-38 senescentes, y se monitorizaron sus trayectorias de migración en respuesta a NPs@CXCL12 o CXCL12 libre utilizando un dispositivo de microfuídica. En el capítulo experimental tres, nos centramos en el diseño de un nanodispositivo dirigido al surfaceoma senescente. En concreto, demostramos que la inducción de la senescencia con palbociclib en células de melanoma humano desarrollaba un fenotipo senescente con sobreexpresión de dipeptidil peptidasa-4 (DPP4).Aquí, se cargaron MSNs con navitoclax, se cubrieron con polietilenglicol que contiene disulfuro ("puerta molecular" sensible a redox) y se funcionalizaron con un anticuerpo contra DPP4. La eficacia de las NPs(Nav)@DPP4-PE en la detección y eliminación de células senescentes se validó in vitro e in vivo utilizando un modelo murino de melanoma senescente inducido por palbociclib. El tratamiento redujo significativamente el crecimiento tumoral y eliminó preferentemente las células senescentes. En el cuarto capítulo experimental, investigamos el potencial de la terapia fotodinámica para la detección y eliminación de células senescentes. Para ello, se sintetizó un fotosensibilizador (compuesto 1) basado en boro-dipirrometeno (BODIPY) activado con ß-galactosidasa asociada a senescencia (SA-ß-gal). El compuesto 1 permanece inactivo hasta que la hidrólisis de la galactosa por la enzima SA-ß-gal restaura la emisión de fluorescencia y la generación de oxígeno singlete. La restauración de la fluorescencia, la capacidad de producir especies reactivas de oxígeno y de matar células senescentes en presencia de luz en el compuesto 1 se demostró en modelos de senescencia inducida por terapia in vitro e in vivo. Además, los estudios revelaron que el compuesto 1 desencadena un potente efecto senolítico tras la irradiación de tumores senescentes en modelos de ratón., [CA] Esta tesi doctoral titulada "Desenvolupament i validació de noves estratègies senolítiques per a la selecció i eliminació de cèl·lules senescents" se centra en el disseny, síntesi i validació de nanodispositius i profàrmacs per a eliminar cèl·lules senescents, amb l'objectiu de tractar malalties relacionades amb l'envelliment i el càncer. En el primer capítol experimental, presentem un nanodispositiu per a eliminar selectivament cèl·lules senescents explotantl'activitat enzimàtica específica del secretoma senescent. Els resultats van mostrar que després de la inducció de senescència en fibroblasts WI-38 proliferants amb radiació ionitzant, les cèl·lules secreten alts nivells de metaloproteinasa de matriu 3 (MMP-3). Basant-se en això, es van carregar MSNs amb navitoclax i es van recobrir amb un pèptid específic de MMP-3 ("porta molecular"), obtenint NPs(Nav)@MMP-3. Els estudis cel·lulars van demostrar un alliberament preferencial de la càrrega en cèl·lules senescents en comparació amb cèl·lules proliferants. A més, el tractament de cèl·lules senescents amb NPs(Nav)@MMP-3 va induir una disminució de la viabilitat cel·lular similar a la del navitoclax, mentres que es va observar un efecte protector sobre les cèl·lules proliferants. Partint déstos resultats en el segon capítol experimental descrivim una nanopartícula per teràpia senolítica mediada per cèl·lules immunitàries. Per a això, les nanopartícules recobertes amb el pèptid específic de MMP-3 es van decorar amb la quimioquina CXCL12 (NPs@CXCL12), potenciant el reclutament de cèl·lules immunitàries al microambient senescent. Ees va verificar l'alliberament progressiu i específic de la proteïna CXCL12 de la bastida en presència de MMP-3 mitjançant assajos d'alliberament controlat. Posteriorment, es va confirmar la capacitat de les nanopartícules per a atraure cèl·lules T Jurkat a un microambient senescent mitjançant assajos de migració. Els resultats van revelar que les NPs@CXCL12 exercien un efecte quimiotàctic més significatiu que la CXCL12. A més, també es va avaluar la capacitat de les cèl·lules assassines naturals primàries humanes per a eliminar WI-38 senescents, i es van monitorar les seues trajectòries de migració en resposta a NPs@CXCL12 o CXCL12 utilitzant un dispositiu de microfuidica. En el capítol experimental tres, ens centrem en el disseny d'un nanodispositiu dirigit al surfaceoma senescent. En concret, vam demostrar que la inducció de la senescència amb palbociclib en cèl·lules de melanoma humà presentava un fenotip senescent amb sobreexpresión de dipeptidil peptidasa-4 (DPP4). Basant-se en esta troballa, es van carregar MSNs amb navitoclax, es van cobrir amb polietilenglicol que conté disulfur, ("porta molecular" sensible a redox) i es van funcionalitzar amb un anticòs contra DPP4. L'eficàcia de les NPs(Nav)@DPP4-PE en la detecció i eliminació de cèl·lules senescents es va validar in vitro i in vivo utilitzant un model murin de melanoma senescent induït per palbociclib.El tractament va reduir significativament el creixement tumoral i va eliminar preferentment les cèl·lules senescents, com van indicar els biomarcadores de senescència analitzats. En el quart capítol experimental, investiguem el potencial de la teràpia fotodinámica per a la detecció i eliminació de cèl·lules senescents. Per a això, es va sintetitzar un fotosensibilizador (compost 1) basat en bor-dipirrometeno activat amb ß-galactosidasa associada a senescència (SA-ß-gal). El 1 roman inactiu fins que la hidròlisi de la galactosa per SA-ß-gal restaura l'emissió de fluorescència i la generació d'oxigen singlete. La restauració de la fluorescència, la capacitat de produir espècies reactives d'oxigen i de matar cèl·lules senescents en presència de llum en el 1 es va demostrar en models de senescència induïda per teràpia in vitro i in vivo. A més, els estudis van revelar que el 1 desencadena un potent efecte senolítico després de la irradiació de tumors senescents en models de ratolí., [EN] This PhD thesis entitled "Development and validation of novel senolytic strategies for targeting and eliminating senescent cells" focuses on the design, synthesis, and validation of nanodevices and prodrugs to eliminate senescent cells, to treat diseases related to aging and cancer. In the first experimental chapter, we present a nanodevice to selectively remove senescent cells by exploiting the specific enzymatic activity of the senescent secretome. The results showed that after the induction of senescence in proliferating WI-38 fibroblasts with ionizing radiation, the cells secrete high levels of matrix metalloproteinase-3 (MMP-3). Based on this, MSNs were loaded with navitoclax and coated with a specific peptide; a substrate of MMP-3 (gatekeeper), yielding NPs(Nav)@MMP-3. Cellular studies demonstrated preferential cargo release in senescent cells compared to proliferating cells. Furthermore, treatment of senescent cells with NPs(Nav)@MMP-3 induced a decrease in cell viability similar to that of free navitoclax, while a protective effect on proliferating cells was observed. Building on these results, in the second experimental chapter, we describe a nanoparticle for immune cell-mediated senolytic therapy. To this end, MSNs coated with the specific peptide MMP-3 were decorated with the chemokine CXCL12 (NPs@CXCL12), enhancing immune cells' recruitment to the senescent microenvironment. First, the progressive and specific release of CXCL12 protein from the scaffold in the presence of MMP-3 was verified by controlled release assays. Subsequently, the ability of the nanoparticles to attract Jurkat T cells to a senescent microenvironment was confirmed by migration assays. The results revealed that NPs@CXCL12 exerted a more significant chemotactic effect than free CXCL12. In addition, the ability of human primary natural killer cells to clear senescent WI-38 was also evaluated, and their migration trajectories were monitored in response to NPs@CXCL12 or free CXCL12 using a microfluidic device. In experimental chapter three, we focused on the design of a nanodevice targeting senescent surfaceome. Specifically, the research proved that the induction of senescence with palbociclib in human melanoma cells developed a senescent phenotype characterized by the up-regulated expression of dipeptidyl peptidase 4 (DPP4). Based on this finding, MSNs were loaded with navitoclax, capped with disulfide-containing polyethylene glycol (redox-sensitive gatekeeper) and finally functionalized with an antibody that recognized the DPP4 protein. The efficacy of NPs(Nav)@DPP4-PE in detecting and eliminating senescent cells was validated in vitro and in vivo using a mouse model of palbociclib-induced senescent melanoma. Furthermore, treatment of mice with the DPP4-targeted nanoparticle significantly reduced tumor growth, and preferentially removed senescent cells, as indicated by the senescence biomarkers analyzed. In the fourth experimental chapter, we investigated the potential of photodynamic therapy for the detection and eradication of senescent cells. For this purpose, a boron dipyrromethene-based photosensitizer (BODIPY) activated with senescent-associated ß-galactosidase (SA-ß-gal) (compound 1) was synthesized. Compound 1 contains a galactose moiety bound to a BODIPY, so it remains inactive until galactose hydrolysis by the SA-ß-gal enzyme restores fluorescence emission and singlet oxygen generation. The restoration of fluorescence, the ability to produce reactive oxygen species, and to kill senescent cells in the presence of light in compound 1 was demonstrated in models of therapy-induced senescence in vitro and in vivo. Furthermore, studies in palbociclib-induced senescent melanoma mouse models reveal that the galactose-conjugated photosensitizer triggers a potent senolytic effect upon irradiation of senescent tumors., This research was supported by projects PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/ AEI /10.13039/501100011033/ and by EuropeanRegional Development Fund - A way of doing Europe. This study was also supported byGeneralitat Valenciana (CIPROM/2021/007). This research was supported by CIBER(CB06/01/2012), Instituto de Salud Carlos III, and Ministerio de Ciencia e Innovación. Thiswork was also supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). B.E-N. is grateful to the Instituto de Salud Carlos III (ISCIII) for the grant through the project “IFI19/00026”, co-funded by the European Union and the company Senolytic Therapeutics S.L for the support. E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her “Margarita Salas” postdoctoral grant (UP2021-036).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Production of transgenic apricot plants from hypocotyl segments of mature seeds

  • Petri, C.
  • WANG, HONG
  • Burgos, L.
  • Alburquerque, N.
  • Sánchez-Navarro, Jesús-Ángel|||0000-0002-3320-2827
[EN] Apricot (Prunus armeniaca L.) is one of the most recalcitrant species for genetic transformation. In this work; we report the regeneration of transgenic apricot plants from mature seed hypocotyl segments (cv. 'Canino' and 'Moniqui') for the first time. Moreover, this is the first report of the regeneration of apricot transgenic plants by means of the selective bar gene. Agrobacterium tumefaciens strain LB4404 harbouring a binary plasmid with eyfp and nptII genes (pMOG-eyfp-IV2) or a plasmid with gus and bar genes (pFGC5941-gus), was used in this study. A gradual selection strategy with aminoglycoside antibiotics made it possible to produce transgenic plants with 1.5 +/- 0.5% efficiency using 10 mu M paromomycin (PAR). When buds were isolated and placed in a meristem development medium, PAR was changed to 20 mu M kanamycin (KAN). As the buds developed and elongated, the concentration was increased up to 140 mu M KAN based on a 20 mu M increase every 4 weeks. When bar was the marker gene, the regeneration-inhibitory PPT concentration (75.7 mu M) was applied immediately after the co-culture. In this case, the PPT concentration was reduced afterwards to 10.1 mu M in the micropropagation medium. This strategy allowed for the regeneration of transgenic shoots with 3.8 +/- 1.4% efficiency. Transformation events were monitored by detection of the reporter gene (eyfp or gus) expression. PCR and Southern blot analysis confirmed the stable integration of the transgenes into the apricot genome. Transformed shoots were rooted on a selective medium, acclimatised, cultured and raised under greenhouse conditions. Our results confirm that the process used in this study is an efficient transformation system for the apricot species which could be used for functional genomics studies and the development of transgenic rootstocks. (C) 2015 Elsevier B.V. All rights reserved., The authors would like to thank Dr. Ralph Scorza for kindly providing pFGC5941-gus plasmid, and Dr. Jose Egea for providing 'Moniqui' and 'Canino' fruits. This research was supported by the grants AGL2010-20270 and RTA2013-00026-C03-02, cofinanced by FEDER funds and by the grant BIO2011-25018 from the Spanish granting agency DGICYT. C.P. thanks the UPCT and the Spanish Ministry of Economy and Competitiveness for his Ramon & Cajal contract.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy

  • Fleitas-Kanonnikoff, Tania
  • Martinez-Ciarpaglini, Carolina
  • Ayala, Josefina
  • Gauna, Cinthia
  • Denis, Rita
  • Yoffe, Ita
  • Sforza, Silvia
  • Ibarrola-Villava, Maider
  • Pomata, Alicia
  • Ibarrola, Maider
  • Arevshatyan, Sipan
  • Burriel Coll, Verónica
  • Boscá, Diego
  • Ferrer-Martinez, Ana
  • Pastor López, Oscar|||0000-0002-1320-8471
[EN] Somatic mutation analysis and evaluation of microsatellite instability (MSI) have become mandatory for selecting personalized therapy strategies for advanced colorectal cancer and are not available as routine methods in Paraguay. The aims of this study were to analyze the molecular profile as well as the microsatellite status in a series of advanced colorectal patients from two public hospitals from Paraguay, to introduce these methodologies in the routine practice to guide the therapeutic decisions. Thirty-six patients diagnosed with advanced colorectal cancer from two referent public hospitals from Paraguay were recruited from May 2017 to February 2018. Sequenom Mass spectrometry, Oncocarta Panel V.1 was applied to analyze the mutational profile from formalin-fixed paraffin-embedded samples. The microsatellite status was tested by immunohistochemistry (IHC). The mean age of the patients was 52 years with a range from 20 to 74 years. Eighty-three percent of the patients included in the study have advanced-stage tumors at the moment of the diagnosis. Sixteen patients (44.4%) were wild-type for all the oncogene regions analyzed with the Oncocarta panel. Thirty-two hot-spot pathogenic variants on seven oncogenes, among 20 patients (55.6%), were identified, including KRAS, NRAS, BRAF, PI3KCA, FGFR, epidermal growth factor receptor, and PDGFRA. Moreover, 14 (38.8%) of these patients presented pathogenic variants in KRAS/NRAS or BRAF genes that have implications in the clinical practice decisions. Five patients (14%) presented MSI. The IHC study for microsatellite status and the molecular profile analysis through Sequenom mass spectrometry are feasible and useful methods, due to identify those patient candidates for targeted therapies and for the budgetary calculations of the National Health Plans, CONACYT Paraguay, Grant/Award Number: PINV-156/2015; INSTITUTO CARLOS III, Grant/Award Number: 17/00026 and CD15/00153; FONDOS FEDER; Bankia
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Targeting the senescent surfaceome through DPP4 antibody-functionalized nanoparticles. An application to cancer therapy

  • Escriche-Navarro, Blanca
  • Garrido-García, Eva María
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Montoya-Méndez. Isabel |||0009-0003-7755-4853
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Due to the heterogeneity of the senescent phenotype and the lack of a universal biomarker of senescence, the targeting of senescent cells is still an unresolved challenge, and the elimination of senescent cells using specific drugs (senolytics) is still limited in clinical use due to the off-target effects and associated toxicities of current therapeutic strategies. In this study, the induction of senescence in human melanoma cells by palbociclib is found to lead to a senescent phenotype characterized by overexpression of the membrane protein dipeptidyl peptidase 4 (DPP4), previously identified only in ageing contexts. Based on this discovery, a nanoparticle targeting DPP4 overexpression in the senescent surfaceome is designed, synthesized, and characterized to target senescent cancer cells. The nanoparticle based on mesoporous silica is loaded with the senolytic navitoclax, coated with disulfide-containing poly(ethylene glycol) to generate a redox-sensitive gatekeeper (S-S-PEG), and functionalized with an antibody against the DPP4 protein. The ability of the nanoparticles to effectively detect and eliminate senescent cells was confirmed in vitro and in vivo using a mouse model of palbociclib-induced senescent in melanoma. The DPP4-targeted nanoparticle effectively reduces tumor growth and selectively removes senescent cells. Taken together, this study highlights the potential of surfaceome-targeted nanoparticles, as a clinically relevant strategy for improving senolytic therapies., This research was supported by projects PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe and by the ERC Advanced Grant Edison (101052997) . This study was also supported by Generalitat Valenciana (CIPROM/2021/007) . This research was supported by CIBER (CB06/01/2012) , Instituto de Salud Carlos III, and Ministerio de Ciencia e Innovacion. B.E-N. is grateful to the Instituto de Salud Carlos III (ISCIII) for the grant through the project "IFI19/00026", co-funded by the European Union and the company Senolytic Therapeutics S.L for the support. E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her "Margarita Salas" postdoctoral grant (UP2021-036) .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Nanodevice-Mediated Immune Cell Recruitment: Targeting Senescent Cells via MMP-3-Responsive CXCL12-Coated Nanoparticles

  • Escriche-Navarro, Blanca
  • Labernadie, Anna
  • Garrido-García, Eva María
  • Clara-Trujillo, Sandra|||0000-0002-6455-2993
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Senescent cells are involved in age-related disorders in different organs and are therapeutic targets for fibrotic and chronic pathologies. Immune-modulating agents, able to enhance senescent cell detection and elimination by endogenous immune cells, have emerged as pharmacological strategies. We report herein a nanoparticle for immune cell-mediated senolytic therapy designed to recruit immune cells in response to specific enzymatic matrix metalloproteinase-3 (MMP-3) activity in the senescence-associated secretory phenotype. For this, mesoporous silica nanoparticles (MSNs) are coated with a peptide substrate of the metalloproteinase MMP-3, and the peptide is decorated with chemokine CXCL12 that enhances immune cell recruitment (NPs@CXCL12). Controlled release studies confirmed the progressive and specific release of CXCL12 in the presence of MMP-3. The ability of immune cell recruitment in response to a senescent microenvironment (senescent WI-38 fibroblasts) is confirmed by Transwell migration assays with green fluorescent Jurkat T-cells, showing NPs@CXCL12 has an enhanced chemotaxis effect toward senescent cells compared to free CXCL12 (2-fold). Moreover, the cytotoxic capacity of human primary natural killer (NK) cells over senescent WI-38 is also confirmed, and their migration trajectories in response to NPs@CXCL12 or free CXCL12 are monitored by using a microfluidic device. Results confirm the ability of NPs@CXCL12 to generate a chemotactic gradient able to attract NK cells. When compared with free CXCL12, the NPs@CXCL12 system showed a reduction of up to 15.56% in the population of NK cells migrating toward free CXCL12 under competitive conditions. This study demonstrates the potential of designing nanoparticles to recruit immune cells under specific responses to eliminate senescent cells. Results confirm that NPs@CXCL12 can effectively establish a chemotactic gradient to attract NK cells., This research was supported by projects PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/and by the European Regional Development FundyA way of doing Europe. This study was also supported by the ERC Advanced Grant Edison (101052997), the Generalitat Valenciana (CIPROM/2021/007) and CIBER (CB06/01/2012), Instituto de Salud Carlos III, and Ministerio de Ciencia e Innovacion. A.L. is grateful to the RYC2020/029736/I grant and PID2021-125212OA-I00 project funded by MCIN. B.E-N. is grateful to the Instituto de Salud Carlos III (ISCIII) for the grant through the project "IFI19/00026", cofunded by the European Union and the company Senolytic Therapeutics S.L. for the support. E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her "Margarita Salas" postdoctoral grant (UP2021-036).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of senescent cells

  • Escriche-Navarro, Blanca
  • Garrido-García, Eva María
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Cellular senescence is implicated in the occurrence and progression of multiple age-related disorders. In this context, the selective elimination of senescent cells, senolysis, has emerged as an effective therapeu- tic strategy. However, the heterogeneous senescent phenotype hinders the discovery of a universal and robust senescence biomarker that limits the effective of senolytic with off-target toxic effects. Therefore, the development of more selective strategies represents a promising approach to increase the specificity of senolytic therapy. In this study, we have developed an innovative nanodevice for the selective elimi- nation of senescent cells (SCs) based on the specific enzymatic activity of the senescent secretome. The results revealed that when senescence is induced in proliferating WI-38 by ionizing radiation (IR), the cells secrete high levels of matrix metalloproteinase-3 (MMP-3). Based on this result, mesoporous silica nanoparticles (MSNs) were loaded with the senolytic navitoclax (Nav) and coated with a specific peptide which is substrate of MMP-3 (NPs(Nav)@MMP-3). Studies in cells confirmed the preferential release of cargo in IR-induced senescent cells compared to proliferating cells, depending on MMP-3 levels. More- over, treatment with NPs(Nav)@MMP-3 induced a selective decrease in the viability of SCs as well as a protective effect on non-proliferating cells. These results demonstrate the potential use of NPs to develop enhanced senolytic therapies based on specific enzymatic activity in the senescent microenvironment, with potential clinical relevance., This research was supported by projects PID2021-126304OBC41 and PID2021-128141OB-C22 funded by MCIN/ AEI /10.13039/501100011033/ and by European Regional Development Fund - A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER (CB06/01/2012), Instituto de Salud Carlos III and Ministerio de Ciencia e Innovación. This work was also supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). B.E-N. is grateful to the Instituto de Salud Carlos III (ISCIII) for the grant through the project IFI19/00026 , co-funded by the European Union and the company Senolytic Therapeutics S.L for the support. E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her Margarita Salas postdoctoral grant (UP2021-036).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Development of Geometry-Controlled All-Orthogonal BODIPY Trimers for Photodynamic Therapy and Phototheragnosis

  • Prieto-Castañeda, Alejandro
  • García-Garrido, Fernando
  • Díaz-Norambuena, Carolina
  • Escriche-Navarro, Blanca
  • Bañuelos, Jorge
  • Rebollar, Esther
  • García-Moreno, Inmaculada
  • de la Moya, Santiago
  • Agarrabeitia, Antonia R.
  • Ortiz, María J.
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] We have established an easy synthetic protocol for selectively developing all-orthogonal BODIPY trimers with unprece-dented geometries on the basis of selecting methyl oxidation versus electrophilic formylation of key dimeric precursors. Photophysical characterization together with biological assays unraveled the most suitable BODIPY-BODIPY geometrical arrangements within the trimer, forcing them to serve as molecular platforms for the development of new, advanced heavy-atom-free photosensitizers for photodynamic therapy and phototheragnosis., The authors acknowledge Spanish MICINN (PID2020-11455GB-C31, -C32, and -C33 and RTI2018-100910-BC41), Spanish Instituto de Salud Carlos III (IFI19/00026), Gobierno Vasco (IT1639-22), and Generalitat Valenciana (PROMETEO 2018/024) for financial support. A.P.-C. thanks Comunidad de Madrid for a research contract. C.D.-N. thanks MICINN for a FPI contract. B.E.-N. thanks the IFI19/00026 project, which is co-funded by the European Union, for a research contract.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Mesoporous Silica Materials as an Emerging Tool for Cancer Immunotherapy

  • Escriche-Navarro, Blanca
  • Lucena-Sánchez, Elena
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Cancer immunotherapy has emerged in the past decade as a promising strategy for treating many forms of cancer by stimulating the patient's immune system. Although immunotherapy has achieved some promising results in clinics, more efforts are required to improve the limitations of current treatments related to lack of effective and targeted cancer antigens delivery to immune cells, dose-limiting toxicity, and immune-mediated adverse effects, among others. In recent years, the use of nanomaterials has proven promising to enhance cancer immunotherapy efficacy and reduce side effects. Among nanomaterials, attention has been recently paid to mesoporous silica nanoparticles (MSNs) as a potential multiplatform for enhancing cancer immunotherapy by considering their unique properties, such as high porosity, and good biocompatibility, facile surface modification, and self-adjuvanticity. This review explores the role of MSN and other nano/micro-materials as an emerging tool to enhance cancer immunotherapy, and it comprehensively summarizes the different immunotherapeutic strategies addressed to date by using MSN., B.E.-N., A.E., and E.L.-S. contributed equally to this work. The authors would like to thank the Spanish Government for RTI2018-100910-B-C41 and RTI2018-101599-B-C22 (MCUI/FEDER, EU) and the Generalitat Valenciana (Project PROMETEO 2018/024) for support by Project PROMETEO/2018/024. A.G.-F. acknowledges her current Margarita Salas postdoctoral fellowship from UPV-MIU and "Next Generation EU" program. B.E.-N. is grateful to the Spanish Instituto de Salud Carlos III (ISCIII) for the grant through Project "IFI19/00026", co-funded by European Union. A.E. is grateful for her Ph.D. grant by the Generalitat Valenciana. E.L.-S. thanks MINECO for her FPU fellowship.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions

  • Díez Villares, Sandra
  • García Varela, Lara
  • Groba de Antas, Soraya
  • Caeiro Rey, José Ramón
  • Carpintero-Fernandez, Paula
  • Mayán, María D.
  • Aguiar Fernández, Pablo
  • Fuente, María de la
Intra-articular (IA) administration of drugs for the treatment of diseases such as rheumatoid arthritis, osteoarthritis and psoriatic arthritis is a common strategy; however, the rapid clearance from the synovial fluid restricts their effectivity due to the limited retention time. Drug Delivery Systems (DDS) are currently being developed to increase their joint retention time. This study compares the biodistribution and retention time of a senolytic peptide (PEP), with potential application in osteoarthritis disease, and this senolytic peptide encapsulated in a DDS based on a lipid nanoemulsion (PEPsingle bondNE) by using positron emission tomography (PET) imaging. To this aim, the PEP was conjugated with a chelating agent (DFO) and radiolabeled with zirconium-89 (89Zr). Then, [89Zr]-PEP was encapsulated in a novel nanoemulsion formulation, composed by vitamin E, sphingomyelin, and a lipid-PEG. Afterward, healthy rats were administered with either the [89Zr]-PEP or the [89Zr]-PEP-NE via IA injection and underwent PET scans at 0.5-, 24-, 48-, 72-, 168-, 240- and 336 h post-injection. To assess the biodistribution of both radiotracers, several volume-of-interest were manually drawn in different organs of the rat body and the %ID/organ was calculated. The [89Zr]-PEP was successfully encapsulated in the NE and their physicochemical properties were minimally affected by the radiolabeling buffer. Adequate stability of both [89Zr]-PEP and [89Zr]-PEP-NE was found in synovial fluid over 72 h. Quantitative data from PET images revealed a significantly higher [89Zr]-PEP-NE retention in the injected knee than with [89Zr]-PEP in all follow-up PET scans. The [89Zr]-PEP %ID/organ values in the liver and kidney were significantly higher than those from [89Zr]-PEP-NE, which might indicate a faster elimination of the [89Zr]-PEP. Therefore, the study highlights the higher retention time on the target site of the [89Zr]-PEP-NE which may improve the therapeutic effects of the peptide. Thereby, the novel nanoemulsion formulation seems to be a successful DDS for IA injection. In addition, these results represent the first study that evaluates the distribution of a PET-guided DDS after its IA administration.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Anti-Inflammatory Effect of Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drops in an Endotoxin-Induced Uveitis Model

  • Bermúdez, María José
  • García-Otero, Xurxo
  • Mondelo-García, Cristina
  • González, Francisco
  • Pérez-Fernández, Román
  • Avila, Leandro
  • Antúnez, José
  • González-Barcia, Miguel
  • Adán, Alfredo
  • Aguiar, Pablo
  • Otero Espinar, Francisco Javier
  • Fernández Ferreiro, Anxo
[Abstract] Background: Uveitis is an infrequent disease which constitutes a major cause of ocular morbidity. Correct management is essential, being corticosteroids its cornerstone. In case of contraindication to corticosteroids or treatment failure, the use of topical tacrolimus (TAC) could be an alternative which has already demonstrated safety and effectiveness in other ocular pathologies. However, TAC eye drops are not marketed, thus their elaboration must be carried out in Hospital Pharmacy Departments (HPDs). Methods: 32 Sprague-Dawley rats were divided into 4 groups of 8 rats each: (a) untreated healthy rats (Healthy); (b) untreated Endotoxin-Induced Uveitis model-rats (EIU); (c) EIU-rats treated with standard treatment of dexamethasone ophthalmic drops (DXM) and (d) EIU-rats treated with TAC-hydroxypropyl-β-cyclodextrin eye drops previously developed by our group (TAC-HPβCD). The mRNA expression levels of IL-6, IL-8, MIP-1α and TNF-α, quantitative analysis of leucocytes in aqueous humor and histological evaluation were performed. Results: TAC-HPβCD eye drops demonstrated to reduce ocular inflammation, expression of IL-6, TNF-α, MIP-1α and leukocyte infiltration in aqueous humor. Conclusions: TAC-HPβCD eye drops showed beneficial effect in EIU model in rats, positioning as an alternative for uveitis treatment in case of corticosteroids resistance or intolerance., This project was partially funded by Health Research Institute Carlos III (PI20/00719, RETICS RD16/0008/0003), FEDER, Axencia Galega Innovación (Grupos de Potencial Crecimiento IN607B2020/11 y Grupo de Referencia Competitiva ED431C2021/01) and Spanish Ministry of Science, Innovation and Universities (RTI2018-099597-B-100). X. García-Otero is grateful to the IDIS (Health Research Institute of Santiago de Compostela) for financing his predoctoral research fellowship. C. Mondelo-García and A. Fernández-Ferreiro are grateful to the Carlos III Health Institute for financing their personnel contracts: JR20/00026 and JR18/00014., Xunta de Galicia; IN607B2020/11, Xunta de Galicia; ED431C2021/01
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification

  • Gato, Eva
  • Guijarro-Sánchez, Paula
  • Alonso-García, Isaac
  • Pedraza-Merino, Rosa
  • Conde, Adrián
  • Lence, Emilio
  • Rumbo-Feal, Soraya
  • Peña-Escolano, Andrea
  • Lasarte-Monterrubio, Cristina
  • Blanco Martín, Tania
  • Fernández González, Ana
  • Fernández-López, María del Carmen
  • Maceiras, Romina
  • Martínez Guitián, Marta
  • Vázquez-Ucha, Juan Carlos
  • Martínez-Martínez, Luis
  • González-Bello, Concepción
  • Arca-Suárez, Jorge
  • Beceiro Casas, Alejandro
  • Bou, Germán
[Abstract] Objectives: In order to inform and anticipate potential strategies aimed at combating KPC-producing Klebsiella pneumoniae infections, we analysed imipenem/relebactam and ceftazidime/avibactam single-step mutant frequencies, resistance development trajectories, differentially selected resistance mechanisms and their associated fitness cost using four representative high-risk K. pneumoniae clones. Methods: Mutant frequencies and mutant preventive concentrations were determined using agar plates containing incremental concentrations of β-lactam/β-lactamase inhibitor. Resistance dynamics were determined through incubation for 7 days in 10 mL MH tubes containing incremental concentrations of each antibiotic combination up to their 64 × baseline MIC. Two colonies per strain from each experiment were characterized by antimicrobial susceptibility testing, whole genome sequencing and competitive growth assays (to determine in vitro fitness). KPC variants associated with imipenem/relebactam resistance were characterized by cloning and biochemical experiments, atomic models and molecular dynamics simulation studies. Results: Imipenem/relebactam prevented the emergence of single-step resistance mutants at lower concentrations than ceftazidime/avibactam. In three of the four strains evaluated, imipenem/relebactam resistance development emerged more rapidly, and in the ST512/KPC-3 clone reached higher levels compared to baseline MICs than for ceftazidime/avibactam. Lineages evolved in the presence of ceftazidime/avibactam showed KPC substitutions associated with high-level ceftazidime/avibactam resistance, increased imipenem/relebactam susceptibility and low fitness costs. Lineages that evolved in the presence of imipenem/relebactam showed OmpK36 disruption, KPC modifications (S106L, N132S, L167R) and strain-specific substitutions associated with imipenem/relebactam resistance and high fitness costs. Imipenem/relebactam-selected KPC derivatives demonstrated enhanced relebactam resistance through important changes affecting relebactam recognition and positioning. Conclusions: Our findings anticipate potential resistance mechanisms affecting imipenem/relebactam during treatment of KPC-producing K. pneumoniae infections., This work was supported by MSD through the Investigator Initiated Studies Program, which provided financial support (to G.B.) and relebactam. This work was also supported by the Fondo de Investigación Sanitaria (grant numbers PI17/01482 and PI20/01212 for A.B. and PI18/00501 and PI21/00704 for G.B.) integrated in the Plan Nacional de I1D and funded by the Instituto de Salud Carlos III (ISCIII), CIBERINFEC (CIBER de Enfermedades Infecciosas). The research was also funded by the Spanish Network of Research in Infectious Diseases (REIPI), no. RD16/0016/0004 and no. RD16/0016/0006, integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013–2016 and funded by the ISCIII–General Subdirection of Assessment and Promotion of the Research—European Regional Development Fund (FEDER) ‘A way of making Europe.’ The study was also funded by GAIN (Agencia Gallega de Innovacion, Conselleria de Economia, Emprego e Industria; IN607D2021/12, A.B. and IN607A 2016/22, G.B.). PGS was financially supported by IN606A-2021/021. I.A.-G was financially supported by the Rio Hortega program (ISCIII, CM21/00076). J.C.V.-U. was financially supported by the ISCIII project FI18/00315. C.L.-M. was financially supported by IN606A-2019/ 029. J.A.-S. was financially supported by the Juan Rodés program (ISCIII, JR21/00026). Financial support from the Spanish Agency of Research (PID2019-105512RB-I00/AEI/10.13039/501100011033, CG-B), the Xunta de Galicia [ED431C 2021/29 and the Centro singular de investigación de Galicia accreditation 2019–2022 (ED431G 2019/03), CG-B], and the European Regional Development Fund (ERDF) is gratefully acknowledged. AC acknowledges Banco Santander for his fellowship. We are also grateful to the Centro de Supercomputación de Galicia (CESGA) for use of the Finis Terrae computer., Xunta de Galicia; IN607D2021/12, Xunta de Galicia; IN607A 2016/22, Xunta de Galicia; IN606A-2021/021, Xunta de Galicia; ED431C 2021/29, Xunta de Galicia; ED431G 2019/03
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain

  • Vázquez-Ucha, Juan Carlos
  • Alonso-García, Isaac
  • Guijarro-Sánchez, Paula
  • Lasarte-Monterrubio, Cristina
  • Álvarez-Fraga, Laura
  • Cendón-Esteve, Arnau
  • Outeda, Michelle
  • Maceiras, Romina
  • Peña-Escolano, Andrea
  • Martínez Guitián, Marta
  • Arca-Suárez, Jorge
  • Bou, Germán
  • Beceiro Casas, Alejandro
Multicenter study, [Abstract] Metallo-β-lactamase (MBL)-producing Enterobacterales are of particular concern because they are widely disseminated and difficult to treat, being resistant to almost all β-lactam antibiotics. Aztreonam is not hydrolysed by MBLs but is labile to serine β-lactamases (SBLs), which are usually co-produced by MBL-producing Enterobacterales. This study investigated the activity of aztreonam in combination with novel β-lactamase inhibitors (BLIs) against a national multi-centre study collection of strains co-producing MBLs and SBLs. Fifty-five clinical isolates co-producing MBLs (41 VIM producers, 10 NDM producers and 4 IMP producers) and SBLs were selected, and whole-genome sequencing (WGS) was performed. The minimum inhibitory concentration (MIC) values of aztreonam, aztreonam/avibactam, aztreonam/relebactam, aztreonam/zidebactam, aztreonam/taniborbactam, aztreonam/vaborbactam and aztreonam/enmetazobactam were determined. β-lactam/BLI resistance mechanisms were analysed by WGS. All BLIs decreased the MIC values of aztreonam for strains that were not susceptible to aztreonam. Aztreonam/zidebactam (MIC ≤1 mg/L for 96.4% of isolates), aztreonam/avibactam (MIC ≤1 mg/L for 92.7% of isolates) and aztreonam/taniborbactam (MIC ≤1 mg/L for 87.3 % of isolates) were the most active combinations. For other aztreonam/BLI combinations, 50-70% of the isolates yielded MIC values ≤1 mg/L. WGS data revealed that mutations in PBP3, defective OmpE35/OmpK35 porins, and the presence of extended-spectrum β-lactamases and class C β-lactamases were some of the resistance mechanisms involved in reduced susceptibility to aztreonam/BLIs. Combinations of aztreonam with new BLIs show promising activity against Enterobacterales co-producing MBLs and SBLs, particularly aztreonam/zidebactam, aztreonam/avibactam and aztreonam/taniborbactam. The present results show that these novel drugs may represent innovative therapeutic strategies by their use in yet-unexplored combinations as solutions for difficult-to-treat infections., This study was funded by Instituto de Salud Carlos III (ISCIII) through Projects N° Exp PI20/01212 and PI18/00501, integrated in the National Plan for Scientific Research, Development and Technological Innovation 2017-2020, and co-funded by European Union – European Regional Development Fund ‘A way to make Europe’. The work was also supported by CIBER -Consorcio Centro de Investigación Biomédica en Red- (CB21/13/00055), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU. In addition, the study was funded by Project IN607A 2020/05 (Agencia Gallega de Innovación – Consellería de Economía, Emprego e Industria) awarded to GB, and Project IN607D 2021/12 awarded to AB. The work was also supported by Planes Nacionales de I+D+i 2017-2020 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/006), co-financed by European Development Regional Fund ‘A way to achieve Europe’ and operative programme Intelligent Growth 2014-2020. JA-S was financially supported by the Juan Rodés programme (ISCIII, JR21/00026), JCV-U was financially supported by IN606B-2022/009 (Xunta de Galicia), CL-M was financially supported by IN606A-2019/029 (Xunta de Galicia) and PI20/01212 (ISCIII), and PG-S was financially supported by IN606A 2021/021 (Xunta de Galicia). AC and MO were financially supported by IN607D 2021/12. IA-G was financially supported by the Río Hortega programme (ISCIII, CM21/00076). LA-F was financially supported by IN606B- 2018/011 (Xunta de Galicia). MM-G was financially supported by RSU.UDC.M505 (Ministerio de Universidades)., Xunta de Galicia; IN606B-2022/009, Xunta de Galicia; IN606A-2019/029, Xunta de Galicia; IN606A 2021/021, Xunta de Galicia; IN606B- 2018/011, Xunta de Galicia; IN607A 2020/05, Xunta de Galicia; IN607D 2021/12
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Artificial Intelligence and Machine Learning Applications to Pharmacokinetic Modeling and Dose Prediction of Antibiotics: A Scoping Review

  • Varela Rey, Iria
  • Bandín Vilar, Enrique José
  • Toja-Camba, Francisco José
  • Cañizo-Outeiriño, Antonio
  • Cajade-Pascual, Francisco
  • Ortega Hortas, Marcos
  • Mangas-Sanjuan, Víctor
  • González Barcia, Miguel
  • Zarra Ferro, Irene
  • Mondelo-García, Cristina
  • Fernández Ferreiro, Anxo
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics13121203/s1, [Abstract]: Background and Objectives: The use of artificial intelligence (AI) and, in particular, machine learning (ML) techniques is growing rapidly in the healthcare field. Their application in pharmacokinetics is of potential interest due to the need to relate enormous amounts of data and to the more efficient development of new predictive dose models. The development of pharmacokinetic models based on these techniques simplifies the process, reduces time, and allows more factors to be considered than with classical methods, and is therefore of special interest in the pharmacokinetic monitoring of antibiotics. This review aims to describe the studies that use AI, mainly oriented to ML techniques, for dose prediction and analyze their results in comparison with the results obtained by classical methods. Furthermore, in the review, the techniques employed and the metrics to evaluate the precision are described to improve the compression of the results. Methods: A systematic search was carried out in the EMBASE, OVID, and PubMed databases and the results obtained were analyzed in detail. Results: Of the 13 articles selected, 10 were published in the last three years. Vancomycin was monitored in seven and none of the studies were performed on new antibiotics. The most used techniques were XGBoost and neural networks. Comparisons were conducted in most cases against population pharmacokinetic models. Conclusions: AI techniques offer promising results. However, the diversity in terms of the statistical metrics used and the low power of some of the articles make the overall assessment difficult. For now, AI-based ML techniques should be used in addition to classical population pharmacokinetic models in clinical practice., This work was partially supported by Axencia Galega Innovación (Grupos de Referencia Competitiva IN607A2023/04 and Excelencia (IN607D2023/05). I.V.-R., E.B.-V., F.J.T.-C., C.M.-G. and A.F.-F. acknowledge the support of the Instituto de Salud Carlos III (ISCIII) (research grants CM22/00055, CM20/00135, CM22/00146, JR20/00026 and JR18/00014). C.M.-G. and A.F.-F. acknowledge the support of the Instituto de Salud Carlos III (ISCIII) PI22/00038 and ICI21/00043., Xunta de Galicia; IN607A2023/04, Xunta de Galicia; IN607D2023/05
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Prevalencia de artrosis sintomática en España: estudio EPISER2016, Prevalence of Symptomatic Osteoarthritis in Spain: EPISER2016 Study

  • Blanco García, Francisco J
  • Silva-Díaz, Maite
  • Quevedo Vila, Víctor
  • Seoane-Mato, Daniel
  • Pérez-Ruiz, Fernando
  • Juan Mas, Antonio
  • Pego-Reigosa, José María
  • Narváez, Javier
  • Quilis, Neus
  • Cortés Verdú, Raúl
  • Romero Pérez, Antonio
  • Fábregas Canales, Dolores
  • Font Gayá, Teresa
  • Bordoy Ferrer, Carolina
  • Sánchez-Piedra, Carlos
  • Díaz-González, Federico
  • Bustabad, Sagrario
[Resumen] Introducción. La Sociedad Española de Reumatología elaboró en el año 2000 el estudio EPISER2000 para conocer la prevalencia de la artrosis y otras enfermedades reumáticas en España. Los cambios sociodemográficos y en los hábitos de vida ocurridos en los últimos años en España justifican actualizar los datos de las enfermedades reumáticas (EPISER2016). Objetivo. Estimar la prevalencia de artrosis sintomática de columna cervical, columna lumbar, cadera, rodilla y mano, en población adulta en España. Material y métodos. Estudio transversal de base poblacional. Se realizó un muestreo aleatorizado polietápico estratificado y por conglomerados. Los participantes fueron contactados por teléfono para cumplimentar un cuestionario de cribado de artrosis. El reumatólogo confirmaba o descartaba el diagnóstico. Se utilizaron los criterios-clínicos-ACR para diagnosticar artrosis de manos y los criterios clínico-radiológicos-ACR para diagnosticar la artrosis de rodilla y cadera. Resultados. La prevalencia de artrosis en España en una o más de las localizaciones estudiadas fue de 29,35%. La prevalencia de artrosis-cervical fue del 10,10% y de artrosis-lumbar del 15,52%. Ambas son más frecuentes en mujeres y a mayor edad, así como en personas con niveles de estudios bajos y obesidad. La prevalencia de artrosis de cadera fue del 5,13% y la de artrosis de rodilla del 13,83%; estas se asocian con el sexo femenino, sobrepeso y obesidad, menor frecuencia en nivel de estudios alto y con la edad. La prevalencia de la artrosis de mano fue del 7,73%. Es más frecuente en mujeres, obesas, con bajo nivel de estudios y mayor edad. Conclusiones. El estudio EPISER2016 es el primero que analiza la prevalencia de artrosis sintomática en 5 localizaciones (columna cervical, lumbar, rodilla, cadera y manos) en España. La artrosis de la columna lumbar es la más prevalente., [Abstract] Introduction. The Spanish Society of Rheumatology carried out the EPISER2000 study in 2000 to determine the prevalence of osteoarthritis and other rheumatic diseases in the Spanish population. Recent sociodemographic changes and lifestyle habits in Spain justified updating the epidemiological data on osteoarthritis and other rheumatic diseases (EPISER2016-study). Objective. To estimate the prevalence of symptomatic osteoarthritis of the cervical spine, lumbar spine, hip, knee and hand in the adult population in Spain. Material and methods. Cross-sectional population-based study. A multistage and stratified random cluster sampling was carried out. The participants were contacted by telephone to complete an osteoarthritis screening questionnaire. A rheumatologist confirmed or discarded the diagnosis. The ACR-clinical-criteria were used to diagnose hand-osteoarthritis and the ACR-clinical-radiological criteria to diagnose knee- and hip-osteoarthritis. To estimate the prevalence and its 95% confidence interval, weights were calculated according to the probability of selection in each of the sampling stages. Results. The prevalence of osteoarthritis in Spain in one or more of the locations studied was 29.35%. The prevalence of cervical-osteoarthritis was 10.10% and of lumbar-osteoarthritis 15.52%. Both are more frequent in women and at older ages, as well as in people with low levels of education and obesity. The prevalence of hip-osteoarthritis was 5.13%, that of knee-osteoarthritis 13.83%, these are associated with female sex, overweight and obesity. The prevalence of hand osteoarthritis was 7.73%. It is more frequent in women, who are obese, with a low educational level and who are older. Conclusion. The EPISER2016 study is the first to analyse the prevalence of symptomatic osteoarthritis in 5 locations (cervical, lumbar, knee, hip and hands) in Spain. Lumbar spine osteoarthritis is the most prevalent., EPISER2016 ha sido financiado por Celgene, Laboratorios, Gebro Pharma, Merck Sharp and Dohme de España, Pfizer y Sanofi-Aventis. Los financiadores no han intervenido en el diseño del estudio, recogida ni análisis de datos, ni en la redacción de este artículo. IRP yMS fueron financiados con programas Miguel Servet II y Contrato Río Hortega-Fondo de Investigación Sanitaria (CPII17/00026 y CM17/00101), respectivamente. El Fondo de Investigación Sanitaria, integrado en el Plan Nacional de Programa Científico, Desarrollo e Innovación Tecnológica 2013-2016, es financiado por el ISCIII-Subdirección General de Evaluación y Promoción de la Investigación-Fondo Europeo de Desarrollo Regional (FEDER) «Una forma de hacer Europa»
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

mtDNA haplogroup A enhances the effect of obesity on the risk of knee OA in a mexican population

  • Ramos-Louro, Paula
  • Arellano Pérez Vertti, Rubén Daniel
  • López-Reyes, Alberto
  • Martínez-Nava, Gabriela Angélica
  • Espinosa, Rolando
  • Pineda, Carlos
  • González Galarza, Faviel Francisco
  • Argüello Astorga, Rafael
  • Aguilar Muñiz, Lizette Sarai
  • Hernández Terán, Fernando
  • Parra Torres, Nancy Marbella
  • Durán-Sotuela, Alejandro
  • Fernández-Moreno, Mercedes
  • Balboa-Barreiro, Vanesa
  • Blanco García, Francisco J
  • Rego-Pérez, I.
[Abstract] To evaluate the influence of mitochondrial DNA haplogroups on the risk of knee OA in terms of their interaction with obesity, in a population from Mexico. Samples were obtained from (n = 353) knee OA patients (KL grade ≥ I) and (n = 364) healthy controls (KL grade = 0) from Mexico city and Torreon (Mexico). Both Caucasian and Amerindian mtDNA haplogroups were assigned by single base extension assay. A set of clinical and demographic variables, including obesity status, were considered to perform appropriate statistical approaches, including chi-square contingency tables, regression models and interaction analyses. To ensure the robustness of the predictive model, a statistical cross-validation strategy of B = 1000 iterations was used. All the analyses were performed using boot, GmAMisc and epiR package from R software v4.0.2 and SPSS software v24. The frequency distribution of the mtDNA haplogroups between OA patients and healthy controls for obese and non-obese groups showed the haplogroup A as significantly over-represented in knee OA patients within the obese group (OR 2.23; 95% CI 1.22-4.05; p-value = 0.008). The subsequent logistic regression analysis, including as covariate the interaction between obesity and mtDNA haplogroup A, supported the significant association of this interaction (OR 2.57; 95% CI 1.24-5.32; p-value = 0.011). The statistical cross-validation strategy confirmed the robustness of the regression model. The data presented here indicate a link between obesity in knee OA patients and mtDNA haplogroup A., This work is supported by Grants from Fondo de Investigación Sanitaria (PI17/00210, PI16/02124, PI20/00614, RETIC-RIER-RD16/0012/0002 and PRB3-ISCIII-PT17/0019/0014) integrated in the National Plan for Scientific Program, Development and Technological Innovation 2013–2016 and funded by the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) “A way of making Europe” and Grant IN607A2017/11 from Xunta de Galicia. The authors further acknowledge AE CICA-INIBIC (ED431E 2018/03) for financial support. IRP is supported by Contrato Miguel Servet-II Fondo de Investigación Sanitaria (CPII17/00026) and AD-S is supported by Grant IN606A-2018/023 from Xunta de Galicia, Spain. The Biomedical Research Networking Center (CIBER) is an initiative from Instituto de Salud Carlos III (ISCIII), Xunta de Galicia; IN607A2017/11, Xunta de Galicia; ED431E 2018/03, Xunta de Galicia; IN606A-2018/023
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

A clinical model including protein biomarkers predicts radiographic knee osteoarthritis: a prospective study using data from the Osteoarthritis Initiative

  • Lourido Salas, Lucía María
  • Balboa-Barreiro, Vanesa
  • Ruiz-Romero, Cristina
  • Rego-Pérez, I.
  • Camacho Encina, María
  • Paz González, Rocío
  • Calamia, Valentina
  • Oreiro Villar, Natividad
  • Nilsson, Peter
  • Blanco García, Francisco J
The Osteoarthritis Initiative (OAI) is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Pfizer, Inc.; Novartis Pharmaceuticals Corporation; Merck Research Laboratories; and GlaxoSmithKline. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This work has been supported by grants from Fondo Investigación Sanitaria (PI16/02124, PI17/00404, PI19/01206, DTS17/00200, CIBER-CB06/01/0040 and RETIC-RIER-RD16/0012/0002), integrated in the National Plan for Scientific Program, Development and Technological Innovation 2013–2016 and funded by the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) “A way of making Europe”. This study has been also supported by grants IN607A2017/11, IN607D2020/10 and AE CICA-INIBIC (ED431E 2018/03) from Xunta de Galicia. The Proteomics Unit of GIR belongs to ProteoRed, PRB3- ISCIII (PT17/0019/0014). L.L. is supported by Xunta de Galicia (IN606B-2016/2005) and Contrato Sara Borrell (CD19/00229) Fondo de Investigación Sanitaria, ISCIII. I.R.P. is supported by Contrato Miguel Servet-II Fondo de Investigación Sanitaria (CPII17/00026). This work was also supported by the KTH Center for Applied Precision Medicine funded by the Ehrling Persson foundation, as well as the Human Protein Atlas project funded by Knut and Alice Wallenberg Foundation, Xunta de Galicia; IN607A2017/11, Xunta de Galicia; IN607D2020/10, Xunta de Galicia; ED431E 2018/03, Xunta de Galicia; IN606B-2016/2005
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Antimicrobial activity of Cefiderocol against the Carbapenemase-producing Enterobacter cloacae complex and characterization of reduced susceptibility associated with Metallo-β-Lactamase VIM-1

  • Lasarte-Monterrubio, Cristina
  • Guijarro-Sánchez, Paula
  • Vázquez-Ucha, Juan Carlos
  • Alonso-García, Isaac
  • Álvarez-Fraga, Laura
  • Outeda-García, Michelle
  • Martínez Guitián, Marta
  • Peña-Escolano, Andrea
  • Maceira, Romina
  • Lence, Emilio
  • González-Bello, Concepción
  • Arca-Suárez, Jorge
  • Bou, Germán
  • Beceiro Casas, Alejandro
[Abstract] Emergence of cefiderocol resistance among carbapenemase-producing Enterobacterales, particularly those in the Enterobacter cloacae complex (ECC), is becoming of alarming concern; however, the mechanistic basis of this phenomenon remains poorly understood. We describe the acquisition of VIM-1-mediated reduced cefiderocol susceptibility (MICs 0.5 to 4 mg/L) in a collection of 54 carbapenemase-producing isolates belonging to the ECC. MICs were determined by reference methodologies. Antimicrobial resistance genomic analysis was performed through hybrid WGS. The impact of VIM-1 production on cefiderocol resistance in the ECC background was examined at microbiological, molecular, biochemical, and atomic levels. Antimicrobial susceptibility testing yielded 83.3% susceptible isolates and MIC50/90 values of 1/4 mg/L. Decreased susceptibility to cefiderocol was mainly associated with isolates producing VIM-1, with cefiderocol MICs 2- to 4-fold higher than for isolates carrying other types of carbapenemases. E. cloacae and Escherichia coli VIM-1 transformants displayed significantly enhanced cefiderocol MICs. Biochemical assays with purified VIM-1 protein revealed low but detectable cefiderocol hydrolysis. Simulation studies revealed how cefiderocol is anchored to the VIM-1 active site. Additional molecular assays and WGS data analysis highlighted the implication of SHV-12 coproduction and suggested the inactivation of the FcuA-like siderophore receptor as further contributors to the higher cefiderocol MICs. Our findings warn of the potential of the VIM-1 carbapenemase to at least partly limit the activity of cefiderocol in the ECC. This effect is probably enhanced due to combination with additional mechanisms, such as ESBL production and siderophore inactivation, and indicates the need for active surveillance to extend the life span of this promising cephalosporin., This research was supported by Projects PI17/01482 and PI20/01212 awarded to AB, PI22/01212 to JAS and PI18/00501 to GB, within in the National Plan for Scientific Research, Development and Technological Innovation 2017 to 2020 and funded by the ISCIII-General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A way of making Europe.” The work was also supported by CIBERINFEC (CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III). The study was also funded by project IN607A 2020/05 (GAIN-Agencia Gallega de Innovación-Consellería de Economía, Emprego e Industria) awarded to GB and project IN607D 2021/12 awarded to AB. It was also supported by Planes Nacionales de I+D+i2017 to 2020 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/006) cofinanced by European Development Regional Fund “A way to achieve Europe” and operative program Intelligent Growth2014 to 2020. J.A.-S. was financially supported by the Juan Rodés program (ISCIII, JR21/00026), J.C.V.-U. was financially supported by IN606B-2022/009 Grant (Xunta de Galicia), C.L.-M. was financially supported by IN606A-2019/029 Grant (Xunta de Galicia) and PGS was financially supported by IN606A 2021/021 Grant (Xunta de Galicia). M.O. was financially supported by IN607D 2021/12 (Xunta de Galicia). I.A.-G. was financially supported by the Rio Hortega program (ISCIII, CM21/00076). C.G.-B. acknowledges financial support from the Spanish Ministry of Science and Innovation (PID2019-105512RB-I00), the Xunta de Galicia (ED431C 2021/29 and the Centro singular de investigación de Galicia accreditation2019 to 2022 [ED431G 2019/03]), and the European Regional Development Fund (ERDF)., Xunta de Galicia; IN607A 2020/05, Xunta de Galicia; IN607D 2021/12, Xunta de Galicia; IN606B-2022/009, Xunta de Galicia; IN606A-2019/029, Xunta de Galicia; IN606A 2021/021, Xunta de Galicia; ED431C 2021/29, Xunta de Galicia; ED431G 2019/03
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study

  • Lasarte-Monterrubio, Cristina
  • Guijarro, Paula
  • Alonso-García, Isaac
  • Outeda-García, Michelle
  • Maceiras, Romina
  • González-Pinto, Lucía
  • Martínez Guitián, Marta
  • Fernández-Lozano, Carlos
  • Vázquez-Ucha, Juan Carlos
  • Bou, Germán
  • Arca-Suárez, Jorge
  • Beceiro Casas, Alejandro
[Abstract]: Background: As increasing antibiotic resistance in Acinetobacter baumannii poses a global healthcare challenge, understanding its evolution is crucial for effective control strategies. Aim: We aimed to evaluate the epidemiology, antimicrobial susceptibility and main resistance mechanisms of Acinetobacter spp. in Spain in 2020, and to explore temporal trends of A. baumannii. Methods: We collected 199 single-patient Acinetobacter spp. clinical isolates in 2020 from 18 Spanish tertiary hospitals. Minimum inhibitory concentrations (MICs) for nine antimicrobials were determined. Short-read sequencing was performed for all isolates, and targeted long-read sequencing for A. baumannii. Resistance mechanisms, phylogenetics and clonality were assessed. Findings on resistance rates and infection types were compared with data from 2000 and 2010. Results: Cefiderocol and colistin exhibited the highest activity against A. baumannii, although colistin susceptibility has significantly declined over 2 decades. A. non-baumannii strains were highly susceptible to most tested antibiotics. Of the A. baumannii isolates, 47.5% (56/118) were multidrug-resistant (MDR). Phylogeny and clonal relationship analysis of A. baumannii revealed five prevalent international clones, notably IC2 (ST2, n = 52; ST745, n = 4) and IC1 (ST1, n = 14), and some episodes of clonal dissemination. Genes blaOXA-23, blaOXA-58 and blaOXA-24/40 were identified in 49 (41.5%), eight (6.8%) and one (0.8%) A. baumannii isolates, respectively. ISAba1 was found upstream of the gene (a blaOXA-51-like) in 10 isolates. Conclusions: The emergence of OXA-23-producing ST1 and ST2, the predominant MDR lineages, shows a pivotal shift in carbapenem-resistant A. baumannii (CRAB) epidemiology in Spain. Coupled with increased colistin resistance, these changes underscore notable alterations in regional antimicrobial resistance dynamics., This work was supported by Projects PI20/01212 and PI23/00851 awarded to AB, Project PI21/00704 awarded to GB, and Project PI22/01212 awarded to JA-S, funded by the Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. The work was also supported by CIBER-Consorcio Centro de Investigación Biomédica en Red- de Enfermedades Infecciosas, Instituto de Salud Carlos III (CB21/13/00055), Ministerio de Ciencia e Innovación and Unión Europea—NextGenerationEU and by project IN607A 2020/05 (GAIN-Agencia Gallega de InnovaciónConsellería de Economía, Emprego e Industria) awarded to GB and project IN607D 2021/12 awarded to AB. JA-S was financially supported by the Juan Rodés program (ISCIII, JR21/00026), JCV-U was financially supported by IN606B-2022/009 (Xunta de Galicia), CL-M was financially supported by PI20/01212 (ISCIII), PG-S was financially supported by IN606A 2021/021 Grant (Xunta de Galicia). MO was financially supported by IN607D 2021/12. IA-G was financially supported by the Rio Hortega program (ISCIII, CM21/00076). MM-G was financially supported by RSU.UDC.M505 (Ministerio de Universidades)., Xunta de Galicia; IN607A 2020/05, Xunta de Galicia; IN607D 2021/12, Xunta de Galicia; IN606B-2022/009, Xunta de Galicia; IN606A 2021/021, Xunta de Galicia; IN607D 2021/12, Universidade da Coruña; RSU.UDC.M505
eBiltegia. Repositorio Institucional de Mondragon Unibertsitatea
Publication Contribución de congreso (ConferenceOutput)

Comfort improvement of an elevator car by viscoelastic sandwich panels

Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Building a metadata framework for sharing feed information in Spain

  • Maroto-Molina, Francisco
  • Gómez-Cabrera, Augusto
  • Guerrero-Ginel, José Emilio
  • Garrido-Varo, Ana
  • Pérez-Marín, D.C.
Information about the nutritional aspects and uses of feed is of widespread interest, hence systematic efforts of laboratories to obtain it. The way this information is currently being handled leaves something to be desired, underscoring the need to use computerized systems and statistical techniques that allow the management of large volumes of heterogeneous information. This project seeks to develop a structure that will facilitate the exchange and exploitation of information on feeds produced in Spain. To this end, metadata and data mining techniques have been adopted by the Feed Information Service at the University of Cordoba. The structure has been designed to work on the basis of a server-client architecture, in which information is stored on local software (Califa) by its own creators so that it can subsequently be incorporated into a database server where it can be accessed online. Various aspects of the structure are described in this paper: organization (participants and data shared), format (physical features), logistics (data description), quality (reliability of information), legality (correct use of data), and financing (revenue and expenditure). An indication is given of the amount of information accumulated to date, now exceeding 200,000 numerical data and associated metadata, arranged in several thematic databases. The activities carried out highlight the heterogeneous nature of the information produced, as well as the large number of errors and ambiguities that slip through the normal filters and reach the end-user of the data.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Estimation of soil coverage of chopped pruning residues in olive orchards by image analysis

  • Jiménez Jiménez, Francisco
  • Blanco Roldán, Gregorio L.
  • Márquez García, Francisco
  • Castro García, Sergio
  • Agüera Vega, Juan
Residue chopping from orchard pruning is becoming a common practice in conservation agriculture after the establishment of eco-conditionality policies in the European Union. This type of residue is used to protect the soil from erosion and improve the water balance and fertility of soils by improving the organic matter content. However, no studies have evaluated the influence of pruning residues and size on soil coverage. This study examines the effect of different treatments on pruning residue soil coverage in an olive orchard (cv. Picual). Treatments consisted of two quantities of pruning residues, specifically, high (2.04 kg m-2) and low (1.02 kg m-2), and two chopping speeds, low (2.4 km h-1) and high (3.2 km h-1). The different treatments were evaluated by image analysis and pixel counting to determine the soil cover percentage, size, number and distribution of the pruning residues after chopping. After chopping, the soil cover percentage was 39% higher in the high quantity pruning residue treatments but was not significantly influenced by the chopping speed. The size and number of lignified residues was quantified via pixel counting. In the high quantity pruning residue treatments, the number of large lignified residues (> 6 cm2) was higher, and the number of pruning residues smaller than 2 cm2 was lower, when compared with low quantity pruning residue treatments. The high chopping speed treatments produced more smaller-sized pruning residues.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Improvement of soil carbon sink by cover crops in olive orchards under semiarid conditions. Influence of the type of soil and weed

  • Márquez García, Francisco
  • González Sánchez, Emilio Jesús
  • Castro García, Sergio
  • Ordóñez Fernández, Rafaela
The olive tree is one of the most important crops in Spain, and the main one in the region of Andalusia. Most orchards are rain-fed, with high slopes where conventional tillage (CT) is the primary soil management system used. These conditions lead to high erosion and a significant transport of organic carbon (OC). Moreover, soil tillage accelerates the oxidation of the OC. Cover crops (CC) are the conservation agriculture (CA) approach for woody crops. They are grown in-between tree rows to protect the soil against water erosion and their organic residues also help to increase the soil carbon (C) sink. Soil and OC losses associated to the sediment were measured over four seasons (2003-07) using micro-plots for the collection of runoff and sediment in five experimental fields located in rain-fed olive orchards in Andalusia. Two soil management systems were followed, CC and CT. Furthermore, the changes in soil C in both systems were analyzed at a depth of 0-25 cm. CC reduced erosion by 80.5%, and also OC transport by 67.7%. In addition, Cover crops increased soil C sink by 12.3 Mg ha-1 year-1 of carbon dioxide (CO2) equivalent, with respect to CT. CC in rainfed olive orchards in a Mediterranean climate could be an environmental friendly and profitable system for reducing erosion and increasing the soil C sink. However, C fixing rate is not regular, being very high for the initial years after shifting from CT to CC and gradually decreasing over time.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Transformation of plum plants with a cytosolic ascorbate peroxidase transgene leads to enhanced water stress tolerance

  • Díaz-Vivancos, Pedro
  • Faize, Lydia
  • Nicolás Nicolás, Emilio
  • Clemente-Moreno, María José
  • Bru-Martínez, Roque
  • Burgos Ortiz, Lorenzo
  • Hernández, José Antonio
[Background and Aims] Water deficit is the most serious environmental factor limiting agricultural production. In this work, the tolerance to water stress (WS) of transgenic plum lines harbouring transgenes encoding cytosolic antioxidant enzymes was studied, with the aim of achieving the durable resistance of commercial plum trees., [Methods] The acclimatization process was successful for two transgenic lines: line C3-1, co-expressing superoxide dismutase (two copies) and ascorbate peroxidase (one copy) transgenes simultaneously; and line J8-1, harbouring four copies of the cytosolic ascorbate peroxidase gene (cytapx). Plant water relations, chlorophyll fluorescence and the levels of antioxidant enzymes were analysed in both lines submitted to moderate (7 d) and severe (15 d) WS conditions. Additionally, in line J8-1, showing the best response in terms of stress tolerance, a proteomic analysis and determination of the relative gene expression of two stress-responsive genes were carried out., [Key Results] Line J8-1 exhibited an enhanced stress tolerance that correlated with better photosynthetic performance and a tighter control of water-use efficiency. Furthermore, this WS tolerance also correlated with a higher enzymatic antioxidant capacity than wild-type (WT) and line C3-1 plum plants. On the other hand, line C3-1 displayed an intermediate phenotype between WT plants and line J8-1 in terms of WS tolerance. Under severe WS, the tolerance displayed by J8-1 plants could be due to an enhanced capacity to cope with drought-induced oxidative stress. Moreover, proteomic analysis revealed differences between WT and J8-1 plants, mainly in terms of the abundance of proteins related to carbohydrate metabolism, photosynthesis, antioxidant defences and protein fate., [Conclusions] The transformation of plum plants with cytapx has a profound effect at the physiological, biochemical, proteomic and genetic levels, enhancing WS tolerance. Although further experiments under field conditions will be required, it is proposed that J8-1 plants would be an interesting Prunus rootstock for coping with climate change., P.D.V. thanks CSIC and the Spanish Ministry of Economy and Competitiveness for his ‘Ramon y Cajal’ research contract, co-financed by FEDER funds. M.J.C.M. acknowledges the Spanish Ministry of Economy and Competitiveness for her ‘Juan de la Cierva’ research contract. This work was supported by the Spanish Ministry of Economy and Competitiveness (Project CICYT BFU2009-07443 and Project INIA RTA2013-00026-C03-00), co-financed by FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Oxidative stress and antioxidative responses in plant–virus interactions

  • Hernández, José Antonio
  • Gullner, Gábor
  • Clemente-Moreno, María José
  • Künstler, András
  • Juhász, Csilla
  • Díaz-Vivancos, Pedro
  • Király, Lóránt
During plant–virus interactions, defence responses are linked to the accumulation of reactive oxygen species (ROS). Importantly, ROS play a dual role by (1) eliciting pathogen restriction and often localized death of host plant cells at infection sites and (2) as a diffusible signal that induces antioxidant and pathogenesis-related defence responses in adjacent plant cells. The outcome of these defences largely depends on the speed of host responses including early ROS accumulation at virus infection sites. Rapid host reactions may result in early virus elimination without any oxidative stress (i.e. a symptomless, extreme resistance). A slower host response allows a certain degree of virus replication and movement resulting in oxidative stress and programmed death of affected plant cells before conferring pathogen arrest (hypersensitive response, HR). On the other hand, delayed host attempts to elicit virus resistance result in an imbalance of antioxidative metabolism and massively stressed systemic plant tissues (e.g. systemic chlorotic or necrotic symptoms). The final consequence of these processes is a partial or almost complete loss of control over virus invasion (compatible infections)., Research in the author's laboratories is supported by grants of the Hungarian Scientific Research Fund (K111995 and PD108455) and the Spanish Ministry of Economy and Competitiveness (Project INIA, RTA2013-00026-C03-00). PDV acknowledges the CSIC and the Spanish Ministry of Economy and Competitiveness for his ‘Ramon y Cajal’ research contract, cofinanced by FEDER funds. MJCM acknowledges the Spanish Ministry of Economy and Competitivenes for her ‘Juan de la Cierva’ research contract., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cytosolic ascorbate peroxidase and Cu, Zn-superoxide dismutase improve seed germination, plant growth, nutrient uptake and drought tolerance in tobacco

  • Faize, Mohamed
  • Nicolás Nicolás, Emilio
  • Faize, Lydia
  • Díaz-Vivancos, Pedro
  • Burgos Ortiz, Lorenzo
  • Hernández, José Antonio
The effects of over-expression of two cytosolic antioxidant enzymes (Cu, Zn-SOD and/or APX) on plant nutrition, gas exchange, chlorophyll fluorescence, seed viability and germination in transgenic tobacco (Nicotiana tabacum cv. Xanthi) under deficit irrigation or salinity conditions were investigated. Three transgenic lines of tobacco were used in this study: line 17, harboring 2 copies of the cytosolic CuZn-SOD (cytsod) gene; line 51, with 2 copies of the cytosolic APX (cytapx) gene and line 39, harboring one copy of each gene. Over-expression of cytosolic antioxidants enzymes in tobacco plants resulted in a better growth performance that correlated with an improved photosynthetic capacity and nutrient uptake. Moreover, cytsod or cytapx genes promoted seed germination, and enhanced tolerance to mild water stress. In addition, this enhanced antioxidant capacity protected seeds from ageing during prolonged storage, and stimulated germination under salt stress conditions. These results suggest that cytosolic antioxidant transgenes are useful tools to improve drought tolerance, nutrient uptake and seed germination under stressful conditions., PDV acknowledges the CSIC and the Spanish Ministry of Economy and Competitiveness for his ‘Ramon y Cajal’ research contract, co-financed by FEDER funds. This work was supported by the Spanish Ministry of Economy and Competitiveness (Project CICYT BFU2009-07443) co-financed by FEDER funds, and the Spanish Ministry of Economy and Competitiveness (Project INIA, RTA2013-00026-C03-00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The salt-stress response of the transgenic plum line J8-1 and its interaction with the salicylic acid biosynthetic pathway from mandelonitrile

  • Bernal Vicente, Agustina
  • Cantabella, Daniel
  • Petri Serrano, César
  • Hernández, José Antonio
  • Díaz-Vivancos, Pedro
Salinity is considered as one of the most important abiotic challenges that affect crop productivity. Plant hormones, including salicylic acid (SA), are key factors in the defence signalling output triggered during plant responses against environmental stresses. We have previously reported in peach a new SA biosynthetic pathway from mandelonitrile (MD), the molecule at the hub of the cyanogenic glucoside turnover in Prunus sp. In this work, we have studied whether this new SA biosynthetic pathway is also present in plum and the possible role this pathway plays in plant plasticity under salinity, focusing on the transgenic plum line J8-1, which displays stress tolerance via an enhanced antioxidant capacity. The SA biosynthesis from MD in non-transgenic and J8-1 micropropagated plum shoots was studied by metabolomics. Then the response of J8-1 to salt stress in presence of MD or Phe (MD precursor) was assayed by measuring: chlorophyll content and fluorescence parameters, stress related hormones, levels of non-enzymatic antioxidants, the expression of two genes coding redox-related proteins, and the content of soluble nutrients. The results from in vitro assays suggest that the SA synthesis from the MD pathway demonstrated in peach is not clearly present in plum, at least under the tested conditions. Nevertheless, in J8-1 NaCl-stressed seedlings, an increase in SA was recorded as a result of the MD treatment, suggesting that MD could be involved in the SA biosynthesis under NaCl stress conditions in plum plants. We have also shown that the plum line J8-1 was tolerant to NaCl under greenhouse conditions, and this response was quite similar in MD-treated plants. Nevertheless, the MD treatment produced an increase in SA, jasmonic acid (JA) and reduced ascorbate (ASC) contents, as well as in the coefficient of non-photochemical quenching (qN) and the gene expression of Non-Expressor of Pathogenesis-Related 1 (NPR1) and thioredoxin H (TrxH) under salinity conditions. This response suggested a crosstalk between different signalling pathways (NPR1/Trx and SA/JA) leading to salinity tolerance in the transgenic plum line J8-1., This work was supported by the Spanish Ministry of Economy and Competitiveness (Projects AGL2014-52563-R and INIA-RTA2013-00026-C03-00). PDV and CP thank CSIC and UPCT, respectively, as well as the Spanish Ministry of Economy and Competitiveness for their ‘Ramon and Cajal’ research contract, co-financed by FEDER funds. This work was supported by the Spanish Ministry of Economy and Competitiveness (Projects AGL2014-52563-R and INIA-RTA2013-00026-C03-00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Discriminant analysis using fatty acids profile, stable carbon isotopes and tocopherols content as tool for feeding system prediction in Iberian pigs

  • García Casco, Juan María
  • Delgado-Chavero, C. L.
  • Zapata, Elena
  • Paredes, Andrés
  • Muñoz, María
  • Rey, Ana I.
11 Pág., Aim of study: The application of three analytical methods (fatty acids: FA, tocopherols: TOC, and isotope ratio: ISO) to distinguish the feeding type received by Iberian pigs during the fattening stage. Area of study: This distinction is very important for the labelling of Iberian high-quality products in the Quercus forest located on the southwest of Iberian Peninsula, where several production systems coexist. Material and methods: Discriminant analysis on fat samples with unknown background obtained from commercial pigs was applied. The feasibility of the combination method to determine the authentication of feeding background was studied on samples from different fattening system: free-range feeding with acorn and pastures (BE); free-range feeding acorn and pastures plus commercial feeds (RE); open-air feeding with commercial feeds (CA); standard feeding with commercial feeds (CE). Main results: In a first application of the methods, the overall success rate was 60.1% for FA, 49.7% for ISO and 49.3% for TOC. When some of the batches were reclassified attending to those previous results and additional information available about farm characteristics, ISO and TOC analyses had a 70% of success rate in the four categories, whereas FA showed 40.5%, attributable to the use of high-oleic commercial diets. The predictions improved with the method combination. The ISO+TOC combination achieved a 84.1% of success in prediction. When it was reduced to just two categories (acorn vs non-acorn), the success reached a 95% for FA+TOC and ISO+TOC. Research highlights: The use of these methods as a complementary tool for quality controls is highly recommended to avoid undesirable misclassifications., INIA, Spain (INIA-RTA2008-00026) Agreement INIA-Ministerio de Medio Ambiente, Medio Rural y Marino (CC08-0031), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Variability in subcutaneous fat composition of Iberian pigs reared in free-range conditions in the southwest of the Iberian Peninsula

  • Tejeda, Juan Florencio
  • Hernández-Matamoros, A.
  • García Casco, Juan María
  • González-Sánchez, Elena
9 Pág., A total of 80 free-range Iberian pigs reared with acorns and grass in eight different free-range systems (n =10)inthesouthwestoftheIberianPeninsulawereused to determine the relationship between fatty acid, tocopherol, and neophytadiene subcutaneous fat composition. The pigs were fed extensively for 79.1 ± 9.5 d from 110.9 ± 11.9 kg live weight at the beginning of the final fattening phase to 175.0 ± 15.9 kg slaughtered weight. Quercus suber and Quercus rotundifolia acorns were characterised by a high content of C18:1n-9 (58.3 and 63.1%, respectively) and γ-tocopherol [43.7 and 43.0 mg kg−1 dry matter (DM), respectively], while grass exhibited a high content of C18:3n-3 (42.5%), α-tocopherol (366.5 mg kg−1 DM) and neophytadiene (136.2 relative area units). The C18:1n-9 (54.4%–57.7%) and γ-tocopherol (2.7–4.1 mg kg−1 DM) contents in subcutaneous fat from Iberian pigs differed (p < 0.001) between the free-range systems studied. Pasture intake had a significant effect (p < 0.01) on subcutaneous fat content of C18:3n-3 (0.5%–0.8%), α-tocopherol (7.8–13.1 mg kg−1 DM) and neophytadiene (2.6–6.3 relative area units). However, the results demonstrated no correlations between accumulated levels of these compounds throughout the free-range period. In conclusion, the absence of correlations corroborated the heterogeneity of extensive rearing systems, with variations between years and geographical areas where the Iberian pigs were reared., This study was supported by the project RTA2008-00026-C07-07., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Regulatory circuits involving bud dormancy factor PpeDAM6

  • Lloret, Alba
  • Quesada-Traver, Carles
  • Conejero, Ana
  • Arbona, Vicent
  • Gómez-Mena, Concepción
  • Petri, César
  • Sánchez-Navarro, Jesús A
  • Zuriaga, Elena
  • Leida, Carmen
  • Badenes, María Luisa
  • Ríos, Gabino
[Data availability] RNA-seq data can be found in the National Center for Biotechnology Information (NCBI) BioProject database ID PRJNA630876., DORMANCY-ASSOCIATED MADS-BOX (DAM) genes have recently emerged as key potential regulators of the dormancy cycle and climate adaptation in perennial species. Particularly, PpeDAM6 has been proposed to act as a major repressor of bud dormancy release and bud break in peach (Prunus persica). PpeDAM6 expression is downregulated concomitantly with the perception of a given genotype-dependent accumulation of winter chilling time, and the coincident enrichment in H3K27me3 chromatin modification at a specific genomic region. We have identified three peach BASIC PENTACYSTEINE PROTEINs (PpeBPCs) interacting with two GA-repeat motifs present in this H3K27me3-enriched region. Moreover, PpeBPC1 represses PpeDAM6 promoter activity by transient expression experiments. On the other hand, the heterologous overexpression of PpeDAM6 in European plum (Prunus domestica) alters plant vegetative growth, resulting in dwarf plants tending toward shoot meristem collapse. These alterations in vegetative growth of transgenic lines associate with impaired hormone homeostasis due to the modulation of genes involved in jasmonic acid, cytokinin, abscisic acid, and gibberellin pathways, and the downregulation of shoot meristem factors, specifically in transgenic leaf and apical tissues. The expression of many of these genes is also modified in flower buds of peach concomitantly with PpeDAM6 downregulation, which suggests a role of hormone homeostasis mechanisms in PpeDAM6-dependent maintenance of floral bud dormancy and growth repression., This research was funded by Instituto Nacional de Investigación y Tecnologıa Agraria y Alimentaria (INIA)-FEDER (RTA2013-00026-C03-01, RTA2017-00011-C03-01). A. L. was funded by a fellowship from Ministerio de Ciencia (Spanish Government). C. Q.-T. was funded by a fellowship co-financed by the European Social Fund and the IVIA, Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Application of genomic technologies to the breeding of trees

  • Badenes, M.L.
  • Fernández i Marti, A.
  • Ríos, G.
  • Rubio-Cabetas, M.J.
The recent introduction of next generation sequencing (NGS) technologies represents a major revolution in providing new tools for identifying the genes and/or genomic intervals controlling important traits for selection in breeding programs. In perennial fruit trees with long generation times and large sizes of adult plants, the impact of these techniques is even more important. High-throughput DNA sequencing technologies have provided complete annotated sequences in many important tree species. Most of the high-throughput genotyping platforms described are being used for studies of genetic diversity and population structure. Dissection of complex traits became possible through the availability of genome sequences along with phenotypic variation data, which allow to elucidate the causative genetic differences that give rise to observed phenotypic variation. Association mapping facilitates the association between genetic markers and phenotype in unstructured and complex populations, identifying molecular markers for assisted selection and breeding. Also, genomic data provide in silico identification and characterization of genes and gene families related to important traits, enabling new tools for molecular marker assisted selection in tree breeding. Deep sequencing of transcriptomes is also a powerful tool for the analysis of precise expression levels of each gene in a sample. It consists in quantifying short cDNA reads, obtained by NGS technologies, in order to compare the entire transcriptomes between genotypes and environmental conditions. The miRNAs are non-coding short RNAs involved in the regulation of different physiological processes, which can be identified by high-throughput sequencing of RNA libraries obtained by reverse transcription of purified short RNAs, and by in silico comparison with known miRNAs from other species. All together, NGS techniques and their applications have increased the resources for plant breeding in tree species, closing the former gap of genetic tools between trees and annual species.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Ability of Swept-Source Optical Coherence Tomography to Detect Retinal and Choroidal Changes in Patients with Multiple Sclerosis

  • Garcia-Martin, E.
  • Jarauta, L.
  • Vilades, E.
  • Ara, J.R.
  • Martin, J.
  • Polo, V.
  • Larrosa, J.M.
  • Pablo, L.E.
  • Satue, M.
Purpose. To evaluate the ability of new swept-source (SS) optical coherence tomography (OCT) technology to detect changes in retinal and choroidal thickness in patients with multiple sclerosis (MS). Methods. A total of 101 healthy and 97 MS eyes underwent retinal and choroidal assessment using SS Triton OCT (Topcon). Macular thickness and peripapillary data (retinal, ganglion cell layer (GCL+, GCL++) and retinal nerve fiber layer (RNFL) thickness) were analyzed, including choroidal thickness evaluation. Results. Significant macular thinning was observed in all ETDRS areas (p<0.001) in MS patients. Peripapillary retinal, RNFL, and GCL ++ thickness showed a significant reduction in patients in all sectors (p<0.001) except in the nasal quadrant/sector (p>0.05). GCL+ measurements were found to be reduced in the nasal (p=0.003), inferonasal (p=0.045), and temporal (p=0.001) sectors and total thickness (p<0.001). Choroidal thickness was reduced in the outer macular ring in MS patients compared with controls (p=0.038). Conclusion. New swept-source technology for OCT devices detects retinal thinning in MS patients, providing increased depth analysis of the choroid in these patients. MS patients present reduced retinal and choroidal thickness in the macular area and reduced peripapillary retinal, RNFL, and GCL thickness.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Functional Evaluation of the Visual Pathway in Patients with Multiple Sclerosis Using a Multifunction Stimulator Monitor

  • Satue, M.
  • Jarauta, L.
  • Obis, J.
  • Cipres, M.
  • Rodrigo, M.J.
  • Almarcegui, C.
  • Dolz, I.
  • Ara, J.R.
  • Martin, J.
  • Pablo, L.E.
  • Garcia-Martin, E.
Objectives. To assess the capability of the vision monitor unit Monpack One of detecting visual function alterations in patients with multiple sclerosis (MS) and to evaluate the correlation between structural retinal parameters and functional measurements obtained with this device. Methods. Forty-eight patients with MS and 46 healthy controls were included in a cross-sectional study. All participants underwent a complete functional evaluation of the visual pathway, which included low-contrast visual acuity (LCVA), contrast sensitivity vision (CSV), automated perimetry, multifocal visual evoked potentials (mfVEPs), and pattern electroretinogram (ERG). All tests were performed using the vision monitor unit Monpack One (Metrovision, France), a multifunction stimulator device. Retinal structural measurements were obtained in all subjects using Triton swept source optical coherence tomography (Topcon, Japan). Results. Patients with MS presented reduced low-contrast VA (p<0.001) and reduced CSV at medium (p=0.001, p=0.013) and low (p=0.001, p=0.002) spatial frequencies. All visual field parameters were found to be altered in MS patients compared with controls (<= 0.001). Patients with MS presented lower amplitude of the P100 waveform of the mfVEP in areas corresponding to central (p<0.001), inferonasal (p=0.001), and inferotemporal (p=0.003) retina. The pattern ERG did not show significant differences. Significant correlations were observed between structural retinal measurements and functional parameters, especially between the inner macular areas and measurements corresponding to contrast sensitivity and perimetry indexes. Conclusions. Patients with MS present visual dysfunction detectable with the vision monitor unit Monpack One. This device may be a fast and useful tool to provide a full evaluation of axonal damage in patients with multiple sclerosis.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Evaluation of progressive visual dysfunction and retinal degeneration in patients with parkinson’s disease

  • Satue, M.
  • Rodrigo, M.J.
  • Obis, J.
  • Vilades, E.
  • Gracia, H.
  • Otin, S.
  • Fuertes, M.I.
  • Alarcia, R.
  • Crespo, J.A.
  • Polo, V.
  • Larrosa, J.M.
  • Pablo, L.E.
  • Garcia-Martin, E.
PURPOSE. To quantify changes in visual function parameters and in the retinal nerve fiber layer and macular thickness over a 5-year period in patients with Parkinson’s disease (PD). METHODS. Thirty patients with PD and 30 healthy subjects underwent a complete ophthalmic evaluation, including assessment of visual acuity, contrast sensitivity vision, color vision, and retinal evaluation with spectral-domain optical coherence tomography (SD-OCT). All subjects were reevaluated after 5 years to quantify changes in visual function parameters, the retinal nerve fiber layer, and macular thickness. Association between progressive ophthalmologic changes and disease progression was analyzed. RESULTS. Changes were detected in visual function parameters and retinal nerve fiber layer thickness in patients compared with controls. Greater changes were found during the follow-up in the PD group than healthy subjects in visual acuity, contrast sensitivity, Lanthony color test (P < 0.016), in superotemporal and temporal retinal nerve fiber layer sectors (P < 0.001), and in macular thickness (all sectors except inner superior and inner inferior sectors, P < 0.001). Progressive changes in the retinal nerve fiber layer were associated with disease progression (r = 0.389, P = 0.028). CONCLUSIONS. Progressive visual dysfunction, macular thinning, and axonal loss can be detected in PD. Analysis of the macular thickness and the retinal nerve fiber layer by SD-OCT can be useful for evaluating Parkinson’s disease progression.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Clinical phenotypes for risk stratification in small-for-gestational-age fetuses

  • Ruiz-Martinez, S.
  • Delgado, J. L.
  • Paules, C.
  • Cavallaro, A.
  • De Paco, C.
  • Villar, J.
  • Papageorghiou, A.
  • Oros, D.
ABSTRACTObjectiveTo evaluate whether clinical phenotypes of small‐for‐gestational‐age (SGA) fetuses can be identified and used for adverse perinatal outcome risk stratification to facilitate clinical decision‐making.MethodsThis was a multicenter observational cohort study conducted in two tertiary care university hospitals. SGA fetuses were classified according to maternal, fetal and placental conditions using a two‐step cluster algorithm, in which fetuses with more than one condition were assigned to the cluster associated with the highest mortality risk. Delivery and perinatal outcomes were compared using chi‐square test among SGA clusters, and the associations between outcomes and each cluster were evaluated by calculating odds ratios (OR), adjusted for gestational age.ResultsThe study included 17 631 consecutive singleton pregnancies, of which 1274 (7.2%) were defined as SGA at birth according to INTERGROWTH‐21st standards. Nine SGA clinical phenotypes were identified using a predefined conceptual framework. All delivery and perinatal outcomes analyzed were significantly different among the nine phenotypes. The whole SGA cohort had a three‐times higher risk of perinatal mortality compared with non‐SGA fetuses (1.4% vs 0.4%; P < 0.001). SGA clinical phenotypes exhibited three patterns of perinatal mortality risk: the highest risk was associated with congenital anomaly (8.3%; OR, 17.17 (95% CI, 2.17–136.12)) and second‐ or third‐trimester hemorrhage (8.3%; OR, 9.94 (95% CI, 1.23–80.02)) clusters; medium risk was associated with gestational diabetes (3.8%; OR, 9.59 (95% CI, 1.27–72.57)), preterm birth (3.2%; OR, 4.65 (95% CI, 0.62–35.01)) and intrauterine growth restriction (3.1%; OR, 5.93 (95% CI, 3.21–10.95)) clusters; and the lowest risk was associated with the remaining clusters. Perinatal mortality rate did not differ between SGA fetuses without other clinical conditions (54.1% of SGA fetuses) and appropriate‐for‐gestational‐age fetuses (0.1% vs 0.4%; OR, 0.41 (95% CI, 0.06–2.94); P = 0.27). SGA combined with other obstetric pathologies increased significantly the risk of perinatal mortality, as demonstrated by the increased odds of perinatal death in SGA cases with gestational diabetes compared to non‐SGA cases with the same condition (OR, 24.40 (95% CI, 1.31–453.91)).ConclusionsWe identified nine SGA clinical phenotypes associated with different patterns of risk for adverse perinatal outcome. Our findings suggest that considering clinical characteristics in addition to ultrasound findings could improve risk stratification and decision‐making for management of SGA fetuses. Future clinical trials investigating management of fetuses with SGA should take into account clinical information in addition to Doppler parameters and estimated fetal weight. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Designing interventions guided by digital phenotype and pharmacogenetics in Spain for suicidal behaviour based on retrospective data: the multicentre SMARTomicS study protocol

  • Artés, Carmen
  • Porras-Segovia, Alejandro
  • Ruiz-Veguilla, Miguel
  • Giner, Lucas
  • Garcia-Campayo, Javier
  • López del Hoyo, Yolanda
  • Alejandra-Saiz, Pilar
  • García-Fernández, Ainoa
  • Martínez-Jambrina, Juan José
  • Villa-Díez, Rocío
  • Gili, Margalida
  • Roca, Miquel
  • de Andrés, Fernando
  • Pérez Sola, Víctor
  • Elices, Matilde E.
  • Grande, Iria
  • Cebria, Ana Isabel
  • Irigoyen-Otiñano, Maria
  • Galván-Santiago, Leonardo
  • Aguilar Garcia-Iturrospe, Eduardo Jesús
  • Mesones-Peral, Jesús
  • Mora-Marín, Rafael
  • Sierra, Pîlar
  • Penas-Lledo, Eva
  • LLerena, Adrian
  • Lopez-Castroman, Jorge
  • Cruz, Raquel
  • Arrojo, Manuel
  • Ovejero, Santiago
  • de la Torre-Luque, Alejandro
  • Palao-Tarrero, Ángela
  • Vaquero-Lorenzo, Concepción
  • Toma, Claudio
  • Barrigon, Maria Luisa
  • Artes, Antonio
  • Díaz-Marsá, Marina
  • Ayad-Ahmed, Wala
  • Ibáñez, Ángela
  • Díaz-Sastre, Carmen
  • Salvador-Robert, Mercè
  • Álvarez-García, Raquel
  • Mata-Iturralde, Laura
  • Benavente-López, Sergio
  • Muñoz-Lorenzo, Laura
  • Di Stasio, Ezequiel Fernando
  • Carmona-Camacho, Rodrigo
  • Peñuelas-Calvo, Inmaculada
  • Valencia, Miguel
  • López Peña, Purificación
  • Albarracín-García, Lucía
  • Baca-Garcia, Enrique
Introduction: Each year, suicide claims approximately 700 000 lives worldwide and generates a significant financial burden. Integrating genomic data, exposomic factors and digital phenotypes can enhance the development of short-term predictive models. Current knowledge and available tools provide the basis for designing personalised treatment strategies that incorporate real-time interventions to prevent suicide attempt recurrence cost-effectively. This study aims to develop a predictive algorithm for suicidal behaviour integrating psychiatric assessments, genetic risk markers, digital phenotypes and exposomic data. Methods and analysis: This protocol describes a retrospective multicentre study that will recruit participants with a clinical history of suicide across 25 hospitals across Spain with a catchment area of 8.6 million people (17.8% of Spain’s population). Our sample target is over 5000 participants, aged over 12 years old, ensuring 93.5% statistical power for genetic analysis. Eligible participants must be over 12 years old. Data collection will include psychiatric assessments, biospecimen collections (DNA, RNA, plasma and serum), Google Takeout data for digital phenotyping, and a standardised set of administrative and clinical data registered for each patient. Genotyping will be performed with the Axiom Spanish array (>750 000 markers), and genome-wide association studies (GWAS) will be performed after genetic imputation in a whole sample of >10 000 individuals (5000 suicide attempters; 5000 controls). Prescription and clinical history will also be retrospectively integrated, and codified data statistics forms will periodically be sent to the Government. Statistical analyses will combine traditional regression models and AI-based algorithms to identify predictive behavioural, genomic profiles, and digital markers of suicidal behaviour. Cost-effectiveness analyses of pharmacogenomic markers for antidepressant response will also be conducted. By successfully implementing this project, we aim to help reduce suicide reattempts and lessen the emotional and economic burden on families and the healthcare system.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Association Between Suicidal Ideation and Negative Affect: 6-Month Ecological Momentary Assessment Study

  • Porras-Segovia, Alejandro
  • Pérez-Balaguer, Ana
  • Alacreu-Crespo, Adrián
  • Barrigón, Maria Luisa
  • García-Barja, Paula
  • Courtet, Philippe
  • López-Castroman, Jorge
  • Peñuelas-Calvo, Inmaculada
  • Baca-García, Enrique
Background Suicide is a major public health challenge. Traditional assessments of suicidal thoughts and behaviors rely on retrospective measures that are subject to recall bias and show limited predictive accuracy. Ecological momentary assessment (EMA) can improve suicide risk assessment by capturing real-time information in participants’ natural environments. However, EMA burden often results in short follow-up periods. Objective This study aimed to examine the association between suicidal ideation (SI) and multiple variables collected in real time using smartphone-based EMA over 6 months, with the goal of identifying short-term predictors of suicide risk in a clinical population. A secondary objective was to explore whether baseline depression and psychological pain predicted EMA-reported SI. Methods This is a prospective EMA-based study carried out among outpatients at high risk of suicide, recruited in Madrid, Spain. At baseline, depression, suicidality, and psychological and physical pain were assessed using traditional questionnaires (Inventory of Depressive Symptomatology, Columbia Suicide Severity Rating Scale, and Visual Analog Scales). During the 6-month follow-up, participants completed daily smartphone-based EMA prompts assessing SI, nonsuicidal self-injury, negative affect, interpersonal experiences, sleep, and eating habits. Each day, 2-4 questions derived from validated instruments were randomly selected from a pool of 34 items to minimize participant burden. Mixed-effects models examined within-person variability, temporal trends, and real-time associations between EMA variables and SI. Intraindividual variability was quantified using intraclass correlation coefficients and root mean squared successive differences. Linear regression analyses explored associations between EMA variables and demographic covariates and evaluated whether baseline depression and psychological pain predicted the mean and variability of SI and negative affect. Results A total of 99 participants were included in the final analysis, and 13,900 EMA responses were obtained. The slope of SI showed no significant changes over time, with similar results for negative affect, interpersonal difficulties, sleep problems, and appetite. Substantial within-person variability was observed across all EMA domains. Negative affect (ß=0.193, SE 0.03; t98=6.21; P<.001) and interpersonal difficulties (ß=0.03, SE 0.168; t98=5.96; P=.001) were significantly associated with SI and remained significant in combined models. In a subsample of 37 participants, lower baseline psychological pain was associated with lower levels of negative affect and SI over time, whereas higher baseline depression was associated with greater negative affect. Conclusions This study provides novel insights into the real-time relationship between SI and key psychological and behavioral variables, particularly negative affect and interpersonal difficulties, using smartphone-based EMA in a high-risk clinical population. The substantial within-person variability highlights the dynamic nature of suicide risk and the limitations of traditional assessments. Future studies should aim to translate EMA-based monitoring into actionable interventions to provide real-time support for individuals at high risk of suicide.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

  • Vega-Garcia, Nerea
  • Benito, Rocío
  • Esperanza-Cebollada, Elena
  • Llop, Marta
  • Robledo, Cristina
  • Vicente-Garcés, Clara
  • Ortega Blanco, Margarita
Leucèmia limfoblàstica aguda infantil; Seqüenciació de nova generació, Leucemia linfoblástica aguda infantil; Secuenciación de nueva generación, Childhood acute lymphoblastic leukemia; Next-generation sequencing, The development of Next-Generation Sequencing (NGS) has provided useful diagnostic, prognostic, and therapeutic strategies for individualized management of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) patients. Consequently, NGS is rapidly being established in clinical practice. However, the technology’s complexity, bioinformatics analysis, and the different available options difficult a broad consensus between different laboratories in its daily routine introduction. This collaborative study among Spanish centers was aimed to assess the feasibility, pros, and cons of our customized panel and other commercial alternatives of NGS-targeted approaches. The custom panel was tested in three different sequencing centers. We used the same samples to assess other commercial panels (OncomineTM Childhood Cancer Research Assay; Archer®FusionPlex® ALL, and Human Comprehensive Cancer Panel GeneRead Panel v2®). Overall, the panels showed a good performance in different centers and platforms, but each NGS approach presented some issues, as well as pros and cons. Moreover, a previous consensus on the analysis and reporting following international guidelines would be preferable to improve the concordance in results among centers. Our study shows the challenges posed by NGS methodology and the need to consider several aspects of the chosen NGS-targeted approach and reach a consensus before implementing it in daily practice., This study has been supported by a grant from “Fundación Unoentrecienmil”; grants from Instituto de Salud Carlos III (PI12/02417; PI16/00246; PI12/00816; PI16CIII/00026; PI16/0665); Asociación Pablo Ugarte (TPY-M 1149/13; TRPV 205/18), ASION (TVP 141/17); Fundación Sonrisa de Alex & Todos somos Iván (TVP 1324/15); Consejería de Educación, Junta de Castilla y León (SA271P18); Fondos FEDER (CIBERONC [CB16/12/00284]), Proyectos de Investigación del SACYL, GRS 1847/A/18, Generalitat Valenciana GV2019/077 and Fundación AMPILE. J.M.H.S. is supported with a research grant by FEHH (“Fundación Española de Hematología y Hemoterapia”), A.M. a grant from Junta provincial de Salamanca de la Asociación Española Contra el Cáncer (AECC), and M.M. holds the grant “Ayuda predoctoral de la Junta de Castilla y León” by the Fondo Social Europeo (JCYL-EDU/556/2019 Ph.D. scholarship).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Machine learning-based health environmental-clinical risk scores in European children

  • Guimbaud, Jean-Baptiste
  • Siskos, Alexandros
  • Sakhi, Amrit Kaur
  • Heude, Barbara
  • Sabidó, Eduard
  • Borràs, Eva
  • Alemany, Silvia
Environmental exposure; Machine learning; European children, Exposición ambiental; Aprenentatge automàtic; Nens europeus, Exposición ambiental; Aprendizaje automático; Niños europeos, Background Early life environmental stressors play an important role in the development of multiple chronic disorders. Previous studies that used environmental risk scores (ERS) to assess the cumulative impact of environmental exposures on health are limited by the diversity of exposures included, especially for early life determinants. We used machine learning methods to build early life exposome risk scores for three health outcomes using environmental, molecular, and clinical data. Methods In this study, we analyzed data from 1622 mother-child pairs from the HELIX European birth cohorts, using over 300 environmental, 100 child peripheral, and 18 mother-child clinical markers to compute environmental-clinical risk scores (ECRS) for child behavioral difficulties, metabolic syndrome, and lung function. ECRS were computed using LASSO, Random Forest and XGBoost. XGBoost ECRS were selected to extract local feature contributions using Shapley values and derive feature importance and interactions. Results ECRS captured 13%, 50% and 4% of the variance in mental, cardiometabolic, and respiratory health, respectively. We observed no significant differences in predictive performances between the above-mentioned methods.The most important predictive features were maternal stress, noise, and lifestyle exposures for mental health; proteome (mainly IL1B) and metabolome features for cardiometabolic health; child BMI and urine metabolites for respiratory health. Conclusions Besides their usefulness for epidemiological research, our risk scores show great potential to capture holistic individual level non-hereditary risk associations that can inform practitioners about actionable factors of high-risk children. As in the post-genetic era personalized prevention medicine will focus more and more on modifiable factors, we believe that such integrative approaches will be instrumental in shaping future healthcare paradigms., The authors would like to thank all the participating children, parents, practitioners, and researchers in the six countries who took part in this study. The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. We also acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, and the CERCA Programme / Generalitat de Catalunya. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is supported by “Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya” (2021SGR01225 and 2021SGR01563). This project was funded by the H2020-EU.3.1.2.—Preventing Disease Programme under grant agreement no 874583 (ATHLETE project). JB Guimbaud was supported by a CIFRE PhD fellowship (#2020/1297). Léa Maitre is funded by a Juan de la Cierva-Incorporación fellowship (IJC2018-035394-I) awarded by the Spanish Ministerio de Economía, Industria y Competitividad. ISGlobal and the Exposome hub acknowledges support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. Jose Urquiza is supported by Catalan program PERIS (Ref.: SLT017/20/000119), granted by Departament de Salut de la Generalitat de Catalunya (Spain). Oliver Robinson was funded by the UK Research and Innovation Future Leaders Fellowship (MR/S03532X/1). Silvia Alemany holds a Miquel Servet-I contract (CP22/00026) awarded by the Instituto de Salud Carlos III co-funded by the European Union Found: Fondo Social Europeo Plus, FSE + . Mónica López-Vicente is funded by a Juan de la Cierva-Incorporación fellowship (project IJC2020-045355-I, funded by MCIN/AEI/10.13039/501100011033 and for the European Union NextGenerationEU/PRTR). The data of the cohorts (BiB, EDEN, INMA, KANC, MoBa and RHEA) provided to this research leading to these results has received funding from the European Community’s Seventh Framework Programme (FP7/2007‐2013) under grant agreement no 308333—the HELIX project. Fig. 2 was created with BioRender.com.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Bosch, Rosa
  • Carabí-Gassol, Pau
  • MACÍAS CHIMBORAZO, VALERIA
  • Español Martin, Gemma
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Attention-deficit/hyperactivity disorder; Autism spectrum disorder; School performance, Trastorn per dèficit d'atenció i hiperactivitat; Trastorn de l'espectre autista; Rendiment escolar, Trastorno por déficit de atención e hiperactividad; Trastorno del espectro autista; Rendimiento escolar, Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404, PI23/00026 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Network Center for Biomedical Research (CIBER) to J.C.D.; the European Regional Development Fund (ERDF); the ECNP Network ‘ADHD across the Lifespan’; “la Marató de TV3” (202228-30 and 202228-31), “Fundació ‘la Caixa’, Diputació de Barcelona, Pla Estratègic de Recerca i Innovació en Salut” (PERISSLT006/17/285); “Fundació Privada d’Investigació Sant Pau” (FISP); and Ministry of Health of Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Experimental study on ferritic stainless steel trapezoidal decks for composite slabs in construction stage

  • Arrayago Luquin, Itsaso
  • Real Saladrigas, Esther
  • Mirambell Arrizabalaga, Enrique
  • Marimón Carvajal, Federico
  • Ferrer Ballester, Miquel
The use of composite floor slabs is well established and provides an opportunity to promote the use of visually exposed composite slabs. Stainless steels, with the combination of good mechanical properties and excellent corrosion resistance, are key to this strategy, specially ferritic stainless steels, whose price is lower and more stable than that corresponding to the more widely used austenitic grades, due to their low nickel content whilst still maintaining good mechanical properties and aesthetic appeal. In addition, the emissivity of these grades contributes to lowering the heating and cooling requirements of buildings, reducing the costs associated to maintenance. Generally used as cold-formed members with high resistance-to-weight ratios, stainless steel decks are slender and highly sensitive to buckling phenomena and so the study of the structural performance of composite slabs using ferritic stainless steel decking is required due to the complex nonlinear behaviour of stainless steels, which is very different from that exhibited by carbon steel. Thus, this paper presents a comprehensive experimental programme on ferritic stainless steel trapezoidal decks for composite slabs under several structural configurations occurring during construction stage: simply supported decks under positive and negative bending moment, continuous decks and internal and end support tests. All the experimental results have been compared with the predicted ultimate loads in EN 1993-1-4, which remits to EN 1993-1-3 for carbon steel, and also with some previous tests on galvanized carbon steel decks. The paper concludes that EN 1993-1-3 provisions are applicable to ferritic stainless steels., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The Salt-Stress Response of the Transgenic Plum Line J8-1 and Its Interaction with the Salicylic Acid Biosynthetic Pathway from Mandelonitrile

  • Bernal-Vicente, Agustina
  • Cantabella, Daniel
  • Petri, Cesar
  • Hernández, José Antonio
  • Diaz-Vivancos, Pedro
Salinity is considered as one of the most important abiotic challenges that affect crop productivity. Plant hormones, including salicylic acid (SA), are key factors in the defence signalling output triggered during plant responses against environmental stresses. We have previously reported in peach a new SA biosynthetic pathway from mandelonitrile (MD), the molecule at the hub of the cyanogenic glucoside turnover in Prunus sp. In this work, we have studied whether this new SA biosynthetic pathway is also present in plum and the possible role this pathway plays in plant plasticity under salinity, focusing on the transgenic plum line J8-1, which displays stress tolerance via an enhanced antioxidant capacity. The SA biosynthesis from MD in non-transgenic and J8-1 micropropagated plum shoots was studied by metabolomics. Then the response of J8-1 to salt stress in presence of MD or Phe (MD precursor) was assayed by measuring: chlorophyll content and fluorescence parameters, stress related hormones, levels of non-enzymatic antioxidants, the expression of two genes coding redox-related proteins, and the content of soluble nutrients. The results from in vitro assays suggest that the SA synthesis from the MD pathway demonstrated in peach is not clearly present in plum, at least under the tested conditions. Nevertheless, in J8-1 NaCl-stressed seedlings, an increase in SA was recorded as a result of the MD treatment, suggesting that MD could be involved in the SA biosynthesis under NaCl stress conditions in plum plants. We have also shown that the plum line J8-1 was tolerant to NaCl under greenhouse conditions, and this response was quite similar in MD-treated plants. Nevertheless, the MD treatment produced an increase in SA, jasmonic acid (JA) and reduced ascorbate (ASC) contents, as well as in the coefficient of non-photochemical quenching (qN) and the gene expression of Non-Expressor of Pathogenesis-Related 1 (NPR1) and thioredoxin H (TrxH) under salinity conditions. This response suggested a crosstalk between different signalling pathways (NPR1/Trx and SA/JA) leading to salinity tolerance in the transgenic plum line J8-1., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Arribas, Lorena
  • Demontis, Ditte
  • Cabana-Dominguez, Judit
  • Llonga, Natalia
  • Alemany, Silvia
  • Vilar-Ribo, Laura
  • Fadeuilhe, Christian
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Soler Artigas, María
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Transcriptomic risk scores; Attention deficit and hyperactivity disorder, Puntuaciones de riesgo transcriptómico; Trastorno por déficit de atención e hiperactividad, Puntuació de risc transcriptòmic; Trastorn per dèficit d'atenció i hiperactivitat, Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus (FSE+) (P19/01224, PI20/00041, PI22/00464 and FI18/00285 to LVR, CP22/00128 to MSA and CP22/00026 to SA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD), the Network Center for Biomedical Research (CIBER) to JCD, the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’ and the “la Marató de TV3” (202228-30 and 202228-31). ADB was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003) and NIH/NIMH (1R01MH124851-01). DD was supported by the Novo Nordisk Foundation (NNF20OC0065561) and the Lundbeck Foundation (R344-2020-1060).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

  • GRAU-LÓPEZ, LARA
  • Daigre, Constanza
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Heterogeneity; Substance use disorder; Genome, Heterogeneidad; Trastorno por consumo de sustancias; Genoma, Heterogeneïtat; Trastorn per consum de substàncies; Genoma, Substance use disorder (SUD) is a global health problem with a significant impact on individuals and society. The presentation of SUD is diverse, involving various substances, ages at onset, comorbid conditions, and disease trajectories. Current treatments for SUD struggle to address this heterogeneity, resulting in high relapse rates. SUD often co-occurs with other psychiatric and mental health-related conditions that contribute to the heterogeneity of the disorder and predispose to adverse disease trajectories. Family and genetic studies highlight the role of genetic and environmental factors in the course of SUD, and point to a shared genetic liability between SUDs and comorbid psychopathology. In this study, we aimed to disentangle SUD heterogeneity using a deeply phenotyped SUD cohort and polygenic scores (PGSs) for psychiatric disorders and related traits. We explored associations between PGSs and various SUD-related phenotypes, as well as PGS-environment interactions using information on lifetime emotional, physical, and/or sexual abuse. Our results identify clusters of individuals who exhibit differences in their phenotypic profile and reveal different patterns of associations between SUD-related phenotypes and the genetic liability for mental health-related traits, which may help explain part of the heterogeneity observed in SUD. In our SUD sample, we found associations linking the genetic liability for attention-deficit hyperactivity disorder (ADHD) with lower educational attainment, the genetic liability for post-traumatic stress disorder (PTSD) with higher rates of unemployment, the genetic liability for educational attainment with lower rates of criminal records and unemployment, and the genetic liability for well-being with lower rates of outpatient treatments and fewer problems related to family and social relationships. We also found evidence of PGS-environment interactions showing that genetic liability for suicide attempts worsened the psychiatric status in SUD individuals with a history of emotional physical and/or sexual abuse. Collectively, these data contribute to a better understanding of the role of genetic liability for mental health-related conditions and adverse life experiences in SUD heterogeneity., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840 and 2021-SGR-01093), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to M.S.A, RYC2021-031324-I to J.C.D and PID2021-1277760B-I100 to B.C. and N.F-C.), the Ministry of Health, Social Services and Equality (PNSD-2020I042 to N.F-C.), the Network Center for Biomedical Research (CIBER) to J.C.D., the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’, “Fundació La Marató de TV3” (202228-30, 202228-31 and 202218-31) and ICREA Academia 2021.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Draft genome sequences of Mycobacterium setense type strain DSM-45070 and the nonpathogenic strain Manresensis, isolated from the bank of the Cardener river in Manresa, Catalonia, Spain

  • Rech, Gabriel
  • Vilaplana i Massaguer, Cristina
  • Velasco, Juan
  • Pluvinet, Raquel
  • Santín, Sheila
  • Julián, Esther|||0000-0002-6558-3978
  • Alcaide, Fernando|||0000-0002-4097-1499
  • Comas, I.|||0000-0001-5504-9408
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Cardona, Pere-Joan|||0000-0001-5623-7873
We present here the draft genome sequences of two Mycobacterium setense strains. One of them corresponds to the M. setense type strain DSM-45070, originally isolated from a patient with a posttraumatic chronic skin abscess. The other one corresponds to the nonpathogenic M. setense strain Manresensis, isolated from the Cardener River crossing Manresa, Catalonia, Spain. A comparative genomic analysis shows a smaller genome size and fewer genes in M. setense strain Manresensis relative to those of the type strain, and it shows the genome segments unique to each strain.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Text mining and expert curation to develop a database on psychiatric diseases and their genes

  • Gutiérrez-Sacristán, Alba
  • Bravo, Àlex
  • Portero Tresserra, Marta|||0000-0003-4149-1339
  • Valverde, Olga|||0000-0003-2264-7852
  • Armario Garcia, Antonio|||0000-0001-9524-3635
  • Blanco-Gandía, M. C.
  • Farré Martínez, Adriana|||0000-0001-5399-9389
  • Fernández Ibarrondo, Lierni|||0000-0003-2612-0484
  • Fonseca, Francina|||0000-0002-0779-6545
  • Giraldo, Jesús|||0000-0001-7082-4695
  • Leis, Angela
  • Mané, Anna|||0000-0003-2127-349X
  • Mayer, M. A.
  • Montagud-Romero, Sandra
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
  • Ortiz de Pablo, Jordi|||0000-0002-9748-2290
  • Pavon, Francisco Javier
  • Perez, Ezequiel Jesús
  • Rodríguez-Arias, Marta
  • Serrano, Antonia
  • Torrens, Marta
  • Warnault, Vincent
  • Sanz, Ferran|||0000-0002-7534-7661
  • Furlong, Laura I.
Psychiatric disorders constitute one of the main causes of disability worldwide. During the past years, considerable research has been conducted on the genetic architecture of such diseases, although little understanding of their etiology has been achieved. The difficulty to access up-to-date, relevant genotype-phenotype information has hampered the application of this wealth of knowledge to translational research and clinical practice in order to improve diagnosis and treatment of psychiatric patients. PsyGeNET () has been developed with the aim of supporting research on the genetic architecture of psychiatric diseases, by providing integrated and structured accessibility to their genotype-phenotype association data, together with analysis and visualization tools. In this article, we describe the protocol developed for the sustainable update of this knowledge resource. It includes the recruitment of a team of domain experts in order to perform the curation of the data extracted by text mining. Annotation guidelines and a web-based annotation tool were developed to support the curators' tasks. A curation workflow was designed including a pilot phase and two rounds of curation and analysis phases. Negative evidence from the literature on gene-disease associations (GDAs) was taken into account in the curation process. We report the results of the application of this workflow to the curation of GDAs for PsyGeNET, including the analysis of the inter-annotator agreement and suggest this model as a suitable approach for the sustainable development and update of knowledge resources. Database URL : PsyGeNET corpus:.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease

  • Morenas-Rodríguez, Estrella|||0000-0002-7591-6051
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Suárez Calvet, Marc|||0000-0002-2993-569X
  • Muñoz, Laia|||0000-0003-0578-3094
  • Vilaplana, Eduard|||0000-0002-1809-8435
  • Sala Matavera, Isabel|||0000-0002-9886-4792
  • Subirana, Andrea
  • Querol-Vilaseca, Marta|||0000-0002-8589-1636
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Ribosa-Nogué, Roser|||0000-0002-9233-4336
  • Blesa, Rafael|||0000-0003-4026-2884
  • Haass, Christian|||0000-0002-4869-1627
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
The role of innate immunity in dementia with Lewy bodies (DLB) has been little studied. We investigated the levels in cerebrospinal fluid (CSF) of glial proteins YKL-40, soluble TREM2 (sTREM2) and progranulin in DLB and their relationship with Alzheimer's disease (AD) biomarkers. We included patients with DLB (n = 37), prodromal DLB (prodDLB, n = 23), AD dementia (n = 50), prodromal AD (prodAD, n = 53), and cognitively normal subjects (CN, n = 44). We measured levels of YKL-40, sTREM2, progranulin, Aβ, total tau (t-tau) and phosphorylated tau (p-tau) in CSF. We stratified the group DLB according to the ratio t-tau/Aβ (≥0.52, indicative of AD pathology) and the A/T classification. YKL-40, sTREM2 and progranulin levels did not differ between DLB groups and CN. YKL-40 levels were higher in AD and prodAD compared to CN and to DLB and prodDLB. Patients with DLB with a CSF profile suggestive of AD copathology had higher levels of YKL-40, but not sTREM2 or PGRN, than those without. T+ DLB patients had also higher YKL-40 levels than T-. Of these glial markers, only YKL-40 correlated with t-tau and p-tau in DLB and in prodDLB. In contrast, in prodAD, sTREM2 and PGRN also correlated with t-tau and p-tau. In conclusion, sTREM2 and PGRN are not increased in the CSF of DLB patients. YKL-40 is only increased in DLB patients with an AD biomarker profile, suggesting that the increase is driven by AD-related neurodegeneration. These data suggest a differential glial activation between DLB and AD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Acute and subacute effects of oropharyngeal sensory stimulation with TRPV1 agonists in older patients with oropharyngeal dysphagia, a biomechanical and neurophysiological randomized pilot study

  • Tomsen, Noemí|||0000-0001-7149-7948
  • Ortega, Omar|||0000-0001-6178-3748
  • Rofes, Laia|||0000-0002-1628-5253
  • Arreola, Viridiana|||0000-0003-3913-317X
  • Martín-Martínez, Alberto|||0000-0002-6805-764X
  • Mundet, Lluís|||0000-0001-9091-8998
  • Clavé i Civit, Pere|||0000-0002-0696-8560
Background: Older people with oropharyngeal dysphagia (OD) present a decline in pharyngeal sensory function. The aim of this proof-of-concept study was to assess the biomechanical and neurophysiological effects of acute and subacute oropharyngeal sensory stimulation with transient receptor potential vanilloid 1 (TRPV1) agonists (capsaicinoids) in older patients with OD. Methods: We studied the effect of a single dose versus multiple doses (2 weeks) of oral capsaicin treatment (10 M) or placebo in 28 older patients with OD (81.2 ± 4.6 years) using videofluoroscopy (penetration-aspiration scale [PAS], timing of swallow response) and electroencephalography (EEG) (latency and amplitude of pharyngeal event-related potential [ERP]). Results: Acute stimulation by capsaicinoids 10 M did not improve swallow function and did not produce significant changes in pharyngeal ERP. In contrast, after 10 days of treatment, patients presented a clinically relevant and statistically significant reduction in the laryngeal vestibule closure (LVC) time (22.5%, p = 0.042), and in the PAS (24.2%, p = 0.038), compared with the placebo group. EEG results showed a reduction in the latency of the N1 peak (28.6%, p = 0.007) and an increase of the amplitude of the P1-N2 (59.4%, p = 0.038) and the N2-P2 (43.6%, p = 0.050) peaks. We observed a strong and significant correlation between the reduction in the latency of the N1 peak and change in LVC time after subacute treatment (r = 0.750, p = 0.003). Conclusions: After 2 weeks of treatment, oropharyngeal sensory stimulation with capsaicinoids induced cortical changes that were correlated with improvements in swallowing biomechanics in older patients with OD. These results further show that sensory stimulation by TRPV1 agonists can become a useful pharmacological treatment for older patients with OD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Effect of a gum-based thickener on the safety of swallowing in patients with poststroke oropharyngeal dysphagia

  • Bolivar-Prados, Mireia|||0000-0002-8896-1150
  • Rofes, L.
  • Arreola, Viridiana|||0000-0003-3913-317X
  • Guida, S.
  • Nascimento, Weslania Viviane|||0000-0003-1267-3475
  • Martín-Martínez, Alberto|||0000-0002-6805-764X
  • Vilardell, N.|||0000-0002-1357-9889
  • Ortega, Omar|||0000-0001-6178-3748
  • Ripken, D.
  • Lansink, M.
  • Clavé i Civit, Pere|||0000-0002-0696-8560
Background: Increasing viscosity with thickening agents is a valid therapeutic strategy for oropharyngeal dysphagia (OD). To assess the therapeutic effect of a xanthan gum-based thickener (Nutilis Clear) at six viscosities compared with thin liquid in poststroke OD (PSOD) patients. Methods: A total of 120 patients with PSOD were studied in this controlled, multiple-dose, fixed-order, and single-blind study using videofluoroscopy (VFSS). A series of boluses of 10 mL thin liquid and 2000, 1400, 800, 450, 250, and 150 mPa s viscosities were given in duplicate, interrupted in case of aspiration. We assessed the safety and efficacy of swallow and the kinematics of the swallow response. Key Results: A total of 41.2% patients had safe swallow at thin liquid which significantly increased for all viscosities from 71.9% at 150 mPa s to 95.6% at 1400 mPa s (P <.001). PAS score (3.7 ± 2.3) at thin liquid was also reduced by increasing bolus viscosity (P <.001). The prevalence of patients with aspiration at thin liquid was 17.5% and decreased at all viscosities (P <.01), except at 150 mPa s. Increasing viscosity shortened time to laryngeal vestibule closure (LVC) at all viscosities (P <.01) and reduced bolus velocity at ≥450 mPa s (P <.05). The prevalence of patients with pharyngeal residue at each viscosity 37.7%-44.7% was similar to that at thin liquid (41.2%). Conclusions and Inferences: The prevalence of unsafe swallow with thin liquids is very high in PSOD. Increasing shear bolus viscosity with this xanthan gum-based thickener significantly increased the safety of swallow in patients with PSOD in a viscosity-dependent manner without increasing the prevalence of pharyngeal residue.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Assessment of kinship detection using RNA-seq data

  • Blay, Natalia|||0000-0002-7160-8529
  • Casas Masnou, Eduard|||0000-0002-6001-1276
  • Galván-Femenía, Iván|||0000-0002-6124-3730
  • Graffelman, Jan|||0000-0003-3900-0780
  • de Cid, Rafael|||0000-0003-3579-6777
  • Vavouri, Tanya|||0000-0003-2352-9049
Analysis of RNA sequencing (RNA-seq) data from related individuals is widely used in clinical and molecular genetics studies. Prediction of kinship from RNA-seq data would be useful for confirming the expected relationships in family based studies and for highlighting samples from related individuals in case-control or population based studies. Currently, reconstruction of pedigrees is largely based on SNPs or microsatellites, obtained from genotyping arrays, whole genome sequencing and whole exome sequencing. Potential problems with using RNA-seq data for kinship detection are the low proportion of the genome that it covers, the highly skewed coverage of exons of different genes depending on expression level and allele-specific expression. In this study we assess the use of RNA-seq data to detect kinship between individuals, through pairwise identity by descent (IBD) estimates. First, we obtained high quality SNPs after successive filters to minimize the effects due to allelic imbalance as well as errors in sequencing, mapping and genotyping. Then, we used these SNPs to calculate pairwise IBD estimates. By analysing both real and simulated RNA-seq data we show that it is possible to identify up to second degree relationships using RNA-seq data of even low to moderate sequencing depth.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Long-Term Outcomes of Patients With Cocaine Use Disorder, A 18-years Addiction Cohort Study

  • Sanvisens, Arantza|||0000-0001-6269-5491
  • Hernandez Rubio, Anna|||0000-0001-8612-7827
  • Zuluaga Cruz, Andrea Paola|||0000-0002-3003-4856
  • Fuster, Daniel|||0000-0003-1262-5860
  • Papaseit, Esther|||0000-0003-2620-4274
  • Galan, Sara
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Muga, Roberto|||0000-0001-6301-431X
Objective: Cocaine Use Disorder (CUD) has been associated with multiple complications and premature death. The purpose of the present study was to analyze the relationship between baseline medical comorbidity and long-term medical outcomes (i.e., hospitalization, death) in a cohort of patients primarily admitted for detoxification. In addition, we aimed to analyze cause-specific mortality. Methods: longitudinal study in CUD patients admitted for detoxification between 2001 and 2018. Substance use characteristics, laboratory parameters and medical comorbidity by VACS Index were assessed at admission. Follow-up and health-related outcomes were ascertained through visits and e-health records. Kaplan-Meier and Cox regression models were used to analyze survival and predictors of hospitalization and death. Results: 175 patients (77.7% men) were included. Age at admission was 35 years [IQR: 30-41 years], 59.4% of the patients being intranasal users, 33.5% injectors, and 7.1% smokers. Almost 23% of patients had concomitant alcohol use disorder, 39% were cannabis users and 9% opiate users. The median VACS Index score on admission was 10 points [IQR: 0-22]. After 12 years [IQR: 8.6-15 years] of follow-up there were 1,292 (80.7%) ED admissions and 308 (19.3%) hospitalizations. The incidence rate of ED admission and hospitalization was 18.6 × 100 p-y (95% CI: 15.8-21.8 × 100 p-y). Mortality rate was 1.4 × 100 p-y (95% CI: 0.9-2.0 × 100 p-y) and, baseline comorbidity predicted hospitalization and mortality: those with VACS Index.
Dipòsit Digital de Documents de la UAB
Publication

Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program, A longitudinal study

  • Sanvisens, Arantza|||0000-0001-6269-5491
  • Rivas, Inmaculada|||0000-0003-2633-5530
  • Faure, Eva|||0000-0002-5056-0888
  • Espinach, Néstor|||0000-0002-5726-5435
  • Hernandez Rubio, Anna|||0000-0001-8612-7827
  • Majó, Xavier|||0000-0003-4338-6014
  • Colom Farran, J.|||0000-0001-6861-7865
  • Muga, Roberto|||0000-0001-6301-431X
Direct-acting antivirals (DAAs) are recommended for the treatment of hepatitis C virus (HCV) infection in patients treated with methadone or buprenorphine. To assess HCV treatment rates in an Opioid Treatment Program (OTP). This longitudinal study included 501 patients (81.4% men, median age: 45 years; interquartile range: 39-50 years) enrolled in an OTP between October 2015 and September 2017. Patients were followed until September 2019. Data on socio-demographics, substance use, HCV infection, human immunodeficiency virus (HIV) infection and laboratory parameters were collected at entry. We analyzed medical records to evaluate HCV treatment. Kaplan-Meier methods and Cox regression models were used to analyze the DAA treatment uptake and to identify treatment predictors. Prevalence of HCV and HIV infection was 70% and 34%, respectively. Among anti-HCV-positive (n = 336) patients, 47.2%, 41.3%, and 31.9% used alcohol, cannabis, and cocaine, respectively. HCV-RNA tests were positive in 233 (69.3%) patients. Twentyeight patients (8.3%) cleared the infection, and 59/308 (19.1%) had received interferon-based treatment regimens before 2015. Among 249 patients eligible, 111 (44.6%) received DAAs. Treatment rates significantly increased over time from 7.8/100 person-years (p-y) (95%CI: 5.0-12.3) in 2015 to 18.9/100 p-y (95%CI: 11.7-30.3) in 2019. In a multivariate analysis, patients with HIV co-infection were twice as likely to receive DAAs (HR = 1.94, 95%CI: 1.21-3.12) than patients with HCV mono-infection. Current drug use was an independent risk factor for not receiving treatment against infection (HR = 0.48, 95%CI: 0.29-0.80). HCV treatment is evolving in patients with HCV-HIV co-infection. Ongoing drug use while in an OTP might negatively impact the readiness to treat infection.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use

  • Fuster, Daniel|||0000-0003-1262-5860
  • García Calvo, Xavier|||0000-0001-8165-8717
  • Zuluaga Blanco, Yenny Paola|||0000-0002-0247-0351
  • Bolao, Ferran|||0000-0002-9104-6615
  • Muga, Roberto|||0000-0001-6301-431X
Hepatitis C virus (HCV) infection and unhealthy alcohol use are major drivers of the burden of liver disease worldwide and commonly co-occur. Assessment of underlying liver damage is a cornerstone of the clinical care of patients with chronic HCV infection and/or unhealthy alcohol use because many of them are diagnosed at advanced stages of disease. Early diagnosis of liver disease before decompensated liver cirrhosis becomes established is essential for treatment with direct acting antivirals and/or abstinence from alcohol consumption, which are the main therapeutic approaches for clinical management. In this review, we discuss current knowledge around the use of non-invasive methods to assess liver disease, such as abdominal ultrasound, controlled attenuation parameter, transient elastography, magnetic resonance imaging, and indices based on serum markers of liver injury.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mid-holocene palaeoenvironment, plant resources and human interaction in northeast Iberia, An archaeobotanical approach

  • Piqué Huerta, Raquel|||0000-0002-8253-6874
  • Alcolea, Marta|||0000-0003-4280-3971
  • Antolín, Ferran|||0000-0002-0533-5788
  • Berihuete Azorin, Marian|||0000-0002-6248-1562
  • Barberà Berrocal, Anna|||0000-0003-4379-5635
  • Rodríguez Antón, David|||0000-0003-4116-2308
  • Herrero Otal, Maria|||0000-0002-3846-1238
  • López-Bultó, Oriol|||0000-0001-5327-1881
  • Obea Gómez, Laura|||0000-0003-4512-8473
  • Revelles, Jordi|||0000-0003-4803-9513
The role of the adoption of farming economies in the transformation of mid-Holocene landscapes in Northeast Iberia is under discussion given that the Neolithization coincides with the cold climatic phase dated ca. 7500-7000 cal BP. The main aim of this paper is to assess whether human activities or climate were the main driver of vegetation changes during the Middle Holocene through the study of the archaeobotanical data from three case studies: Cova del Sardo, La Draga, and Coves del Fem. The application of diverse archaeobotanical techniques to the different plant remains provides a complete picture of the vegetation composition and plant uses. During the early Neolithic, settlement surroundings were intensively exploited for firewood, wood raw material, timber, and plant fibers. The resources were obtained mainly from deciduous and pine forests, de-pending on the site localization, but also from riparian zones. The diversity of plants exploited was high, not only trees but shrubs and herbs. Evidence of deforestation has been identified in the settlement surroundings in La Draga and Cova del Sardo. The combination of plant exploitation with other agropastoral activities favored the expansion of colonizing species and enhanced biodiversity at a local scale.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

BARD1 Pathogenic Variants Are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort

  • Rofes, Paula|||0000-0001-6045-7879
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Torres Esquius, Sara|||0000-0001-7540-7284
  • Feliubadaló, Lidia|||0000-0002-1736-0112
  • Stradella, Agostina|||0000-0002-2307-8869
  • Moreno-Cabrera, José Marcos|||0000-0001-8570-0345
  • López-Doriga, Adriana
  • Munté, Elisabet|||0000-0001-8396-8284
  • de Cid, Rafael|||0000-0003-3579-6777
  • Campos, Olga
  • Cuesta, Raquel
  • Teulé, Álex
  • Grau, Èlia
  • Sanz, Judit
  • Capella, Gabriel|||0000-0002-4669-7320
  • Diez, Orland|||0000-0001-7339-0570
  • Brunet, Joan|||0000-0003-1945-3512
  • Balmaña Gelpí, Judith|||0000-0002-0762-6415
  • Lázaro García, Conxi|||0000-0002-7198-5906
Only a small fraction of hereditary breast and/or ovarian cancer (HBOC) cases are caused by germline variants in the high-penetrance breast cancer 1 and 2 genes (BRCA1 and BRCA2). BRCA1-associated ring domain 1 (BARD1), nuclear partner of BRCA1, has been suggested as a potential HBOC risk gene, although its prevalence and penetrance are variable according to populations and type of tumor. We aimed to investigate the prevalence of BARD1 truncating variants in a cohort of patients with clinical suspicion of HBOC. A comprehensive BARD1 screening by multigene panel analysis was performed in 4015 unrelated patients according to our regional guidelines for genetic testing in hereditary cancer. In addition, 51,202 Genome Aggregation Database (gnomAD) non-Finnish, non-cancer European individuals were used as a control population. In our patient cohort, we identified 19 patients with heterozygous BARD1 truncating variants (0.47%), whereas the frequency observed in the gnomAD controls was 0.12%. We found a statistically significant association of truncating BARD1 variants with overall risk (odds ratio (OR) = 3.78; CI = 2.10-6.48; p = 1.16 × 10 -5). This association remained significant in the hereditary breast cancer (HBC) group (OR = 4.18; CI = 2.10-7.70; p = 5.45 × 10 -5). Furthermore, deleterious BARD1 variants were enriched among triple-negative BC patients (OR = 5.40; CI = 1.77-18.15; p = 0.001) compared to other BC subtypes. Our results support the role of BARD1 as a moderate penetrance BC predisposing gene and highlight a stronger association with triple-negative tumors.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Tetraploidy-associated genetic heterogeneity confers chemo-radiotherapy resistance to colorectal cancer cells

  • Galofré, Claudia|||0000-0003-4415-4987
  • Gönül Geyik, Öykü
  • Asensio, Elena
  • Wangsa, Darawalee
  • Hirsch, Daniela|||0000-0001-8883-922X
  • Parra, Carolina
  • Saez, Jordi|||0000-0003-4888-9323
  • Mollà, Meritxell|||0000-0001-6215-2251
  • Yüce, Zeynep
  • Castells, Antoni|||0000-0001-8431-2033
  • Ried, Thomas|||0000-0002-0767-6009
  • Camps Polo, Jordi|||0000-0003-2929-4228
Tetraploidy, or whole-genome duplication, is a common phenomenon in cancer and preludes chromosome instability, which strongly correlates with disease progression, metastasis, and treatment failure. Therefore, it is reasonable to hypothesize that tetraploidization confers multidrug resistance. Nevertheless, the contribution of whole-genome duplication to chemo-radiotherapy resistance remains unclear. Here, using isogenic diploid and near-tetraploid clones from three colorectal cancer cell lines and one non-transformed human epithelial cell line, we show a consistent growth impairment but a divergent tumorigenic potential of near-tetraploid cells. Next, we assessed the effects of first-line chemotherapeutic drugs, other commonly used agents and ionizing radiation, and found that whole-genome duplication promoted increased chemotherapy resistance and also conferred protection against irradiation. When testing the activation of apoptosis, we observed that tetraploid cells were less prone to caspase 3 activation after treatment with first-line chemotherapeutic agents. Furthermore, we found that pre-treatment with ataxia telangiectasia and Rad3 related (ATR) inhibitors, which targets response to replication stress, significantly enhanced the sensitivity of tetraploid cells to first-line chemotherapeutic agents as well as to ionizing radiation. Our findings provide further insight into how tetraploidy results in greater levels of tolerance to chemo-radiotherapeutic agents and, moreover, we show that ATR inhibitors can sensitize near-tetraploid cells to commonly used chemo-radiotherapy regimens.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Centrosome reduction in newly-generated tetraploid cancer cells obtained by separase depletion

  • Galofré, Claudia|||0000-0003-4415-4987
  • Asensio, Elena
  • Ubach, Maria
  • Torres, Irianna M.
  • Quintanilla, Isabel
  • Castells, Antoni|||0000-0001-8431-2033
  • Camps Polo, Jordi|||0000-0003-2929-4228
Tetraploidy, a common feature in cancer, results in the presence of extra centrosomes, which has been associated with chromosome instability (CIN) and aneuploidy. Deregulation in the number of centrosomes triggers tumorigenesis. However, how supernumerary centrosomes evolve during the emergence of tetraploid cells remains yet to be elucidated. Here, generating tetraploid isogenic clones in colorectal cancer and in non-transformed cells, we show that near-tetraploid clones exhibit a significant increase in the number of centrosomes. Moreover, we find that centrosome area in near-tetraploids is twice as large as in near-diploids. To evaluate whether centrosome clustering was occurring, we next analysed the number of centrioles revealing centriole amplification. Notwithstanding, more than half of the near-tetraploids maintained in culture do not present centrosome aberrations. To test whether cells progressively lost centrioles after becoming near-tetraploid, we transiently transfected diploid cells with siRNA against ESPL1 /Separase, a protease responsible for triggering anaphase, to generate newly near-tetraploid cells. Finally, using this model, we assessed the number of centrioles at different time-points after tetraploidization finding that near-tetraploids rapidly lose centrosomes over time. Taken together, these data demonstrate that although most cells reduce supernumerary centrosomes after tetraploidization, a small fraction retains extra centrioles, potentially resulting in CIN.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

  • Vega-Garcia, Nerea
  • Benito, Rocío|||0000-0001-9781-4198
  • Esperanza-Cebollada, Elena|||0000-0001-5451-0370
  • Llop, Marta
  • Robledo, Cristina|||0000-0003-0445-3210
  • Vicente-Garcés, Clara|||0000-0002-2556-043X
  • Alonso, Javier|||0000-0002-6287-8391
  • Barragán, Eva
  • Fernández, Guerau
  • Hernández-Sánchez, Jesús M.
  • Martín-Izquierdo, Marta
  • Maynou, Joan
  • Minguela, Alfredo|||0000-0003-2472-5893
  • Montaño, Adrián|||0000-0002-3178-6726
  • Ortega, Margarita
  • Torrebadell, Montserrat
  • Cervera, José|||0000-0001-8252-1106
  • Sánchez, Joaquín
  • Jiménez-Velasco, Antonio|||0000-0001-6421-7872
  • Riesco, Susana
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
  • Lassaletta, Álvaro|||0000-0003-2881-1473
  • Fernández, José María
  • Rives, Susana|||0000-0002-5658-1831
  • Dapena, José Luis|||0000-0002-6711-7479
  • Ramírez, Manuel|||0000-0003-0332-6973
  • Camós, Mireia|||0000-0003-3658-7942
The development of Next-Generation Sequencing (NGS) has provided useful diagnostic, prognostic, and therapeutic strategies for individualized management of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) patients. Consequently, NGS is rapidly being established in clinical practice. However, the technology's complexity, bioinformatics analysis, and the different available options difficult a broad consensus between different laboratories in its daily routine introduction. This collaborative study among Spanish centers was aimed to assess the feasibility, pros, and cons of our customized panel and other commercial alternatives of NGS-targeted approaches. The custom panel was tested in three different sequencing centers. We used the same samples to assess other commercial panels (Oncomine TM Childhood Cancer Research Assay; Archer ® FusionPlex ® ALL, and Human Comprehensive Cancer Panel GeneRead Panel v2 ®). Overall, the panels showed a good performance in different centers and platforms, but each NGS approach presented some issues, as well as pros and cons. Moreover, a previous consensus on the analysis and reporting following international guidelines would be preferable to improve the concordance in results among centers. Our study shows the challenges posed by NGS methodology and the need to consider several aspects of the chosen NGS-targeted approach and reach a consensus before implementing it in daily practice.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Disease networks identify specific conditions and pleiotropy influencing multimorbidity in the general population

  • Amell, A.
  • Roso-Llorach, Albert|||0000-0002-9264-0405
  • Palomero, L.
  • Cuadras, Daniel|||0000-0001-8780-1764
  • Galván-Femenía, Iván|||0000-0002-6124-3730
  • Serra-Musach, J.
  • Comellas, Francesc|||0000-0003-4523-0240
  • de Cid, Rafael|||0000-0003-3579-6777
  • Pujana, Miguel Angel|||0000-0003-3222-4044
  • Violán, Concepció|||0000-0003-3309-5360
Multimorbidity is an emerging topic in public health policy because of its increasing prevalence and socio-economic impact. However, the age- and gender-dependent trends of disease associations at fine resolution, and the underlying genetic factors, remain incompletely understood. Here, by analyzing disease networks from electronic medical records of primary health care, we identify key conditions and shared genetic factors influencing multimorbidity. Three types of diseases are outlined: "central", which include chronic and non-chronic conditions, have higher cumulative risks of disease associations; "community roots" have lower cumulative risks, but inform on continuing clustered disease associations with age; and "seeds of bursts", which most are chronic, reveal outbreaks of disease associations leading to multimorbidity. The diseases with a major impact on multimorbidity are caused by genes that occupy central positions in the network of human disease genes. Alteration of lipid metabolism connects breast cancer, diabetic neuropathy and nutritional anemia. Evaluation of key disease associations by a genome-wide association study identifies shared genetic factors and further supports causal commonalities between nervous system diseases and nutritional anemias. This study also reveals many shared genetic signals with other diseases. Collectively, our results depict novel population-based multimorbidity patterns, identify key diseases within them, and highlight pleiotropy influencing multimorbidity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

PCIG, a web-based application to explore immune-genomics interactions across cancer types

  • Pedrola Gómez, Anna|||0000-0002-0490-3851
  • Franch-Expósito, Sebastià|||0000-0002-4542-1701
  • Lahoz, Sara|||0000-0002-4491-9911
  • Esteban-Fabró, Roger
  • Dienstmann, Rodrigo|||0000-0001-5997-318X
  • Bassaganyas, Laia|||0000-0002-4575-0214
  • Camps Polo, Jordi|||0000-0003-2929-4228
Genomic alterations can modulate the tumor immunophenotype depending on their nature and tissue of origin. Although this immune-genomic interaction may shape disease progression and response to immunotherapy, the factors governing such dynamics and the influence of each tissue-specific context remain poorly understood. Here, we have developed the PanCancer ImmunoGenomics (PCIG) tool, a web-based resource that provides researchers with the opportunity to mine immunome-genome relationships across several cancer types using data from the Pan-Cancer Analysis of Whole-Genomes (PCAWG) study, which comprises.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

GCAT|Panel, a comprehensive structural variant haplotype map of the Iberian population from high-coverage whole-genome sequencing

  • Valls-Margarit, Jordi|||0000-0002-0766-0349
  • Galván-Femenía, Iván|||0000-0002-6124-3730
  • Matías-Sánchez, Daniel|||0000-0003-4760-6512
  • Blay, Natalia|||0000-0002-7160-8529
  • Puiggròs, Montserrat
  • Carreras Nolla, Anna|||0000-0002-8789-067X
  • Salvoro, Cecilia
  • Cortés, Beatriz|||0000-0002-2656-7051
  • Amela, Ramon
  • Farré Ramon, Xavier|||0000-0001-6838-9479
  • Lerga Jaso, Jon|||0000-0003-4807-1900
  • Puig Font, Marta|||0000-0002-4439-6372
  • Sánchez Herrero, José Francisco|||0000-0001-6771-4807
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Perucho, Manuel|||0000-0002-2169-2662
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Armengol, Lluís
  • Delaneau, Olivier|||0000-0002-3906-8446
  • Cáceres Aguilar, Mario|||0000-0002-7736-3251
  • de Cid, Rafael|||0000-0003-3579-6777
  • Torrents, David|||0000-0002-6086-9037
The combined analysis of haplotype panels with phenotype clinical cohorts is a common approach to explore the genetic architecture of human diseases. However, genetic studies are mainly based on single nucleotide variants (SNVs) and small insertions and deletions (indels). Here, we contribute to fill this gap by generating a dense haplotype map focused on the identification, characterization, and phasing of structural variants (SVs). By integrating multiple variant identification methods and Logistic Regression Models (LRMs), we present a catalogue of 35 431 441 variants, including 89 178 SVs (≥50 bp), 30 325 064 SNVs and 5 017 199 indels, across 785 Illumina high coverage (30x) whole-genomes from the Iberian GCAT Cohort, containing a median of 3.52M SNVs, 606 336 indels and 6393 SVs per individual. The haplotype panel is able to impute up to 14 360 728 SNVs/indels and 23 179 SVs, showing a 2.7-fold increase for SVs compared with available genetic variation panels. The value of this panel for SVs analysis is shown through an imputed rare Alu element located in a new locus associated with Mononeuritis of lower limb, a rare neuromuscular disease. This study represents the first deep characterization of genetic variation within the Iberian population and the first operational haplotype panel to systematically include the SVs into genome-wide genetic studies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

  • Degenhardt, Frauke|||0000-0001-7516-3179
  • Ellinghaus, David|||0000-0002-4332-6110
  • Juzenas, Simonas
  • Lerga Jaso, Jon|||0000-0003-4807-1900
  • Wendorff, Mareike
  • Maya-Miles, Douglas|||0000-0002-0669-6526
  • Uellendahl-Werth, Florian
  • ElAbd, Hesham
  • Rühlemann, Malte C.
  • Arora, Jatin
  • Özer, Onur
  • Lenning, Ole Bernt
  • Myhre, Ronny
  • Vadla, May Sissel
  • Wacker, Eike M.
  • Wienbrandt, Lars|||0000-0001-5685-2032
  • Blandino Ortiz, Aaron|||0000-0002-3184-6418
  • de Salazar, Adolfo|||0000-0002-4318-858X
  • Garrido Chercoles, Adolfo
  • Palom, Adriana|||0000-0002-0130-1302
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Garcia-Fernandez, Alba-Estela|||0000-0003-4957-0373
  • Blanco-Grau, Albert|||0000-0002-4213-3827
  • Mantovani, Alberto
  • Zanella, Alberto
  • Holten, Aleksander Rygh
  • Mayer, Alena
  • Bandera, Alessandra
  • Cherubini, Alessandro
  • Protti, Alessandro|||0000-0002-0172-6079
  • Aghemo, Alessio
  • Gerussi, Alessio
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Braun, Alice|||0000-0003-1145-0261
  • Nebel, Almut
  • Barreira-Diaz, Ana|||0000-0002-4368-8939
  • Lleo, Ana
  • Teles, Ana
  • Kildal, Anders Benjamin|||0000-0002-1319-6511
  • Biondi, Andrea
  • Caballero, Andrea|||0000-0003-2891-6347
  • Ganna, Andrea|||0000-0002-8147-240X
  • Gori, Andrea|||0000-0001-6587-4794
  • Glück, Andreas
  • Lind, Andreas
  • Tanck, Anja
  • Hinney, Anke|||0000-0001-5659-0706
  • Carreras Nolla, Anna|||0000-0002-8789-067X
  • Fracanzani, Anna Ludovica
  • Peschuck, Anna
  • Cavallero, Annalisa
  • Dyrhol-Riise, Anne Ma
  • Ruello, Antonella
  • Julià Cano, Antonio|||0000-0001-6064-3620
  • Muscatello, Antonio
  • Pesenti, Antonio|||0000-0003-2593-729X
  • Voza, Antonio
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Solier, Aurora
  • Schmidt, Axel|||0000-0002-9780-7243
  • Cortés, Beatriz|||0000-0002-2656-7051
  • Mateos Muñoz, Beatriz|||0000-0003-0326-4119
  • Nafria-Jimenez, Beatriz|||0000-0002-4698-5680
  • Schaefer, Benedikt
  • Jensen, Björn
  • Bellinghausen, Carla
  • Maj, Carlo
  • Ferrando, Carlos|||0000-0002-1907-5323
  • de la Horra, Carmen
  • Quereda, Carmen
  • Skurk, Carsten
  • Thibeault, Charlotte
  • Scollo, Chiara
  • Herr, Christian
  • Spinner, Christoph D.|||0000-0002-3875-5367
  • Gassner, Christoph
  • Lange, Christoph|||0000-0002-9691-4741
  • Hu, Cinzia
  • Paccapelo, Cinzia
  • Lehmann, Clara
  • Angelini, Claudio
  • Cappadona, Claudio
  • Azuure, Clinton
  • Bianco, Cristiana
  • Cea López, Cristina|||0000-0003-0776-6706
  • Sancho, Cristina
  • Hoff, Dag Arne Lihaug
  • Galimberti, Daniela|||0000-0002-9284-5953
  • Prati, Daniele|||0000-0002-2281-7498
  • Haschka, David
  • Jiménez, David|||0000-0002-4571-7721
  • Pestaña, David
  • Toapanta, David
  • Muñíz Díaz, Eduardo
  • Azzolini, Elena
  • Sandoval, Elena|||0000-0002-4242-5133
  • Binatti, Eleonora
  • Scarpini, Elio|||0000-0002-6395-2119
  • Helbig, Elisa T.
  • Casalone, Elisabetta
  • Urrechaga, Eloisa
  • Paraboschi, Elvezia Maria|||0000-0002-7935-798X
  • Pontali, Emanuele|||0000-0002-1085-0442
  • Reverter, Enric|||0000-0002-4967-6947
  • Calderón, Enrique J.|||0000-0002-3166-5086
  • Navas, Enrique|||0000-0001-9561-1338
  • Solligård, Erik
  • Contro, Ernesto
  • Arana-Arri, Eunate|||0000-0001-9759-333X
  • Aziz, Fátima
  • Garcia, Federico
  • García Sánchez, Félix|||0000-0002-6965-5940
  • Ceriotti, Ferruccio|||0000-0002-0958-5354
  • Martinelli-Boneschi, Filippo
  • Peyvandi, Flora|||0000-0001-7423-9864
  • Kurth, Florian
  • Blasi, Francesco|||0000-0002-2285-9970
  • Malvestiti, Francesco
  • Medrano, Francisco J.
  • Mesonero, Francisco|||0000-0002-7864-8187
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Hanses, Frank
  • Müller, Fredrik
  • Hemmrich-Stanisak, Georg
  • Bellani, Giacomo
  • Grasselli, Giacomo|||0000-0002-1735-1400
  • Pezzoli, Gianni
  • Costantino, Giorgio
  • Albano, Giovanni
  • Cardamone, Giulia
  • Bellelli, Giuseppe
  • Citerio, Giuseppe|||0000-0002-5374-3161
  • Foti, Giuseppe
  • Lamorte, Giuseppe
  • Matullo, Giuseppe
  • Baselli, Guido
  • Kurihara, Hayato
  • Neb, Holger
  • My, Ilaria
  • Kurth, Ingo|||0000-0002-5642-8378
  • Hernández, Isabel|||0000-0001-8119-393X
  • Pink, Isabell
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Galván-Femenía, Iván|||0000-0002-6124-3730
  • Holter, Jan Cato
  • Afset, Jan Egil
  • Heyckendorf, Jan|||0000-0003-4203-8421
  • Kässens, Jan
  • Damås, Jan Kristian
  • Rybniker, Jan
  • Altmüller, Janine|||0000-0003-4372-1521
  • Ampuero, Javier|||0000-0002-8332-2122
  • Martín, Javier|||0000-0002-2202-0622
  • Erdmann, Jeanette|||0000-0002-4486-6231
  • Banales, Jesus|||0000-0002-5224-2373
  • Badia, Joan Ramon
  • Dopazo, Joaquín|||0000-0003-3318-120X
  • Schneider, Jochen
  • Bergan, Jonas|||0000-0003-4267-8904
  • Barretina, Jordi|||0000-0002-3478-4080
  • Walter, Jörn
  • Hernández Quero, José
  • Goikoetxea, Josune
  • Delgado Cuesta, Juan|||0000-0002-5947-6287
  • Guerrero, Juan M.
  • Fazaal, Julia
  • Kraft, Julia|||0000-0001-7306-1179
  • Schröder, Julia
  • Risnes, Kari
  • Banasik, Karina|||0000-0003-2489-2499
  • Müller, Karl Erik
  • Gaede, Karoline I.
  • Garcia-Etxebarria, Koldo
  • Tonby, Kristian
  • Heggelund, Lars
  • Izquierdo-Sanchez, Laura
  • Bettini, Laura Rachele|||0000-0002-0280-1704
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Sander, Leif Erik
  • Lippert, Lena J.
  • Terranova, Leonardo
  • Nkambule, Lindokuhle
  • Knopp, Lisa
  • Gustad, Lise Tuset
  • Garbarino, Lucia
  • Santoro, Luigi
  • Téllez, Luis|||0000-0002-9254-3891
  • Roade, Luisa|||0000-0002-8160-9613
  • Ostadreza, Mahnoosh
  • Intxausti, Maider
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Riveiro Barciela, Mar|||0000-0001-9309-2052
  • Berger, Marc M.
  • Schaefer, Marco
  • Niemi, Mari E. K.
  • Gutiérrez-Stampa, María Ángeles
  • Carrabba, Maria
  • Figuera Basso, Maria E.
  • Valsecchi, Maria Grazia
  • Hernández Tejero, María|||0000-0002-6782-9150
  • Vehreschild, Maria J. G. T.
  • Manunta, Maria|||0000-0002-1875-5335
  • Acosta-Herrera, Marialbert|||0000-0002-9868-6535
  • D'Angio, Mariella|||0000-0001-7889-8576
  • Baldini, Marina
  • Cazzaniga, Marina Elena|||0000-0003-1756-6935
  • Grimsrud, Marit M.
  • Cornberg, Markus|||0000-0002-9141-8001
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Marquié, Marta|||0000-0002-0660-0950
  • Castoldi, Massimo
  • Cordioli, Mattia|||0000-0002-4872-0520
  • Cecconi, Maurizio|||0000-0002-4376-6538
  • D'Amato, Mauro
  • Augustin, Max|||0000-0002-2300-9337
  • Tomasi, Melissa
  • Boada, Mercè|||0000-0003-2617-3009
  • Dreher, Michael
  • Seilmaier, Michael J.
  • Joannidis, Michael
  • Wittig, Michael
  • Mazzocco, Michela
  • Ciccarelli, Michele|||0000-0003-2379-1960
  • Rodríguez-Gandía, Miguel
  • Bocciolone, Monica
  • Miozzo, Monica
  • Imaz Ayo, Natale|||0000-0001-9087-901X
  • Blay, Natalia|||0000-0002-7160-8529
  • Chueca, Natalia|||0000-0002-3420-3290
  • Montano, Nicola
  • Braun, Nicole
  • Ludwig, Nicole|||0000-0003-4703-7567
  • Marx, Nikolaus
  • Martínez, Nilda
  • Cornely, Oliver A.|||0000-0001-9599-3137
  • Witzke, Oliver
  • Palmieri, Orazio
  • Faverio, Paola|||0000-0002-0360-1237
  • Preatoni, Paoletta
  • Bonfanti, Paolo|||0000-0001-7289-8823
  • Omodei, Paolo
  • Tentorio, Paolo
  • Castro Rebollo, Pedro|||0000-0002-6118-8970
  • Rodrigues, Pedro M.
  • España, PP.|||0000-0001-5723-8253
  • Hoffmann, Per|||0000-0002-6573-983X
  • Rosenstiel, Philip|||0000-0002-9692-8828
  • Schommers, Philipp
  • Suwalski, Phillip
  • de Pablo, Raúl
  • Ferrer, Ricard|||0000-0002-4859-4747
  • Bals, Robert
  • Gualtierotti, Roberta
  • Gallego-Durán, Rocío
  • Nieto, Rosa
  • Carpani, Rossana
  • Morilla, Rubén
  • Badalamenti, Salvatore
  • Haider, Sammra
  • Ciesek, Sandra
  • May, Sandra
  • Bombace, Sara
  • Marsal, Sara|||0000-0001-5515-3854
  • Pigazzini, Sara
  • Klein, Sebastian
  • Pelusi, Serena
  • Wilfling, Sibylle
  • Bosari, Silvano
  • Volland, Sonja
  • Brunak, Søren|||0000-0003-0316-5866
  • Raychaudhuri, Soumya|||0000-0002-1901-8265
  • Schreiber, Stefan
  • Heilmann-Heimbach, Stefanie|||0000-0003-1057-465X
  • Aliberti, Stefano|||0000-0002-0090-4531
  • Ripke, Stephan|||0000-0003-3622-835X
  • Dudman, Susanne|||0000-0001-5047-4982
  • Wesse, Tanja
  • Zheng, Tenghao
  • Bahmer, Thomas
  • Eggermann, Thomas
  • Illig, Thomas
  • Brenner, Thorsten
  • Pumarola Suñé, Tomàs|||0000-0002-5171-7461
  • Feldt, Torsten
  • Folseraas, Trine
  • Gonzalez Cejudo, Trinidad
  • Landmesser, Ulf
  • Protzer, Ulrike|||0000-0002-9421-1911
  • Hehr, Ute
  • Rimoldi, Valeria
  • Monzani, Valter
  • Skogen, Vegard
  • Keitel, Verena
  • Kopfnagel, Verena
  • Friaza, Vicente|||0000-0002-2900-4334
  • Andrade, Victor|||0000-0003-0682-269X
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Morros, Rosa|||0000-0001-6752-8748
  • Albrecht, Wolfgang
  • Peter, Wolfgang
  • Poller, Wolfgang
  • Farré Ramon, Xavier|||0000-0001-6838-9479
  • Yi, Xiaoli
  • Wang, Xiaomin
  • Khodamoradi, Yascha|||0000-0001-5972-0967
  • Karadeniz, Zehra
  • Latiano, Anna
  • Goerg, Siegfried
  • Bacher, Petra
  • Koehler, Philipp|||0000-0002-7386-7495
  • Tran, Florian
  • Zoller, Heinz|||0000-0003-1794-422X
  • Schulte, Eva C.|||0000-0003-3105-5672
  • Heidecker, Bettina
  • Ludwig, Kerstin U.|||0000-0002-8541-2519
  • Fernández, Javier|||0000-0002-5622-0489
  • Romero-Gómez, Manuel|||0000-0001-8494-8947
  • Albillos, Agustín|||0000-0001-9131-2592
  • Invernizzi, Pietro|||0000-0003-3262-1998
  • Buti, Maria|||0000-0002-0732-3078
  • Duga, Stefano
  • Bujanda, Luis|||0000-0002-4353-9968
  • Hov, Johannes R.|||0000-0002-5900-8096
  • Lenz, Tobias L.
  • Asselta, Rosanna
  • de Cid, Rafael|||0000-0003-3579-6777
  • Valenti, Luca|||0000-0001-8909-0345
  • Karlsen, Tom H.
  • Cáceres Aguilar, Mario|||0000-0002-7736-3251
  • Franke, Andre|||0000-0003-1530-5811
Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our understanding of underlying disease mechanisms. Here, we describe an extended genome-wide association meta-analysis of a well-characterized cohort of 3255 COVID-19 patients with respiratory failure and 12 488 population controls from Italy, Spain, Norway and Germany/Austria, including stratified analyses based on age, sex and disease severity, as well as targeted analyses of chromosome Y haplotypes, the human leukocyte antigen region and the SARS-CoV-2 peptidome. By inversion imputation, we traced a reported association at 17q21.31 to a ~0.9-Mb inversion polymorphism that creates two highly differentiated haplotypes and characterized the potential effects of the inversion in detail. Our data, together with the 5th release of summary statistics from the COVID-19 Host Genetics Initiative including non-Caucasian individuals, also identified a new locus at 19q13.33, including NAPSA, a gene which is expressed primarily in alveolar cells responsible for gas exchange in the lung.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Muiño, Elena|||0000-0001-5839-7328
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cullell, Natalia|||0000-0001-5118-1014
  • Lledós, Miquel|||0000-0001-8832-789X
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Sobrino, Tomás|||0000-0002-9760-8690
  • Campos, Francisco|||0000-0001-8665-1039
  • Castillo, José
  • Freijo, Marimar
  • Arenillas, Juan F.|||0000-0001-7464-6101
  • Obach, Víctor|||0000-0002-0518-1053
  • Álvarez Sabín, José|||0000-0002-8054-9209
  • Molina, Carlos A.|||0000-0001-6058-6259
  • Ribo, Marc|||0000-0001-9242-043X
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Muñoz-Narbona, Lucia|||0000-0002-0884-3024
  • López-Cancio, Elena|||0000-0001-5757-9074
  • Millán Torné, Mònica|||0000-0002-4692-5936
  • Diaz-Navarro, Rosa
  • Vives-Bauza, Cristòfol
  • Serrano-Heras, Gemma|||0000-0001-9368-4832
  • Segura, Tomás|||0000-0003-3625-0987
  • Ibañez, Laura
  • Heitsch, Laura
  • Delgado, Pilar
  • Dhar, Rajat|||0000-0002-5167-5097
  • Krupinski, Jerzy|||0000-0002-5136-8898
  • Delgado Mederos, Raquel|||0000-0003-3737-7226
  • Prats Sánchez, Luis Antonio|||0000-0002-3192-4631
  • Camps-Renom, Pol|||0000-0001-6587-6271
  • Blay, Natalia|||0000-0002-7160-8529
  • Sumoy, Lauro|||0000-0003-0005-4618
  • de Cid, Rafael|||0000-0003-3579-6777
  • Montaner, Joan|||0000-0003-4845-2279
  • Cruchaga, Carlos|||0000-0002-0276-2899
  • Lee, Jim-Moo
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Background: Occult atrial fibrillation (AF) is one of the major causes of embolic stroke of undetermined source (ESUS). Knowing the underlying etiology of an ESUS will reduce stroke recurrence and/or unnecessary use of anticoagulants. Understanding cardioembolic strokes (CES), whose main cause is AF, will provide tools to select patients who would benefit from anticoagulants among those with ESUS or AF. We aimed to discover novel loci associated with CES and create a polygenetic risk score (PRS) for a more efficient CES risk stratification. Methods: Multitrait analysis of GWAS (MTAG) was performed with MEGASTROKE-CES cohort (n = 362,661) and AF cohort (n = 1,030,836). We considered significant variants and replicated those variants with MTAG p-value < 5 × 10 influencing both traits (GWAS-pairwise) with a p-value < 0.05 in the original GWAS and in an independent cohort (n = 9,105). The PRS was created with PRSice-2 and evaluated in the independent cohort. Results: We found and replicated eleven loci associated with CES. Eight were novel loci. Seven of them had been previously associated with AF, namely, CAV1, ESR2, GORAB, IGF1R, NEURL1, WIPF1, and ZEB2. KIAA1755 locus had never been associated with CES/AF, leading its index variant to a missense change (R1045W). The PRS generated has been significantly associated with CES improving discrimination and patient reclassification of a model with age, sex, and hypertension. Conclusion: The loci found significantly associated with CES in the MTAG, together with the creation of a PRS that improves the predictive clinical models of CES, might help guide future clinical trials of anticoagulant therapy in patients with ESUS or AF.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage colon cancer

  • Lahoz, Sara|||0000-0002-4491-9911
  • Archilla, Ivan|||0000-0002-2142-0608
  • Asensio, Elena
  • Hernández-Illán, Eva
  • Ferrer Menduiña, Queralt|||0000-0003-3177-4618
  • López-Prades, Sandra|||0000-0001-8208-2959
  • Nadeu, Ferran|||0000-0003-2910-9440
  • Rey Azpiri, Javier del|||0000-0001-7887-7871
  • Sanz-Pamplona, Rebeca
  • Lozano, Juan José
  • Castells, Antoni|||0000-0001-8431-2033
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • Camps Polo, Jordi|||0000-0003-2929-4228
Optimal selection of high-risk patients with stage II colon cancer is crucial to ensure clinical benefit of adjuvant chemotherapy. Here, we investigated the prognostic value of genomic intratumor heterogeneity and aneuploidy for disease recurrence. We combined targeted sequencing, SNP arrays, fluorescence in situ hybridization, and immunohistochemistry on a retrospective cohort of 84 untreated stage II colon cancer patients. We assessed the clonality of copy-number alterations (CNAs) and mutations, CD8 + lymphocyte infiltration, and their association with time to recurrence. Prognostic factors were included in machine learning analysis to evaluate their ability to predict individual relapse risk. Tumors from recurrent patients displayed a greater proportion of CNAs compared with non-recurrent (mean 31.3% versus 23%, respectively; p = 0.014). Furthermore, patients with elevated tumor CNA load exhibited a higher risk of recurrence compared with those with low levels [ p = 0.038; hazard ratio (HR) 2.46], which was confirmed in an independent cohort (p = 0.004; HR 3.82). Candidate chromosome-specific aberrations frequently observed in recurrent cases included gain of the chromosome arm 13q (p = 0.02; HR 2.67) and loss of heterozygosity at 17q22-q24.3 (p = 0.05; HR 2.69). CNA load positively correlated with intratumor heterogeneity (R = 0.52; p < 0.0001). Consistently, incremental subclonal CNAs were associated with an elevated risk of relapse (p = 0.028; HR 2.20), which we did not observe for subclonal single-nucleotide variants and small insertions and deletions. The clinico-genomic model rated an area under the curve of 0.83, achieving a 10% incremental gain compared with clinicopathological markers (p = 0.047). In conclusion, tumor aneuploidy and copy-number intratumor heterogeneity were predictive of poor outcome and improved discriminative performance in early-stage colon cancer. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53 -Mutated Metastatic Colorectal Cancer

  • Lahoz, Sara|||0000-0002-4491-9911
  • Rodríguez, Adela|||0000-0002-4899-6607
  • Fernández Barat, Laia|||0000-0001-7528-9636
  • Gorría, Teresa
  • Moreno, Reinaldo
  • Esposito, Francis|||0000-0002-5028-9637
  • Oliveres, Helena|||0000-0003-1801-1181
  • Albiol, Santiago
  • Saurí Nadal, Tamara|||0000-0002-7479-5120
  • Pesantez, David|||0000-0003-0257-8538
  • Riu-Viladoms, G.|||0000-0002-8259-0811
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • Jares, Pedro
  • Pedrosa, Leire|||0000-0002-1852-4975
  • Pineda, Estela|||0000-0003-2128-747X
  • Castells, Antoni|||0000-0001-8431-2033
  • Prat, Aleix|||0000-0003-2377-540X
  • Maurel, Joan|||0000-0002-9413-5592
  • Camps Polo, Jordi|||0000-0003-2929-4228
The mutational status of certain genes can be useful to advance therapeutic decision making and clinical management of cancer patients. In metastatic colorectal cancer, current clinicopathological factors employed in clinical practice have low or modest individual effect on survival, leading to a poor ability to discriminate patients at high risk. Here, we obtained data from metastatic colorectal cancer patients undergoing molecular testing by targeted gene sequencing, and we identified SMAD4 and FBXW7 mutated genes as negative prognostic markers in TP53 -driven tumors, which also improved the predictive performance to discriminate high-risk patients beyond clinical factors alone. This negative prognostic impact of co-occurring SMAD4 / TP53 and FBXW7 / TP53 mutations was confirmed in an independent validation analysis using publicly available data. Next-generation sequencing (NGS) provides a molecular rationale to inform prognostic stratification and to guide personalized treatment in cancer patients. Here, we determined the prognostic and predictive value of actionable mutated genes in metastatic colorectal cancer (mCRC). Among a total of 294 mCRC tumors examined by targeted NGS, 200 of them derived from patients treated with first-line chemotherapy plus/minus monoclonal antibodies were included in prognostic analyses. Discriminative performance was assessed by time-dependent estimates of the area under the curve (AUC). The most recurrently mutated genes were TP53 (64%), KRAS or NRAS (49%), PIK3CA (15%), SMAD4 (14%), BRAF (13%), and FBXW7 (9.5%). Mutations in FBXW7 correlated with worse OS rates (p = 0.036; HR, 2.24) independently of clinical factors. Concurrent mutations in TP53 and FBXW7 were associated with increased risk of death (p = 0.02; HR, 3.31) as well as double-mutated TP53 and SMAD4 (p = 0.03; HR, 2.91). Analysis of the MSK-IMPACT mCRC cohort (N = 1095 patients) confirmed the same prognostic trend for the previously identified mutated genes. Addition of the mutational status of these genes upon clinical factors resulted in a time-dependent AUC of 87%. Gene set enrichment analysis revealed specific molecular pathways associated with SMAD4 and FBXW7 mutations in TP53 -defficient tumors. Conclusively, SMAD4 and FBXW7 mutations in TP53 -altered tumors were predictive of a negative prognostic outcome in mCRC patients treated with first-line regimens.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Los objetos elaborados con fibras vegetales del Neolítico Antiguo de Coves del Fem, Ulldemolins (Tarragona), The fibre-based objects from the Early Neolithic site of Coves del Fem, Ulldemolins (Tarragona)

  • Romero Brugués, Susagna|||0000-0003-1731-1035
  • Herrero Otal, Maria|||0000-0002-3846-1238
  • Piqué Huerta, Raquel|||0000-0002-8253-6874
  • Rosillo Turra, Rafael|||0000-0003-3007-6981
  • Terradas, Xavier|||0000-0002-8000-5607
  • López-Bultó, Oriol|||0000-0001-5327-1881
  • Barberà Berrocal, Anna|||0000-0003-4379-5635
  • Palomo Pérez, Antoni|||0000-0001-9954-7310
Los objetos manufacturados con materias orgánicas raramente se conservan excepto bajo condiciones ambientales específicas, ya sea en medios de sequedad constante, en contextos anaeróbicos sumergidos, bajo congelación o por carbonización. Por ello, las técnicas de cestería y cordelería, así como las materias primas utilizadas están escasamente documentadas en el registro arqueológico del Neolítico peninsular. Se aporta aquí nueva información acerca de las técnicas cesteras y de cordelería, así como de las materias primas utilizadas en Coves del Fem (Ulldemolins, Tarragona). Estos restos fueron recuperados en una fosa adscribible al Neolítico antiguo. La cestería estudiada se encuentra manufacturada a través de la técnica de espiral cosida, mientras que en el caso de la cordelería se trata de un único fragmento torsionado. Se discute su funcionalidad en un contexto de hábitat en cueva, así como su tecnología y materias primas usadas, contextualizándolos con otros ejemplos de cestería de espiral cosida de la península ibérica., Plant-based artefacts are considered one of the first technologies used by human populations playing an important role in the daily life of all societies. Even though, they are made of perishable material which usually disappears in archaeological contexts except for some specific environmental conditions that permit their conservation as arid, anaerobic, waterlogged atmospheres or carbonization. Some examples of the f irst implements produced by organic materials are baskets and cords which are documented since the very beginning of human populations. Nevertheless, these fibre-based materials have been excluded from archaeological studies. The lack of knowledge in this vegetal technology is a consequence of the difficulty of organic material preservation and the non-suitable analysis and identification methodologies. Even they represent a living material culture as history and ethnography demonstrate, vegetal fibres were probably used for producing indispensable everyday objects and artefacts in the past. The aim of this paper is to provide new information about vegetal technology as basketry and cordage techniques, as well as the raw materials used in Neolithic chronologies in the North-East of the Iberian Peninsula. The materials analyzed in this study were recovered at the site of Coves del Fem (Ulldemolins, Tarragona) which is a rock shelter preserved thanks to the fallen rock blocks. Basketry and cordage fragments came from the archaeological fieldwork of 2019 and were recovered inside a pit in levels of the final Early Neolithic. They were preserved thanks to the carbonization and dehydration they were submitted to. Both basketry and cordage examples from Coves del Fem, were deeply described considering their morphology and technology, as well as the raw materials they were made of. The methodology consisted of describing the technique used and taking measures of the different fragments aiming to obtain information about the way the basket and the cord were made. The identification of raw materials was performed by observing cross, peridermal and longitudinal sections of samples using a transmitted optical microscope. Descriptions were based on microanatomical observation by comparing with reference modern material and specialized technical literature. The results showed the basketry assemblage was produced using the coiling technique and all the fragments belong to a single object. In the case of the cordage fragment, it was made by twisting the fibres which had been previously mechanically processed. The identification of raw materials revealed at least the use of sedges for basketry and non-identified herbaceous plants for making cordage. The functionality of the objects is discussed, and they are also contextualized with other Neolithic fibre productions examples from the Iberian Peninsula and the Middle East, both technologically and the chosen raw materials. In summary, fibre-based productions from Coves del Fem, along with the assemblage from the lake dwelling site of La Draga, fill the gap of this archaeological record from the Iberian Peninsula to Europe, demonstrating the long history of the technical skills related to plant exploitation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Describing the neolithic cord production process, Raw materials, techniques and experimental archaeology in La Draga (Girona, Spain, 5207-4862 cal BC)

  • Herrero Otal, Maria|||0000-0002-3846-1238
  • Romero Brugués, Susagna|||0000-0003-1731-1035
  • Piqué Huerta, Raquel|||0000-0002-8253-6874
  • Homs, Anna
  • De Diego, Miriam|||0000-0003-1083-583X
  • Palomo Pérez, Antoni|||0000-0001-9954-7310
Cordage is related to daily activities and as such has been a basic element for self-suffiency since Prehistory. Due to the lack of their preservation in most archaeological contexts, the knowledge of these technologies in the past is limited. This paper analyses the production process through an experimental program of the cordage assemblage from La Draga (Girona, Spain; 5207-4862 cal BC). The site is an Early Neolithic site from north-eastern Iberia, where a wide vegetal set of fibre-based craft was recovered in waterlogged preservation conditions. First, a systematic identification of raw materials used for cord production is done. Subsequently an experimental approach to these cords, considering both the raw materials used and their properties, has been developed. The study aims to infer raw material selection for producing cords, as well as the importance of raw material and group standards involved in the final objects. The results showed a preferable selection of lime tree bark (Tilia sp.) and nettle bast fibre (Urtica sp.), which may be obtained from the surroundings of the site. Both were used to produce different types of cords, twisting preferred above braiding, which should be related to cultural standards and traditional learning processes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

3-D chromatin conformation, accessibility, and gene expression profiling of triple-negative breast cancer

  • Llinàs-Arias, Pere|||0000-0002-3666-0532
  • Ensenyat Méndez, Miquel|||0000-0003-4192-806X
  • Orozco, Javier I. J|||0000-0003-2585-358X
  • Íñiguez-Muñoz, Sandra|||0000-0003-4916-1457
  • Valdez, Betsy
  • Wang, Chuan
  • Mezger, Anja|||0000-0002-7337-9547
  • Choi, Eunkyoung
  • Tran, Yan Zhou
  • Yao, Liqun
  • Bonath, Franziska
  • Olsen, Remi-André
  • Ormestad, Mattias
  • Esteller, M|||0000-0003-4490-6093
  • Lupien, Mathieu|||0000-0003-0929-9478
  • Marzese, Diego|||0000-0002-3258-8852
Objectives: Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype with limited treatment options. Unlike other breast cancer subtypes, the scarcity of specific therapies and greater frequencies of distant metastases contribute to its aggressiveness. We aimed to find epigenetic changes that aid in the understanding of the dissemination process of these cancers. Data description: Using CRISPR/Cas9, our experimental approach led us to identify and disrupt an insulator element, IE8, whose activity seemed relevant for cell invasion. The experiments were performed in two well-established TNBC cellular models, the MDA-MB-231 and the MDA-MB-436. To gain insights into the underlying molecular mechanisms of TNBC invasion ability, we generated and characterized high-resolution chromatin interaction (Hi-C) and chromatin accessibility (ATAC-seq) maps in both cell models and complemented these datasets with gene expression profiling (RNA-seq) in MDA-MB-231, the cell line that showed more significant changes in chromatin accessibility. Altogether, our data provide a comprehensive resource for understanding the spatial organization of the genome in TNBC cells, which may contribute to accelerating the discovery of TNBC-specific alterations triggering advances for this devastating disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer

  • Ensenyat Méndez, Miquel|||0000-0003-4192-806X
  • Orozco, Javier I. J.|||0000-0003-2585-358X
  • Llinàs-Arias, Pere|||0000-0002-3666-0532
  • Íñiguez-Muñoz, Sandra|||0000-0003-4916-1457
  • Baker, Jennifer L.
  • Salomon, Matthew P.
  • Martí, Mercè|||0000-0002-1846-0043
  • DiNome, Maggie L.|||0000-0002-1926-292X
  • Cortés Castán, Javier|||0000-0001-7623-1583
  • Marzese, Diego|||0000-0002-3258-8852
Immune checkpoint inhibitors (ICI) improve clinical outcomes in triple-negative breast cancer (TNBC) patients. However, a subset of patients does not respond to treatment. Biomarkers that show ICI predictive potential in other solid tumors, such as levels of PD-L1 and the tumor mutational burden, among others, show a modest predictive performance in patients with TNBC. We built machine learning models based on pre-ICI treatment gene expression profiles to construct gene expression classifiers to identify primary TNBC ICI-responder patients. This study involved 188 ICI-naïve and 721 specimens treated with ICI plus chemotherapy, including TNBC tumors, HR+/HER2- breast tumors, and other solid non-breast tumors. The 37-gene TNBC ICI predictive (TNBC-ICI) classifier performs well in predicting pathological complete response (pCR) to ICI plus chemotherapy on an independent TNBC validation cohort (AUC = 0.86). The TNBC-ICI classifier shows better performance than other molecular signatures, including PD-1 (PDCD1) and PD-L1 (CD274) gene expression (AUC = 0.67). Integrating TNBC-ICI with molecular signatures does not improve the efficiency of the classifier (AUC = 0.75). TNBC-ICI displays a modest accuracy in predicting ICI response in two different cohorts of patients with HR + /HER2- breast cancer (AUC = 0.72 to pembrolizumab and AUC = 0.75 to durvalumab). Evaluation of six cohorts of patients with non-breast solid tumors treated with ICI plus chemotherapy shows overall poor performance (median AUC = 0.67). TNBC-ICI predicts pCR to ICI plus chemotherapy in patients with primary TNBC. The study provides a guide to implementing the TNBC-ICI classifier in clinical studies. Further validations will consolidate a novel predictive panel to improve the treatment decision-making for patients with TNBC. Triple-Negative Breast Cancer (TNBC) is an aggressive type of breast cancer, responsible for a substantial burden of breast cancer-related deaths. In recent years, immunotherapy, a therapy that triggers the patient's immune system to attack the tumor, has arisen as a promising treatment in various cancers, including TNBC. However, a subset of patients with TNBC does not respond to this treatment. Here, we employed advanced computational techniques to predict response to immunotherapy plus chemotherapy in patients with primary TNBC. Our method is more accurate than using other existing markers, such as PD-L1, but is not very accurate in patients with non-TNBC breast cancers or non-breast cancers. This method could potentially be used to better select patients for immunotherapy, upfront, avoiding the side effects and costs of treating patients in which immunotherapy might not work. Ensenyat-Mendez et al. construct a gene expression-based machine learning classifier to predict the response of triple-negative breast cancer to immune checkpoint inhibition combined with chemotherapy. Predictive performance of the 37-gene classifier is better than that of PD-1 or PD-L1.
Dipòsit Digital de Documents de la UAB
Publication Artículo preliminar (WorkingPaper)

Genome-wide association study identifies 30 obsessive-compulsive disorder associated loci

  • Strom, Nora I.|||0000-0002-5261-8852
  • Gerring, Zachary F.|||0000-0002-2445-1266
  • Galimberti, Marco|||0000-0001-6052-156X
  • Yu, Dongmei|||0000-0001-7901-4365
  • Halvorsen, Matthew W.|||0000-0002-6707-2418
  • Abdellaoui, Abdel|||0000-0003-1088-6784
  • Rodriguez-Fontenla, Cristina|||0000-0002-9829-6393
  • Sealock, Julia M.|||0000-0002-9346-3498
  • Bigdeli, Tim B.|||0000-0003-2215-5946
  • Coleman, Jonathan R. I.|||0000-0002-6759-0944
  • Mahjani, Behrang|||0000-0001-6087-9537
  • Thorp, Jackson G.|||0000-0002-9461-6417
  • Bey, Katharina|||0000-0001-6392-4997
  • Burton, Christie L.|||0000-0002-8955-6528
  • Luykx, Jurjen J.|||0000-0002-6439-2774
  • Zai, Gwyneth|||0000-0002-0894-6867
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Andre, Christine
  • Askland, Kathleen D.|||0000-0003-1467-8923
  • Banaj, Nerisa|||0000-0002-6317-8549
  • Barlassina, Cristina|||0000-0001-7407-2697
  • Nissen, Judith Becker|||0000-0003-4063-6866
  • Bienvenu, O. Joseph|||0000-0002-8466-102X
  • Black, Donald|||0000-0001-8038-1971
  • Bloch, Michael H.|||0000-0003-0352-4080
  • Boberg, Julia|||0000-0003-3399-2838
  • Børte, Sigrid|||0000-0001-9540-3256
  • Bosch, Rosa|||0000-0002-7596-183X
  • Breen, Michael
  • Brennan, Brian P.|||0000-0001-5468-6552
  • Brentani, Helena|||0000-0001-5192-4682
  • Buxbaum, Joseph D.|||0000-0001-8898-8313
  • Bybjerg-Grauholm, Jonas|||0000-0003-1705-4008
  • Byrne, Enda M.|||0000-0002-9491-7797
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Camarena, Beatriz
  • Camarena, Adrian|||0000-0001-8512-0607
  • Cappi, Carolina|||0000-0001-6661-3756
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Cavallini, Maria Cristina|||0000-0001-5913-1468
  • Ciullo, Valentina|||0000-0002-4095-7806
  • Cook, Edwin H.|||0000-0002-5848-5114
  • Crosby, Jesse
  • Cullen, Bernadette A.|||0000-0003-1762-092X
  • De Schipper, Elles J.|||0000-0001-9494-451X
  • Delorme, Richard|||0000-0002-5614-3663
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Elias, Jason A.
  • Estivill, Xavier|||0000-0002-0723-2256
  • Falkenstein, Martha J.|||0000-0001-5074-3409
  • Fundin, Bengt T.|||0000-0002-6037-7331
  • Garner, Lauryn
  • German, Chris
  • Gironda, Christina
  • Goes, Fernando S.|||0000-0001-6262-8264
  • Grados, Marco A.|||0000-0002-0178-1764
  • Grove, Jakob|||0000-0003-2284-5744
  • Guo, Wei|||0000-0002-4322-3699
  • Haavik, Jan|||0000-0001-7865-2808
  • Hagen, Kristen|||0000-0002-4286-1277
  • Harrington, Kelly|||0000-0001-9668-183X
  • Havdahl, Alexandra|||0000-0002-9268-0423
  • Höffler, Kira D.|||0000-0002-0837-1469
  • Hounie, Ana G.|||0000-0002-5026-2880
  • Hucks, Donald|||0000-0002-2700-5798
  • Hultman, Christina|||0000-0002-0327-2410
  • Janecka, Magdalena|||0000-0001-7406-0776
  • Jenike, Eric
  • Karlsson, Elinor K.|||0000-0002-4343-3776
  • Kelley, Kara
  • Klawohn, Julia|||0000-0002-9436-6948
  • Krasnow, Janice E.|||0000-0003-0316-6279
  • Krebs, Kristi|||0000-0003-0494-2751
  • Lange, Christoph|||0000-0002-9691-4741
  • Lanzagorta, Nuria|||0000-0001-6769-6813
  • Levey, Daniel|||0000-0001-8431-9569
  • Lindblad-Toh, Kerstin|||0000-0001-8338-0253
  • Macciardi, Fabio|||0000-0003-0537-4266
  • Maher, Brion|||0000-0001-9809-0064
  • Mathes, Brittany
  • McArthur, Evonne|||0000-0003-4566-4321
  • McGregor, Nathaniel|||0000-0001-7195-4993
  • McLaughlin, Nicole C.|||0000-0002-4016-2747
  • Meier, Sandra|||0000-0002-3287-5894
  • Miguel, Euripedes C.|||0000-0002-9393-3103
  • Mulhern, Maureen|||0000-0001-8642-4741
  • Nestadt, Paul S.
  • Nurmi, Erika L.|||0000-0003-4893-8957
  • O'Connell, Kevin S.|||0000-0002-6865-8795
  • Osiecki, Lisa|||0000-0002-9408-8722
  • Ousdal, Olga Therese|||0000-0002-0728-3141
  • Palviainen, Teemu|||0000-0002-7847-8384
  • Pedersen, Nancy L.|||0000-0001-8057-3543
  • Piras, Fabrizio|||0000-0003-3566-5494
  • Piras, Federica|||0000-0002-9546-7038
  • Potluri, Sriramya|||0000-0003-3877-0038
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Rauch, Scott|||0000-0001-7699-6754
  • Reichenberg, Abraham|||0000-0003-2729-8575
  • Riddle, Mark A.|||0000-0001-8764-2134
  • Ripke, Stephan|||0000-0003-3622-835X
  • Rosário, Maria C.|||0000-0002-8577-3306
  • Sampaio, Aline S.|||0000-0001-5568-6167
  • Schiele, Miriam A.|||0000-0003-2613-6515
  • Skogholt, Anne Heidi|||0000-0001-7466-0405
  • Sloofman, Laura G Sloofman G.|||0000-0001-7628-4378
  • Smit, Jan
  • Soler Artigas, María|||0000-0002-3213-1107
  • Thomas, Laurent|||0000-0003-0548-2486
  • Tifft, Eric|||0000-0002-7480-0276
  • Vallada, Homero|||0000-0001-5123-8295
  • van Kirk, Nathanial|||0000-0002-1975-4238
  • Veenstra-VanderWeele, Jeremy|||0000-0002-6349-1076
  • Vulink, Nienke N.|||0000-0001-8991-9627
  • Walker, Christopher P.|||0000-0002-6069-0184
  • Wang, Ying
  • Wendland, Jens|||0000-0001-5106-5013
  • Winsvold, Bendik Slagsvold|||0000-0003-4171-8919
  • Yao, Yin|||0000-0001-7487-4294
  • Zhou, Hang|||0000-0002-7694-6391
  • Agrawal, Arpana|||0000-0002-0313-793X
  • Alonso, Pino|||0000-0002-5779-9111
  • Berberich, Götz|||0000-0001-8300-9294
  • Bucholz, Kathleen K.|||0000-0003-3794-0736
  • Bulik, Cynthia M.|||0000-0001-7772-3264
  • Cath, Danielle|||0000-0001-9539-4118
  • Denys, Damiaan|||0000-0002-3191-3844
  • Eapen, Valsamma|||0000-0001-6296-8306
  • Edenberg, Howard J.|||0000-0003-0344-9690
  • Falkai, Peter|||0000-0003-2873-8667
  • Fernandez, Thomas V.|||0000-0003-0830-022X
  • Fyer, Abby J.|||0000-0002-0944-2505
  • Gaziano, J M.|||0000-0002-5384-9767
  • Geller, Dan A.|||0000-0001-8692-4156
  • Grabe, Hans J.|||0000-0003-3684-4208
  • Greenberg, Benjamin D.|||0000-0002-5648-0002
  • Hanna, Gregory L.|||0000-0002-0742-6990
  • Hickie, Ian B.|||0000-0001-8832-9895
  • Hougaard, David M.|||0000-0001-5928-3517
  • Kathmann, Norbert|||0000-0002-1348-7060
  • Kennedy, James L.|||0000-0002-8733-3806
  • Lai, Dongbing|||0000-0001-7803-580X
  • Landén, Mikael|||0000-0002-4496-6451
  • Le Hellard, Stéphanie|||0000-0002-8085-051X
  • Leboyer, Marion|||0000-0001-5473-3697
  • Lochner, Christine|||0000-0002-4766-3704
  • McCracken, James T.|||0000-0003-0370-0777
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Mortensen, Preben B.|||0000-0002-4782-1450
  • Neale, Benjamin M.|||0000-0003-1513-6077
  • Nicolini, Humberto|||0000-0003-2494-0067
  • Nordentoft, Merete|||0000-0003-4895-7023
  • Pato, Michele
  • Pato, Carlos|||0000-0002-5858-266X
  • Pauls, David L.|||0000-0002-8107-345X
  • Piacentini, John|||0000-0003-4195-7194
  • Pittenger, Christopher|||0000-0003-2117-9321
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Rasmussen, Steven A.|||0000-0002-8327-0692
  • Richter, Margaret A.|||0000-0001-5450-2936
  • Rosenberg, David R.|||0000-0002-0005-4151
  • Ruhrmann, Stephan|||0000-0002-6022-2364
  • Samuels, Jack F.|||0000-0002-6715-7905
  • Sandin, Sven|||0000-0001-6994-4884
  • Sandor, Paul|||0000-0003-2397-0758
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • Stein, Dan J.|||0000-0001-7218-7810
  • Stewart, S. Evelyn|||0000-0002-0994-6383
  • Storch, Eric A.|||0000-0002-7631-3703
  • Stranger, Barbara E.|||0000-0001-9021-7331
  • Turiel, Maurizio|||0000-0002-8793-2112
  • Werge, Thomas|||0000-0003-1829-0766
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Walitza, Susanne|||0000-0002-8161-8683
  • Hveem, Kristian|||0000-0001-8157-9744
  • Hansen, Bjarne K.|||0000-0001-5659-1119
  • Rück, Christian P.|||0000-0002-8742-0168
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Milani, Lili|||0000-0002-5323-3102
  • Mors, Ole|||0000-0002-5660-0393
  • Reichborn-Kjennerud, Ted|||0000-0003-4653-0034
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Kvale, Gerd|||0000-0001-5449-2344
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Domschke, Katharina|||0000-0002-2550-9132
  • Grünblatt, Edna|||0000-0001-8505-7265
  • Wagner, Michael
  • Zwart, John-Anker|||0000-0001-5721-0154
  • Breen, Gerome|||0000-0003-2053-1792
  • Nestadt, Gerald|||0000-0001-9461-5249
  • Kaprio, Jaakko|||0000-0002-3716-2455
  • Arnold, Paul D.|||0000-0003-2496-4624
  • Grice, Dorothy E.|||0000-0002-8833-2549
  • Knowles, James A.|||0000-0002-3307-5741
  • Ask, Helga|||0000-0003-0149-5319
  • Verweij, Karin|||0000-0001-9868-7821
  • Davis, Lea K.|||0000-0001-5143-2282
  • Smit, Dirk J.|||0000-0001-8301-8860
  • Crowley, James J.|||0000-0001-9051-1557
  • Scharf, Jeremiah M.|||0000-0002-4742-5896
  • Stein, Murray B.|||0000-0001-9564-2871
  • Gelernter, Joel|||0000-0002-4067-1859
  • Mathews, Carol A.|||0000-0003-2208-7058
  • Derks, Eske M.|||0000-0002-6292-6883
  • Mattheisen, Manuel|||0000-0002-8442-493X
Obsessive-compulsive disorder (OCD) affects ~1% of the population and exhibits a high SNP-heritability, yet previous genome-wide association studies (GWAS) have provided limited information on the genetic etiology and underlying biological mechanisms of the disorder. We conducted a GWAS meta-analysis combining 53,660 OCD cases and 2,044,417 controls from 28 European-ancestry cohorts revealing 30 independent genome-wide significant SNPs and a SNP-based heritability of 6.7%. Separate GWAS for clinical, biobank, comorbid, and self-report sub-groups found no evidence of sample ascertainment impacting our results. Functional and positional QTL gene-based approaches identified 249 significant candidate risk genes for OCD, of which 25 were identified as putatively causal, highlighting WDR6, DALRD3, CTNND1 and genes in the MHC region. Tissue and single-cell enrichment analyses highlighted hippocampal and cortical excitatory neurons, along with D1- and D2-type dopamine receptor-containing medium spiny neurons, as playing a role in OCD risk. OCD displayed significant genetic correlations with 65 out of 112 examined phenotypes. Notably, it showed positive genetic correlations with all included psychiatric phenotypes, in particular anxiety, depression, anorexia nervosa, and Tourette syndrome, and negative correlations with a subset of the included autoimmune disorders, educational attainment, and body mass index.. This study marks a significant step toward unraveling its genetic landscape and advances understanding of OCD genetics, providing a foundation for future interventions to address this debilitating disorder.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Llonga, Natalia|||0000-0003-4325-6201
  • Arribas, Lorena|||0000-0002-9683-9999
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Demontis, Ditte|||0000-0001-9124-2766
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Soler Artigas, María|||0000-0002-3213-1107
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Biological basis of extensive pleiotropy between blood traits and cancer risk

  • Pardo-Cea, Miguel Ángel|||0000-0003-4823-6613
  • Farré Ramon, Xavier|||0000-0001-6838-9479
  • Esteve, Anna|||0000-0002-1962-971X
  • Palade, Joanna
  • Espín, Roderic
  • Mateo, Francesca|||0000-0002-2342-7010
  • Alsop, Eric
  • Alorda, Marc
  • Blay, Natalia|||0000-0002-7160-8529
  • Baiges, Alexandra
  • Shabbir, Arzoo
  • Comellas, Francesc|||0000-0003-4523-0240
  • Gómez Moruno, Antonio
  • Arnan, Montserrat
  • Teule, Alex|||0000-0003-0028-7200
  • Salinas, Monica
  • Berrocal, Laura
  • Brunet, Joan|||0000-0003-1945-3512
  • Rofes, Paula|||0000-0001-6045-7879
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Conesa, Miquel
  • Rojas, Juan Jose
  • Velten, Lars
  • Fendler, Wojciech
  • Smyczynska, Urszula
  • Chowdhury, Dipanjan
  • Zeng, Yong
  • He, Housheng Hansen
  • Li, Rong
  • Van Keuren-Jensen, Kendall
  • de Cid, Rafael|||0000-0003-3579-6777
  • Pujana, Miguel Angel|||0000-0003-3222-4044
Background: The immune system has a central role in preventing carcinogenesis. Alteration of systemic immune cell levels may increase cancer risk. However, the extent to which common genetic variation influences blood traits and cancer risk remains largely undetermined. Here, we identify pleiotropic variants and predict their underlying molecular and cellular alterations. Methods: Multivariate Cox regression was used to evaluate associations between blood traits and cancer diagnosis in cases in the UK Biobank. Shared genetic variants were identified from the summary statistics of the genome-wide association studies of 27 blood traits and 27 cancer types and subtypes, applying the conditional/conjunctional false-discovery rate approach. Analysis of genomic positions, expression quantitative trait loci, enhancers, regulatory marks, functionally defined gene sets, and bulk- and single-cell expression profiles predicted the biological impact of pleiotropic variants. Plasma small RNAs were sequenced to assess association with cancer diagnosis. Results: The study identified 4093 common genetic variants, involving 1248 gene loci, that contributed to blood-cancer pleiotropism. Genomic hotspots of pleiotropism include chromosomal regions 5p15-TERT and 6p21-HLA. Genes whose products are involved in regulating telomere length are found to be enriched in pleiotropic variants. Pleiotropic gene candidates are frequently linked to transcriptional programs that regulate hematopoiesis and define progenitor cell states of immune system development. Perturbation of the myeloid lineage is indicated by pleiotropic associations with defined master regulators and cell alterations. Eosinophil count is inversely associated with cancer risk. A high frequency of pleiotropic associations is also centered on the regulation of small noncoding Y-RNAs. Predicted pleiotropic Y-RNAs show specific regulatory marks and are overabundant in the normal tissue and blood of cancer patients. Analysis of plasma small RNAs in women who developed breast cancer indicates there is an overabundance of Y-RNA preceding neoplasm diagnosis. Conclusions: This study reveals extensive pleiotropism between blood traits and cancer risk. Pleiotropism is linked to factors and processes involved in hematopoietic development and immune system function, including components of the major histocompatibility complexes, and regulators of telomere length and myeloid lineage. Deregulation of Y-RNAs is also associated with pleiotropism. Overexpression of these elements might indicate increased cancer risk.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

  • Vega-Garcia, Nerea
  • Benito, Rocío
  • Esperanza-Cebollada, Elena
  • Llop, Marta
  • Robledo, Cristina
  • Vicente-Garcés, Clara
  • Ortega Blanco, Margarita
Leucèmia limfoblàstica aguda infantil; Seqüenciació de nova generació, Leucemia linfoblástica aguda infantil; Secuenciación de nueva generación, Childhood acute lymphoblastic leukemia; Next-generation sequencing, The development of Next-Generation Sequencing (NGS) has provided useful diagnostic, prognostic, and therapeutic strategies for individualized management of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) patients. Consequently, NGS is rapidly being established in clinical practice. However, the technology’s complexity, bioinformatics analysis, and the different available options difficult a broad consensus between different laboratories in its daily routine introduction. This collaborative study among Spanish centers was aimed to assess the feasibility, pros, and cons of our customized panel and other commercial alternatives of NGS-targeted approaches. The custom panel was tested in three different sequencing centers. We used the same samples to assess other commercial panels (OncomineTM Childhood Cancer Research Assay; Archer®FusionPlex® ALL, and Human Comprehensive Cancer Panel GeneRead Panel v2®). Overall, the panels showed a good performance in different centers and platforms, but each NGS approach presented some issues, as well as pros and cons. Moreover, a previous consensus on the analysis and reporting following international guidelines would be preferable to improve the concordance in results among centers. Our study shows the challenges posed by NGS methodology and the need to consider several aspects of the chosen NGS-targeted approach and reach a consensus before implementing it in daily practice., This study has been supported by a grant from “Fundación Unoentrecienmil”; grants from Instituto de Salud Carlos III (PI12/02417; PI16/00246; PI12/00816; PI16CIII/00026; PI16/0665); Asociación Pablo Ugarte (TPY-M 1149/13; TRPV 205/18), ASION (TVP 141/17); Fundación Sonrisa de Alex & Todos somos Iván (TVP 1324/15); Consejería de Educación, Junta de Castilla y León (SA271P18); Fondos FEDER (CIBERONC [CB16/12/00284]), Proyectos de Investigación del SACYL, GRS 1847/A/18, Generalitat Valenciana GV2019/077 and Fundación AMPILE. J.M.H.S. is supported with a research grant by FEHH (“Fundación Española de Hematología y Hemoterapia”), A.M. a grant from Junta provincial de Salamanca de la Asociación Española Contra el Cáncer (AECC), and M.M. holds the grant “Ayuda predoctoral de la Junta de Castilla y León” by the Fondo Social Europeo (JCYL-EDU/556/2019 Ph.D. scholarship).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Bosch, Rosa
  • Carabí-Gassol, Pau
  • MACÍAS CHIMBORAZO, VALERIA
  • Español Martin, Gemma
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Attention-deficit/hyperactivity disorder; Autism spectrum disorder; School performance, Trastorn per dèficit d'atenció i hiperactivitat; Trastorn de l'espectre autista; Rendiment escolar, Trastorno por déficit de atención e hiperactividad; Trastorno del espectro autista; Rendimiento escolar, Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404, PI23/00026 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Network Center for Biomedical Research (CIBER) to J.C.D.; the European Regional Development Fund (ERDF); the ECNP Network ‘ADHD across the Lifespan’; “la Marató de TV3” (202228-30 and 202228-31), “Fundació ‘la Caixa’, Diputació de Barcelona, Pla Estratègic de Recerca i Innovació en Salut” (PERISSLT006/17/285); “Fundació Privada d’Investigació Sant Pau” (FISP); and Ministry of Health of Generalitat de Catalunya.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Machine learning-based health environmental-clinical risk scores in European children

  • Guimbaud, Jean-Baptiste
  • Siskos, Alexandros
  • Sakhi, Amrit Kaur
  • Heude, Barbara
  • Sabidó, Eduard
  • Borràs, Eva
  • Alemany, Silvia
Environmental exposure; Machine learning; European children, Exposición ambiental; Aprenentatge automàtic; Nens europeus, Exposición ambiental; Aprendizaje automático; Niños europeos, Background Early life environmental stressors play an important role in the development of multiple chronic disorders. Previous studies that used environmental risk scores (ERS) to assess the cumulative impact of environmental exposures on health are limited by the diversity of exposures included, especially for early life determinants. We used machine learning methods to build early life exposome risk scores for three health outcomes using environmental, molecular, and clinical data. Methods In this study, we analyzed data from 1622 mother-child pairs from the HELIX European birth cohorts, using over 300 environmental, 100 child peripheral, and 18 mother-child clinical markers to compute environmental-clinical risk scores (ECRS) for child behavioral difficulties, metabolic syndrome, and lung function. ECRS were computed using LASSO, Random Forest and XGBoost. XGBoost ECRS were selected to extract local feature contributions using Shapley values and derive feature importance and interactions. Results ECRS captured 13%, 50% and 4% of the variance in mental, cardiometabolic, and respiratory health, respectively. We observed no significant differences in predictive performances between the above-mentioned methods.The most important predictive features were maternal stress, noise, and lifestyle exposures for mental health; proteome (mainly IL1B) and metabolome features for cardiometabolic health; child BMI and urine metabolites for respiratory health. Conclusions Besides their usefulness for epidemiological research, our risk scores show great potential to capture holistic individual level non-hereditary risk associations that can inform practitioners about actionable factors of high-risk children. As in the post-genetic era personalized prevention medicine will focus more and more on modifiable factors, we believe that such integrative approaches will be instrumental in shaping future healthcare paradigms., The authors would like to thank all the participating children, parents, practitioners, and researchers in the six countries who took part in this study. The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. We also acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, and the CERCA Programme / Generalitat de Catalunya. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is supported by “Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya” (2021SGR01225 and 2021SGR01563). This project was funded by the H2020-EU.3.1.2.—Preventing Disease Programme under grant agreement no 874583 (ATHLETE project). JB Guimbaud was supported by a CIFRE PhD fellowship (#2020/1297). Léa Maitre is funded by a Juan de la Cierva-Incorporación fellowship (IJC2018-035394-I) awarded by the Spanish Ministerio de Economía, Industria y Competitividad. ISGlobal and the Exposome hub acknowledges support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. Jose Urquiza is supported by Catalan program PERIS (Ref.: SLT017/20/000119), granted by Departament de Salut de la Generalitat de Catalunya (Spain). Oliver Robinson was funded by the UK Research and Innovation Future Leaders Fellowship (MR/S03532X/1). Silvia Alemany holds a Miquel Servet-I contract (CP22/00026) awarded by the Instituto de Salud Carlos III co-funded by the European Union Found: Fondo Social Europeo Plus, FSE + . Mónica López-Vicente is funded by a Juan de la Cierva-Incorporación fellowship (project IJC2020-045355-I, funded by MCIN/AEI/10.13039/501100011033 and for the European Union NextGenerationEU/PRTR). The data of the cohorts (BiB, EDEN, INMA, KANC, MoBa and RHEA) provided to this research leading to these results has received funding from the European Community’s Seventh Framework Programme (FP7/2007‐2013) under grant agreement no 308333—the HELIX project. Fig. 2 was created with BioRender.com.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

  • GRAU-LÓPEZ, LARA
  • Daigre, Constanza
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Heterogeneity; Substance use disorder; Genome, Heterogeneidad; Trastorno por consumo de sustancias; Genoma, Heterogeneïtat; Trastorn per consum de substàncies; Genoma, Substance use disorder (SUD) is a global health problem with a significant impact on individuals and society. The presentation of SUD is diverse, involving various substances, ages at onset, comorbid conditions, and disease trajectories. Current treatments for SUD struggle to address this heterogeneity, resulting in high relapse rates. SUD often co-occurs with other psychiatric and mental health-related conditions that contribute to the heterogeneity of the disorder and predispose to adverse disease trajectories. Family and genetic studies highlight the role of genetic and environmental factors in the course of SUD, and point to a shared genetic liability between SUDs and comorbid psychopathology. In this study, we aimed to disentangle SUD heterogeneity using a deeply phenotyped SUD cohort and polygenic scores (PGSs) for psychiatric disorders and related traits. We explored associations between PGSs and various SUD-related phenotypes, as well as PGS-environment interactions using information on lifetime emotional, physical, and/or sexual abuse. Our results identify clusters of individuals who exhibit differences in their phenotypic profile and reveal different patterns of associations between SUD-related phenotypes and the genetic liability for mental health-related traits, which may help explain part of the heterogeneity observed in SUD. In our SUD sample, we found associations linking the genetic liability for attention-deficit hyperactivity disorder (ADHD) with lower educational attainment, the genetic liability for post-traumatic stress disorder (PTSD) with higher rates of unemployment, the genetic liability for educational attainment with lower rates of criminal records and unemployment, and the genetic liability for well-being with lower rates of outpatient treatments and fewer problems related to family and social relationships. We also found evidence of PGS-environment interactions showing that genetic liability for suicide attempts worsened the psychiatric status in SUD individuals with a history of emotional physical and/or sexual abuse. Collectively, these data contribute to a better understanding of the role of genetic liability for mental health-related conditions and adverse life experiences in SUD heterogeneity., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840 and 2021-SGR-01093), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to M.S.A, RYC2021-031324-I to J.C.D and PID2021-1277760B-I100 to B.C. and N.F-C.), the Ministry of Health, Social Services and Equality (PNSD-2020I042 to N.F-C.), the Network Center for Biomedical Research (CIBER) to J.C.D., the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’, “Fundació La Marató de TV3” (202228-30, 202228-31 and 202218-31) and ICREA Academia 2021.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Arribas, Lorena
  • Demontis, Ditte
  • Cabana-Dominguez, Judit
  • Llonga, Natalia
  • Alemany, Silvia
  • Vilar-Ribo, Laura
  • Fadeuilhe, Christian
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Soler Artigas, María
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Transcriptomic risk scores; Attention deficit and hyperactivity disorder, Puntuaciones de riesgo transcriptómico; Trastorno por déficit de atención e hiperactividad, Puntuació de risc transcriptòmic; Trastorn per dèficit d'atenció i hiperactivitat, Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus (FSE+) (P19/01224, PI20/00041, PI22/00464 and FI18/00285 to LVR, CP22/00128 to MSA and CP22/00026 to SA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD), the Network Center for Biomedical Research (CIBER) to JCD, the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’ and the “la Marató de TV3” (202228-30 and 202228-31). ADB was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003) and NIH/NIMH (1R01MH124851-01). DD was supported by the Novo Nordisk Foundation (NNF20OC0065561) and the Lundbeck Foundation (R344-2020-1060).